The best science rarely happens in isolation.
Today at #sfn26, we’re sharing work developed with Leica on High-Plex Spatial Proteomics and AI-Based Image Analysis Reveal Multicellular Architecture of Alzheimer’s Disease Human Tissue.
If you’re exploring spatial proteomics, stop by poster session PSTR204 at 1 pm to learn more and talk to the team behind the work.
#neuroscience2026 #scientificresearch
Abcam
Abcam Limited is a producer, distributor and seller of protein research tools operating worldwide from 13 locations with 1,800 employees of which 400 work in Research and Development (R&D). Abcam was listed on the Nasdaq and the London Stock Exchange until it was acquired by Danaher Corporation in 2023. More on Wikipedia
-
Abcam
@abcam
-
Abcam
@abcam
Want increased sensitivity and a broader measuring range, with results in just 55 minutes?
Join Eric Swanson at #sfn26 today to discover how SimpleStep ELISA Ignite™ can help you get more from your immunoassays.
🕝 2.00 pm
📍 Focused Theater 1
Come along and discover what SimpleStep ELISA Ignite™ could bring to your research.
#neuroscience #sfn26 -
Abcam
@abcam
Sometimes a different perspective changes what you see.
Thanks to everyone who joined us at the Museum of Illusions during #sfn26 for an evening of curiosity, conversation, and a few unexpected perspectives.
Now, let’s see what comes next.
#neuroscience #museumofillusions -
Abcam
@abcam
Another day of neuroscience ahead.
Today at #sfn26:
🧠 Behind the Science at 11.00 am, 1.30 pm, and 3.30 pm
🎤 Eric Swanson on “Revolutionizing ELISA: SimpleStep Ignite™ ELISA: faster, broader, more sensitive” at 2.30 pm
🔬 Meet our team at booth 1509
Want to talk through your research with one of our experts? Sign up to meet the team: events.abcam.com/event/Neuroscience2026/summary
#neuroscience #sfn26 -
Abcam
@abcam
Brain-teasing questions tackled. Lab coat secured. 🧠🥼
Another round of Behind the Science is complete at #sfn26.
Congratulations to the winners!
Fancy joining the fun? We’re back tomorrow at 11.00 am, 1.30 pm, and 3.30 pm at booth 1509.
Come along to play, learn, and connect with fellow neuroscience researchers.
👉 See what else is happening at SfN: events.abcam.com/event/Neuroscience2026/summary
#neuroscience #sfn26 -
Abcam
@abcam
What happens next depends on certainty.
Join us tonight at the Museum of Illusions for an evening with the neuroscience community away from the conference floor.
📍 Museum of Illusions, 927 H St NW
🕖 7.00–9.00 pm
🎟️ Reserve your place: events.abcam.com/event/Neuroscience2026/register
See you there.
#sfn26 #neuroscience -
Abcam
@abcam
What happens Behind the Science? 🧠
Come and find out at #sfn26 with our interactive neuroscience trivia at booth 1509.
Three chances to play today:
11.00 am
1.30 pm
3.30 pm
Stop by to play, learn, and celebrate the discoveries that make future breakthroughs possible.
👉 Discover what else is happening at SfN and connect with our scientific experts: www.abcam.com/en-us/events/neuroscience-2026
#sfn26 #neuroscience -
Abcam
@abcam
Questions about your neuroscience research?
Let’s talk.
Our team is at #sfn26 to share scientific expertise, discuss your research, and help you find the right tools for what comes next.
👉 See what’s happening at the booth and connect with our scientific experts:
www.abcam.com/en-us/events/neuroscience-2026
📍 Booth 1509
Come and meet us.
#neuroscience2026 #lifescience -
Abcam
@abcam
What happens next depends on certainty.
What you see can change with your perspective. But in science, progress depends on the evidence behind it.
Tomorrow, join us at the Museum of Illusions for perception, truth, and the science of certainty during #sfn26.
📍 927 H St NW, Washington, DC
🕖 7.00 pm
👉 Register now for free: www.abcam.com/en-us/events/neuroscience-2026 -
Abcam
@abcam
🧪 At #sfn26 today?
Stop by poster LL5 to meet Eric Swanson and learn more about SimpleStep Ignite™ ELISA, our 55-minute chemiluminescent ELISA platform.
📍 Poster LL5
🕐 1–5 PM
Come along, take a closer look, and chat with Eric about the science behind it.
#neuroscience2026 #research #sfn26 -
Abcam
@abcam
The doors are open at #sfn26.
Over the next few days, we’ll share science from across the meeting, talk with researchers, and explore the questions shaping what comes next in neuroscience.
If you’re here, come and meet our scientific experts at booth 1509. Talk to us about your research, the challenges you’re working through, and the tools and technologies that could help.
👉 Find out what’s happening at SfN and connect with our team: www.abcam.com/en-us/events/neuroscience-2026
📍 Booth 1509
#neuroscience2026 #lifescience -
Abcam
@abcam
Neuroscience is always moving forward. And so are we.
We’re heading to #sfn26 for five days of new ideas, new conversations, and plenty of neuroscience.
Follow along for highlights from the science, the people behind it, and everything happening at the Abcam booth.
📍 Booth 1509
#neuroscience2026 #sfn26 -
Abcam
@abcam
Looking for your next science stop at SfN? 🔬
Come check out our SimpleStep™ Ignite poster and discover how a 55-minute chemiluminescent ELISA platform can deliver a broader range, faster results, and more sensitive quantification.
Pop by for a quick chat. You might just walk away with a new idea, a new perspective, or something worth exploring back in the lab.
🧠 Come curious. Leave with something new to think about.
Learn more: events.abcam.com/event/Neuroscience2026/summary
#sfn2026 #neuroscience #elisa #abcam -
Abcam
@abcam
☕ Another stop on the UNFiltered journey!
Thank you to everyone who joined us at the Old Campus Atrium, University of Oxford, for coffee and conversation, and shared their research experiences and insights with the Abcam team. Here are a few highlights from the day.
There’s plenty more to come. See where UNFiltered is heading next and join us at an upcoming event near you.
Explore upcoming events: events.abcam.com/event/UNFiltered/home
#unfiltered #lifescienceresearch -
Abcam
@abcam
What sits behind evidence researchers can rely on?
For Will Howat, Vice President of Validation and Technical Quality at Abcam, it begins with quality and validation.
As the recipient of the 2026 CiteAb Significant Individual Impact Award, Will has spent 35 years working in immunochemistry. In this new video series, he explores antibody specificity, reproducibility, validation, and the evidence behind reliable scientific results.
Watch the video: www.abcam.com/en-us/about/quality-innovation-collaboratio…
#antibodyvalidation #scientificresearch #reproducibility #lifescience #progresshappenstogether -
Abcam
@abcam
📍Heading to the London Biotech Show?
Join Padamjeet Singh and Georgia Godwin as they connect with the biotech community at the London Biotech Show.
What happens next depends on the science behind it.
We’re looking forward to conversations about what helps researchers keep the science moving forward, from evidence they can rely on to the expertise and new approaches behind the next decision.
Get in touch with the team: go.myabcam.com/account-manager-enquiry
#abcam #londonbiotechshow #biotech #lifesciences #lifescienceresearch -
Abcam
@abcam
A result is rarely the end of the story.
It can shape the next experiment, strengthen a publication, or lead research in an entirely new direction.
That is why every choice matters. Starting with dependable evidence and reproducible performance gives you greater confidence in your data and a stronger foundation for whatever comes next.
Start with evidence you can trust.
Discover the evidence: www.abcam.com/en-us/about/quality-innovation-collaboratio… -
Abcam
@abcam
What could the next generation of ELISA bring to your research?
Join us at SfN for our Focused Theater talk exploring SimpleStep ELISA® technology, innovations in high-throughput immunoassays, and the new chemiluminescent SimpleStep ELISA Ignite™.
We’ll look at how these technologies can help tackle research challenges while improving efficiency in your workflow.
👉 Learn more and plan your day at SFN: events.abcam.com/event/Neuroscience2026/summary
#sfn26 #neuroscience #elisa -
Abcam
@abcam
SfN is almost here, and Booth 1509 is just the beginning. 🧠
From conversations with our experts and a chance to test your neuro knowledge to our scientific poster, product theater talk, and an exclusive evening at the Museum of Illusions, there’s more to discover at SfN this year.
📍 Join us at Booth 1509 and see where the conversation takes you. Learn more and register now for our event: events.abcam.com/event/Neuroscience2026/summary
#sfn26 #neuroscience #abcam -
Abcam
@abcam
Join us for the next InflammaZoom session on November 23, 2026. There's still time to register and be part of the discussion.
Hear from:
✔️Ryan Gaudet (Columbia University) on 'Organelle communication as a target and regulator of the interferon response'
✔️Jonathan Pruneda (Oregon Health & Science University) on 'Studying ubiquitin signaling through the lens of human pathogens'
Chaired by Eva Frickel (University of Birmingham), this session brings together leading researchers to share discoveries and advance discussions in innate immune research.
Register now: events.abcam.com/event/Inflammazoom2026/home -
Abcam
@abcam
Know that every batch performs exactly as expected.
We provide clear evidence of specificity and reproducible performance, so every lab and every stage of your program can keep building on the same science.
Recombinant manufacture and biophysical quality control (our batch-level molecular identity verification) ensure batch-to-batch specificity and consistency, helping you avoid wasted time revalidating reagents and antibodies or questioning earlier results as your program scales.
Discover the evidence: www.abcam.com/en-us/about/quality-innovation-collaboratio… -
Abcam
@abcam
How specific is your ILT4 signal?
The extracellular domains of leukocyte immunoglobulin-like receptor family members share high sequence homology, which can increase the risk of antibody cross-reactivity.
Improve confidence in your results with Anti-ILT4 antibody [EPR29046-643] (ab327056), the first recombinant monoclonal antibody on the market with extensive IHC-P validation for ILT4/LILRB2.
Tested in relevant human tumor models and validated not to cross-react with seven related LILR-family receptors, use it to identify ILT4-positive immunosuppressive myeloid populations and investigate their role in the tumor microenvironment.
Explore ab327056: www.abcam.com/en-us/products/primary-antibodies/ilt-4-ant…
#npi #ilt4 #lilrb2 #myeloidbiology #immunooncology -
Abcam
@abcam
📍Heading to Lab Innovations in Birmingham?
Join our associates Maria Sanchez and Georgia Godwin as they connect with the laboratory community at Lab Innovations.
We’re looking forward to conversations about the tools, ideas, and innovations shaping the future of laboratory research.
See you in Birmingham!
Learn more: www.lab-innovations.com
#abcam #labinnovations #lifesciences #lifescienceresearch #laboratory -
Abcam
@abcam
Start with evidence you can trust.
Our validation is transparent, independent, and verifiable, helping you generate data you can publish, defend, and build on.
With more than 4,900 knockout-validated antibodies, extensive application testing, customer reviews, and independent YCharOS testing, you can assess the evidence before committing time and budget.
Discover the evidence: www.abcam.com/en-us/about/quality-innovation-collaboratio… -
Abcam
@abcam
More expertise behind your research.
We were delighted to welcome Antibody Champions to the Abcam headquarters in Cambridge as part of the Only Good Antibody and NC3Rs initiative.
Researchers, scientists, and antibody experts came together to exchange knowledge and perspectives on antibody quality, validation, reproducibility, and scientific rigor.
It’s exactly the kind of collaboration we believe can move science forward. Through our work with Only Good Antibodies, we’re helping bring expertise from across the scientific community together around the future of antibody validation.
Thank you to everyone who took part and shared their expertise. When we draw on knowledge beyond our own labs, we can build stronger evidence and greater confidence in the results that research depends on.
Progress happens together.
Learn more: www.abcam.com/en-us/about/quality-innovation-collaboratio…
#onlygoodantibodies #antibodyvalidation #reproducibility #lifesciences #researchtools #scientificresearchThis media couldn't be displayed. See it on the original post. -
Abcam
@abcam
Progress depends on everything behind the result.
The quality that builds confidence. The innovation that expands what's possible. The scientific expertise and support that help turn a challenge into a discovery.
At Abcam, we focus on the science behind each result, helping researchers move from one trusted answer to the next.
Because whatever biology you are exploring, we’re here to support it.
Discover the evidence: www.abcam.com/en-us/about/quality-innovation-collaboratio… -
Abcam
@abcam
🧠 Attending #sfn2026? Join us for an exclusive evening at the Museum of Illusions.
Explore mind-bending exhibits, connect with fellow neuroscience researchers, and enjoy an evening of networking, conversation, and discovery in a setting that challenges perception and sparks curiosity. The event brings together the neuroscience community for an unforgettable experience beyond the convention center.
What happens next depends on certainty.
✨ Free to attend. Space is limited, so register now to reserve your spot.
Learn more: events.abcam.com/event/Neuroscience2026/summary -
Abcam
@abcam
Every result is a moment of possibility.
It can unlock the next experiment, inform the next decision, or open the path to the next discovery.
Progress depends on confidence in what came before. The validation behind the reagent. The consistency behind the result. The reproducibility behind the conclusion.
Because when the science stands up, what happens next can move forward.
Start with evidence you can depend on.
Discover the evidence: www.abcam.com/en-us/about/quality-innovation-collaboratio… -
Abcam
@abcam
Join us for the next InflammaZoom session on October 27, 2026. There's still time to register and be part of the discussion.
Hear from:
✔️Daniel Fisch (Gulbenkian Institute for Molecular Medicine (GIMM)) on 'Building Myddosomes: Innate Immune Signaling Organelles in the TLR Pathway'
✔️Isabella Rauch (Oregon Health & Science University) on 'Eicosanoid signals in inflammasome-induced intestinal epithelial cell extrusion'
Chaired by Avinash Shenoy (Imperial College London), this session brings together leading researchers to share discoveries and advance discussions in innate immune research.
Register now: events.abcam.com/event/Inflammazoom2026/home -
Abcam
@abcam
High-quality spatial biology starts with antibodies you can trust.
That’s why we’re collaborating with RareCyte to bring rigorously validated antibodies to the Orion™ spatial proteomics platform, helping researchers build multiplex panels with greater confidence.
Our focus is on:
✔️IHC-first validation to de-risk specificity, sensitivity, and lot-to-lot consistency in tissue workflows.
✔️Multiplex-ready performance for complex panel development.
✔️Reliable performance on Orion to support translational research workflows.
Through our collaboration, we're helping researchers identify antibody options that have been evaluated for use on Orion, making panel development more efficient and reproducible.
Interested in validated antibody options for Orion panel development? Let’s connect 👉 www.abcam.com/en-us/partner-with-us
Read more about our collaboration here: www.abcam.com/en-us/stories/articles/orion-spatial-proteo…
#spatialbiology #translationalresearch #ihc #biomarkers #multipleximaging
#immunofluorescence #orion #rarecyte #abcam -
Abcam
@abcam
☕ Introducing the UNFiltered Tour!
Over the coming months, our team will be visiting research institutions across North America and Europe with a simple invitation:
Insights from you, coffee on us.
Join us for free coffee, conversations about your research, and a chance to share ideas that help shape how we support scientists around the world.
Find out when the UNFiltered Tour is coming to your campus and reserve your spot today: events.abcam.com/event/UNFiltered/home
#unfiltered #lifescience #researchcommunity -
Abcam
@abcam
The countdown to ELRIG Drug Discovery 2026 is on.
We're excited to be exhibiting at Europe's premier drug discovery and life sciences conference as ELRIG celebrates 20 years of advancing scientific collaboration and innovation.
Visit us at Booth J24 to meet our team, discuss your research goals and challenges, and discover how SimpleStep ELISA Ignite™ can accelerate assay workflows with results in as little as 55 minutes, delivering 50x greater sensitivity and up to 35x broader measuring range than a traditional ELISA.
Whether you're focused on target validation, biomarker discovery, or translational research, our scientific experts will be on hand to share insights, answer questions, and help move your research forward.
Learn more: events.abcam.com/event/ELRIG/summary
#abcam #elrig2026 #drugdiscovery -
Abcam
@abcam
Discover everything Abcam has planned for #sfn2026
🎭 Step into the unexpected at our exclusive evening event at the Museum of Illusions, where perception, truth, and the science of certainty take center stage.
🧠 Test your neuro knowledge in our interactive trivia sessions at Booth 1509
🔬 Explore emerging neuroscience research through our scientific poster
🎤 Join our Product Theater presentation to discover tools and solutions designed to support neuroscience research
🤝 Connect with our scientific support team for conversations that can help move your research forward
Learn more, register for the Museum of Illusions event, and plan your SfN experience ➡️ events.abcam.com/event/Neuroscience2026/summary
#neuroscience2026 #neuroscience #lifescience #research -
Abcam
@abcam
📅 There's still time to be part of the discussion
We're excited to welcome Rebecca Heald (University of California, Berkeley) as the keynote speaker for the October Digital Cell Cycle Club, where she'll present: "Hopping Around the Cell Cycle in Xenopus"
In addition to the keynote, the event features short research talks and interactive breakout sessions designed to encourage discussion, idea sharing, and connections across the cell cycle community.
Save your spot today: events.abcam.com/event/CellCycleClub-Oct2026/home
#cellcycle #cellbiology #xenopus #lifescience #researchcommunity -
Abcam
@abcam
Heading to the Ludwig Oxford TEE Meeting this October?
Join our associates Maria Sanchez and Kundan Sharma as they connect with researchers exploring the latest developments in transcription, epigenetics, and epitranscriptomics.
We're excited to support scientists working to better understand the mechanisms that drive health and disease.
See you in Oxford on October 7-8.
Learn more: www.ludwig.ox.ac.uk/seminars-and-events/Ludwig-Oxford-events
#abcam #epigenetics #transcription #generegulation #rnabiology #lifescienceresearch -
Abcam
@abcam
How do you achieve greater ELISA sensitivity and a wider dynamic range without compromising workflow speed?
In this Nature article, our team explains how our next-generation chemiluminescent ELISA, SimpleStep Ignite™, delivers up to 35x broader measuring range and 50x greater sensitivity, helping researchers reduce reruns and generate data faster.
Read the article below.
www.nature.com/articles/d42473-026-00121-5
#elisa #biopharma #drugdiscovery #lifescienceresearch -
Abcam
@abcam
📅 Save the date for our next InflammaZoom session
The conversation continues on October 27, 2026, as we bring together immunologists from around the world to explore the latest advances in innate immunity and inflammasome biology.
We're excited to welcome:
🔬 Daniel Fisch, Gulbenkian Institute for Molecular Medicine, PT
🔬 Isabella Rauch, Oregon Health & Science University, USA
Join the discussion, connect with fellow researchers, and gain insights from leading experts in the field.
Register for free and reserve your spot ➡️ events.abcam.com/event/Inflammazoom2026/home
#inflammazoom #immunology #inflammation #innateimmunity -
Abcam
@abcam
Abcam is excited to join the neuroscience community in Washington, DC, for a week of discovery, collaboration, and conversations that help drive research forward.
We have so much in store for this year's #sfn2026. From an exclusive evening at the Museum of Illusions exploring perception, truth, and the science of certainty to scientific posters, a product theater presentation, and interactive neuro trivia at Booth 1509, there's plenty to discover throughout the meeting.
Plan your #sfn2026 experience. Learn more and register now ➡️ events.abcam.com/event/Neuroscience2026/summary -
Abcam
@abcam
🧬 Join our next InflammaZoom webinar for an exclusive opportunity to hear from keynote speakers Iain Fraser (NIAID/NIH) and Venkat Magupalli (New York Blood Center Enterprises).
Discover the latest research in innate immunity and inflammasome biology as these leading investigators share new insights into the mechanisms that regulate inflammation and immune responses.
🎤 Iain Fraser will present "Metabolomic investigation of macrophage priming and inflammasome triggering; identification of critical nodes for pyroptosis licensing and IL-1 release."
🎤 Venkat Magupalli will present "Spatial control of IL-1β maturation by the inflammasome adaptor ASC."
📅 September 28, 2026
⏰ 1:00 PM BST | 8:00 AM ET
🎟️ Free registration: events.abcam.com/event/Inflammazoom2026/home
#immunology #innateimmunity #inflammasome #inflammationresearch -
Abcam
@abcam
🧠 Explore the latest advances in brain aging and neurodegeneration research
Join chairs Yimin Zou (UC San Diego) and Kang Shen (Stanford University) as they bring together 22 leading researchers to share new discoveries and perspectives on the mechanisms underlying brain aging and neurodegenerative disease. Connect with fellow neuroscientists, discover emerging ideas, and gain insights from experts advancing the field.
Be a part of the conversation by submitting a poster abstract and sharing your latest research with the neuroscience community. Abstract submissions close November 20.
👉 Learn more and register: events.abcam.com/event/BrainAgingAndDegeneration/home -
Abcam
@abcam
📍 Heading to the European Society for Spatial Biology Conference? Let's connect.
We're excited to be attending the upcoming ESSB Conference and look forward to connecting with the community shaping the future of spatial biology.
From September 28 to October 1, you can meet with our associates Marco Kirchenwitz and Monica Vilhelmsson, who would be delighted to discuss your research, challenges, and goals.
We're particularly looking forward to engaging with researchers interested in recombinant antibodies and IHC-validated carrier-free antibodies, and discussing how these tools can help support reliable, reproducible spatial biology workflows.
Plus, don't miss your chance to win a free antibody every day of the event. We'll be running a daily raffle throughout the conference, so be sure to stop by, meet the team, and enter for your opportunity to win.
If you're interested in advancing your spatial biology research or learning more about our solutions, come and say hello.
📅 Book a slot to connect with the team bookings.cloud.microsoft/bookwithme/user/ff3a3a151d584327…
#spatialbiology #recombinantantibodies #ihc #immunohistochemistry #antibodies #lifescienceresearch -
Abcam
@abcam
World Alzheimer's Day | September 21
Every advance in Alzheimer's research starts with scientists asking better questions about the biology of the disease.
This World Alzheimer's Day, we're recognizing the researchers working to deepen our understanding of Alzheimer's disease, from amyloid-β and tau pathology to neuroinflammation and emerging biomarkers.
By generating reliable data and uncovering new insights, researchers are helping drive progress toward earlier detection, improved treatments, and better outcomes for people affected by Alzheimer's disease.
We're proud to support this work with the antibodies, assays, and research tools scientists rely on every day.
Explore Alzheimer's disease research: www.abcam.com/en-us/technical-resources/research-areas/ne…
#worldalzheimersday #alzheimersresearch #neuroscience #biomarkers #lifesciences #abcam -
Abcam
@abcam
📢 Call for abstracts
Have new insights to share in cell cycle research?
Join the next Digital Cell Cycle Club on October 13, 2026.
We're inviting researchers to submit abstracts for a short presentation or breakout discussion. Share your latest findings, exchange ideas with peers, and connect with a global community of cell cycle researchers.
🔬 Share your research
🎤 Present your work
🤝 Build new collaborations
Submit your abstract today 👉 events.abcam.com/event/CellCycleClub-Oct2026/home
#cellcycleclub #scientificcommunity -
Abcam
@abcam
📍 Going to the Annual Conference of the German Society for Cytometry? We’d love to connect.
We're getting ready for the upcoming DGfZ Annual Conference and are excited to connect with researchers and scientists working at the forefront of flow cytometry.
From September 22-25, you can meet with our associates, Dr. Sinem Milanos and Dr. Marco Kirchenwitz, who would be delighted to discuss your current research, laboratory challenges, and what you're aiming to achieve in the lab.
Whether you're developing multicolor flow cytometry panels, optimizing assay performance, or looking for reliable reagents to support your work, we'd love to share how Abcam can help.
We're particularly looking forward to engaging with scientists interested in primary antibodies for flow cytometry, fluorophore-conjugated antibodies, and antibody conjugation kits, and discussing how these tools can support more reliable and efficient research workflows.
If you're interested in advancing your flow cytometry workflows or learning more about our solutions, come and say hello.
Book a slot to connect with the team 👉 Link in bio.
#flowcytometry #cytometry #antibodies #conjugatedantibodies #antibodyconjugation #lifescienceresearch -
Abcam
@abcam
🔬 We're live in Boston for Immunometabolism Across Organs 2026!
Over the next two days, leading researchers will explore how metabolic pathways shape immune responses across tissues, driving discovery in inflammation, cancer, ageing, infection and beyond.
We're excited to bring together experts from across the field to share new insights, spark discussion and accelerate progress in immunometabolism research.
🔗Explore our immunometabolism flow cytometry portfolio and resources: www.abcam.com/en-us/products/product-recommendations/acce… -
Abcam
@abcam
Reliable results start with reliable reagents.
From recombinant monoclonal antibodies with unrivaled batch-to-batch consistency to application-specific validation, our antibody portfolio is designed to help you generate reproducible data with confidence.
For a limited time, buy any 2 primary antibodies and receive a free secondary antibody.*
*T&Cs apply
Claim your offer: www.abcam.com/en-us/campaigns/free-secondary-antibody
#antibodies #lifescience #research #immunology #cellbiology -
Abcam
@abcam
Complex cell populations need clear answers.
Our conjugated antibodies validated for flow cytometry help you generate consistent data, so you can spend less time troubleshooting and more time exploring your immunometabolism research questions.
Discover our flow cytometry solutions: www.abcam.com/en-us/products/product-recommendations/acce…
#abcam #lifescienceresearch #flowcytometry #antibodies #cellanalysis #immunology #scientificresearch #immunometabolism #met-flow -
Abcam
@abcam
Watch the SimpleStep Ignite™ ELISA protocol in action
SimpleStep Ignite™ ELISA is designed to help researchers get sensitive results faster. With 50× greater sensitivity and a measuring range up to 35× broader, you can detect more, even at low concentrations, in a single run.
Unlike traditional ELISAs, SimpleStep Ignite™ combines chemiluminescent detection with a simplified workflow to deliver results in just 55 minutes. With one incubation and one wash step, it’s designed to save hands-on time without disrupting your existing lab setup.
Explore the SimpleStep® ELISA range: www.abcam.com/en-us/products/elisa-kits-and-immunoassays/…
#abcam #elisa #labworkflow #immunoassays #lifescience #researchmethods #biotechThis media couldn't be displayed. See it on the original post. -
Abcam
@abcam
🧬 Join us on October 13 for the next Digital Cell Cycle Club, featuring keynote speaker Rebecca Heald from UC Berkeley.
Connect with researchers from around the world as we explore the latest advances in cell cycle biology through expert presentations, community-driven science, and thought-provoking discussions.
The program will include three community-selected short talks and breakout sessions designed to spark conversation, explore emerging research, and foster new collaborations.
Register for free today and submit your abstract by October 2:
👉 events.abcam.com/event/CellCycleClub-Oct2026/home -
Abcam
@abcam
Accelerating antibody innovation through data-driven science
We're pleased to share our expanded collaboration with Genedata, bringing Genedata Biologics® across Abcam's global R&D organization to strengthen antibody development, enhance data connectivity, and support AI-enabled innovation.
By creating a unified data foundation across our teams in the UK, US, and China, we're improving collaboration, increasing visibility throughout the development process, and helping researchers gain faster access to the high-quality antibodies they depend on.
Together with Genedata, we're building a stronger platform for data-driven discovery, combining scientific expertise, automation, and advanced analytics to accelerate the development of approximately 500 new antibodies every year.
Read more about the collaboration: www.abcam.com/en-us/press-releases/abcam-and-genedata-col…
#antibodies #drugdiscovery #lifesciences #biopharma #scientificinnovation #ai #datascience #researchtools -
Abcam
@abcam
🚨 Final registration call
From tissue-resident immune cells to cross-organ metabolic signaling, immunometabolism is transforming our understanding of health and disease.
Join us in Boston on 14–15 September for Immunometabolism Across Organs and hear from leading researchers sharing the latest breakthroughs and emerging opportunities in the field.
📅 Register by September 7 to secure your place before registration closes.
events.abcam.com/Immunometabolism2026
#immunometabolism #immunology #metabolism #researchconference #boston -
Abcam
@abcam
🧠 Save the Date | Brain Aging and Degeneration Conference
Join us on December 11-12, 2026, at Stanford University for a free, two-day scientific conference that brings together leading researchers to explore the latest advances in neurodegenerative disease research.
Chaired by Yimin Zou (UC San Diego) and Kang Shen (Stanford University), this conference will feature 22 leading speakers who will explore the latest advances in neuroscience research. Through keynote presentations, expert-led sessions, and scientific discussion, attendees will gain insights into:
🔬 Mechanisms driving brain aging and degeneration
⚡ Advances in technology enabling new discoveries
🤝 Opportunities for collaboration across disciplines and institutions
This conference provides a unique opportunity for neuroscientists to connect, exchange ideas, and explore the discoveries and innovations shaping the future of brain aging and neurodegeneration research.
Register now 👉events.abcam.com/event/BrainAgingAndDegeneration/home
#neuroscience #brainaging #neurodegeneration #abcamconference -
Abcam
@abcam
Join us for free on September 28 at 1:00 PM BST for the latest installment of InflammaZoom, the international webinar series dedicated to innate immunity and inflammasome biology.
This session will feature:
✔️Iain Fraser (National Institute of Allergy and Infectious Diseases, NIH)
✔️Venkat Magupalli (New York Blood Center Enterprises)
Established in June 2020 by Professor Clare Bryant, InflammaZoom was created to ensure the continued exchange of groundbreaking science during the pandemic. Today, it remains a vibrant global platform where immunologists connect to share findings, discuss emerging ideas, and foster collaboration.
Register for free today and be part of the conversation shaping the future of immunology. 👉 events.abcam.com/event/Inflammazoom2026/home
#inflammazoom #immunology #innateimmunity #inflammasome -
Abcam
@abcam
Buy 2, Get 1 Free on InstantBlue® Protein Stain
Still spending time fixing, washing, and destaining your gels?
InstantBlue® simplifies protein gel staining with a ready-to-use workflow that delivers clear protein visualization in as little as 15 minutes.
✅ No fixing required
✅ No washing required
✅ No heating required
✅ No destaining required
✅ High-sensitivity protein detection
Buy 2 bottles and get 1 free. The offer is valid until August 31st.
🎟 Use promo code: EMEA-IB3FOR2
Get offer: www.abcam.com/en-us/products/reagents/instantblue-coomass… -
Abcam
@abcam
🔬 Abcam was delighted to support the Helmholtz Summer School on Chromatin Biology: A Hands-On Expedition.
Designed for students and early-career researchers, the program offers a unique opportunity to deepen scientific knowledge, gain practical experience, and connect with leading experts in chromatin biology.
As part of the program, Eleanor Walton, Epigenetics Scientific Lead at Abcam, shared insights into generating robust research data and highlighted how scientists can navigate and advance their careers in the life sciences sector.
We're proud to support educational initiatives that help inspire, educate, and empower the next generation of researchers.
🔗Explore our epigenetics resources and support your next discovery: www.abcam.com/en-us/technical-resources/research-areas/ep…
#helmholtzsummerschool #chromatinbiology #epigenetics #antibodyvalidation #scientificcareers #lifesciences #abcam -
Abcam
@abcam
Two primaries are better than one. Especially when they come with a free secondary antibody.
For a limited time:
✅ Buy any 2 primary antibodies
✅ Get a free secondary antibody*
Whether you're validating targets, exploring pathways, or generating publication-ready data, we're here to help you move your research forward.
Claim offer: www.abcam.com/en-us/campaigns/free-secondary-antibody
*T&Cs apply, learn more: go.myabcam.com/freesecondary
#antibodies #lifescience #research #immunology #cellbiology -
Abcam
@abcam
Get from sample to insight faster
SimpleStep Ignite™ ELISA is designed to help researchers get sensitive results faster, with 50× greater sensitivity and up to 35× broader measuring range.
Unlike traditional ELISAs, SimpleStep Ignite™ uses chemiluminescent detection and a simplified workflow to deliver results in just 55 minutes. With one incubation and one wash step, it’s designed to reduce hands-on time while fitting easily into your existing lab setup.
See the step-by-step protocol in action and follow the workflow from setup to signal in under an hour.
Explore the SimpleStep® ELISA range: www.abcam.com/en-us/products/elisa-kits-and-immunoassays/…
#abcam #elisa #labworkflow #immunoassays #lifescience #researchmethods #biotech -
Abcam
@abcam
🚨Last chance to submit your poster abstract
Today's the deadline to share your research at the Immunometabolism Across Organs Conference in Boston.
Present your latest findings, connect with leading researchers, and join discussions exploring how metabolism shapes immune responses across tissues and organ systems.
📝Poster abstract submissions close today (14 August)
Don't miss your opportunity to showcase your work to the immunometabolism community.
Submit your abstract today: events.abcam.com/event/Immunometabolism2026/home
#immunometabolism #immunology #metabolism #researchcommunity #lifescience -
Abcam
@abcam
Missed our live webinar? Watch it on-demand now
CAR-T cell therapy for blood cancers: Why metabolism matters
Dr Ellen King (Schurich Lab, King’s College London) explores how metabolic pathways shape CAR-T cell function and persistence, and what this means for your research.
In this session, you’ll learn more about:
🔬 Mapping metabolic pathways in immune cells
🧬 The link between metabolism and CAR-T efficacy
📊 Applying tools like Met Flow for single-cell immunometabolism analysis
If you’re working in CAR-T therapy, immunometabolism, or immuno-oncology, this is essential viewing.
▶️ Watch on-demand webinar now: www.abcam.com/en-us/webinars/car-t-cell-therapy-blood-can… -
Abcam
@abcam
⏰ The countdown is on — poster abstract submissions close 14 August!
Got new data, a breakthrough finding, or a novel perspective in immunometabolism?
Share your research at the Immunometabolism Across Organs Conference and join leading experts exploring how metabolism shapes immune responses across tissues and organ systems.
Register now and join us in Boston on September 14-15. Your next collaboration, conversation, or research opportunity could start here.
🔗 events.abcam.com/event/Immunometabolism2026/home
#immunometabolism #immunology #metabolism #researchcommunity #lifescience -
Abcam
@abcam
Sustainable packaging update
📣 We’re excited to share that we’ve taken meaningful steps toward reducing our environmental impact.
📦 If you’re a customer in the America’s and Europe, you might notice that we’ve removed expanded polystyrene (EPS) from blue ice packaging, replacing it with plant-based liners that are fully recyclable along with the shipping box. These are as effective and perform just as well, without the environmental costs associated with EPS.
Our move to paper‑based, recyclable packaging will avoid an estimated 30.6 tons or more per year of expanded polystyrene (EPS) from our shipments, significantly reducing the use of hard‑to‑recycle materials.
Another step towards a more sustainable Abcam. For more information, check out this page: www.abcam.com/en-us/support/shipping-storage-support/sust… -
Abcam
@abcam
We're excited to see our antibodies included in selected Mabtech EYRAplex™ panels, giving researchers access to trusted reagents within a flexible multiplex workflow.
EYRAplex™ is Mabtech's customizable magnetic bead-based multiplex platform, built on Mabtech’s own antibodies and designed to let researchers build biomarker panels tailored to their scientific questions. This collaboration gives the platform added flexibility, letting Mabtech extend the EYRAplex portfolio with select complementary reagents.
At Abcam, we believe partnerships across the industry help accelerate research and open new opportunities for the scientific community.
We're proud to support Mabtech as they expand the EYRAplex portfolio and help researchers generate meaningful insights from biomarker research and multiplex analysis.
Learn more:
🔗 EYRAplex www.mabtech.com/products-and-services/kits/eyraplex
🔗 Partner with Abcam www.abcam.com/en-us/partner-with-us -
Abcam
@abcam
Hear directly from the team behind SimpleStep Ignite™ ELISA.
In this on-demand webinar, discover how our next-generation chemiluminescent ELISA platform was designed to help researchers generate more data with confidence, in less time.
Learn how SimpleStep Ignite™ delivers:
• Up to 35× broader measuring range
• 50× greater sensitivity
• Results in just 55 minutes
• Fewer dilutions, reruns, and workflow interruptions
Moein Mohammadi shares how a broader measuring range and greater sensitivity can help measure more samples in a single run.
Watch now to explore the science behind SimpleStep Ignite™ ELISA and discover how it can support more efficient, reliable biomarker quantification
👉 Watch now: www.abcam.com/en-us/webinars/simplestep-ignite-elisa -
Abcam
@abcam
How do metabolites coordinate immune responses across multiple organs? Can targeting metabolic pathways reshape inflammation, aging, and disease outcomes?
Join leading researchers in Boston, 14–15 September 2026, for two days of cutting-edge science exploring the connections between metabolism and immune function across tissues, organs, and whole-body systems.
Chaired by Luke O'Neill and Evanna Mills, the program features fascinating talks from academia and industry, including:
✔️Braving the elements: Deciphering the role of mineral nutrients in T cell function – Erika Pearce (Johns Hopkins Medicine)
✔️IRG1 goes Nuclear: Noncanonical functions of a mitochondrial enzyme – Chuck Dorsey (Vertex Pharmaceuticals)
✔️How does overnutrition lead to insulin resistance – Sir Stephen O'Rahilly (University of Cambridge) ✔️Systemic one-carbon metabolism buffers for methyl-nutrient deficiency – Tara Teslaa (UCLA)
📢 Still looking to share your work? Abstract submissions remain open for poster and short talk
consideration. Submit by August 14
👥 Bringing colleagues? Group registration discounts are available when booking together.
Explore the program and register today: events.abcam.com/Immunometabolism2026
#immunometabolism #inflammation #immunology #metabolism #researchcommunity -
Abcam
@abcam
Why choose InstantBlue® Coomassie Protein stain?
Traditional Coomassie staining can involve multiple preparation and destaining steps.
With InstantBlue® Coomassie protein stain, you can simplify protein gel staining with a ready-to-use solution that delivers reliable results while eliminating unnecessary workflow steps.
✅ Results in as little as 15 minutes
✅ No fixing or destaining required
✅ High sensitivity: detects as little as 5 ng per band of protein
✅ Single-wash protocol
Learn more: www.abcam.com/en-us/products/reagents/instantblue-coomass…
#proteinresearch #sdspage #westernblotting #proteomics #lablife #proteinstaining -
Abcam
@abcam
Flow cytometry works best when your results are consistent.
That's why we've developed conjugated antibodies validated for flow cytometry, helping you spend less time troubleshooting and more time moving your immunometabolism research forward.
Explore our flow cytometry portfolio: www.abcam.com/en-us/products/product-recommendations/acce…
#abcam #lifescienceresearch #flowcytometry #antibodies #cellanalysis #immunology #scientificresearch #immunometabolism #met-flow -
Abcam
@abcam
Live webinar today!
Join us and Dr Ellen King (KCL) for: CAR‑T Cell Therapy for Blood Cancers: Why Metabolism Matters
Explore how:
🔬 CAR-T metabolism shapes treatment success
📊 Single‑cell tools reveal functional heterogeneity
🧬 Predictive biomarkers and metabolic reprogramming can improve patient outcomes
📅 July 29 | 3–4 pm GMT+1
Register now and join us live!
Can’t make it? Register anyway, and we’ll let you know when the on-demand recording is available:
events.abcam.com/event/CARTCellTherapyWebinar2026/home
#cart #celltherapy #immunotherapy #immunometabolism #cancerresearch #webinar #abcam #kingscollegelondon -
Abcam
@abcam
Every rerun wastes time and slows progress.
When you're working to tight milestones, assay performance matters, not just at the endpoint, but across the whole workflow.
SimpleStep Ignite™ ELISA helps keep your research moving with:
✔️Up to 35× broader measuring range
✔️50× greater sensitivity
✔️Single-wash, 55-minute protocol
✔️Carefully selected antibody pairs for consistent performance
✔️Fewer dilutions and reruns to help accelerate data delivery
This leaves you more time to generate insights and spend less time on repeating assays.
Discover faster with SimpleStep Ignite™ ELISA:
www.abcam.com/en-us/products/elisa-kits-and-immunoassays/…
#elisa #biopharma #translationalresearch #assayworkflow #lifesciencetools #abcam -
Abcam
@abcam
When you’re working with complex intracellular metabolic targets, confidence in your reagents matters.
That’s why our immunometabolism flow antibodies are rigorously validated for flow cytometry and designed to deliver reliable, reproducible data, so you can trust your results and focus on discovery.
🔗Explore the portfolio: www.abcam.com/en-us/products/product-recommendations/acce…
#abcam #lifescienceresearch #antibodies #researchtools #scientificresearch #flowcytometry #flowcytometry #lifesciences #immunology #immunometabolism -
Abcam
@abcam
📢 Live webinar next week - register now 📢
CAR‑T cell therapy for blood cancers: Why metabolism matters
Dr Ellen King, Research Scientist in the Schurich Lab at King’s College London, delves into:
🔬 Mapping metabolic pathways in immune cells
🧬 Linking metabolism to CAR‑T function and persistence
📊 Using tools like Met‑Flow for single-cell immunometabolism analysis
If you're working on CAR-T therapy, immunometabolism, and immuno-oncology, don’t miss this live webinar!
📅 29 July | 3–4 pm (UK)
🔗 Register now: events.abcam.com/event/CARTCellTherapyWebinar2026/home
#cart #celltherapy #immunotherapy #immunometabolism #cancerresearch #webinar #abcam #kingscollegelondon -
Abcam
@abcam
When sample concentrations are unknown, ELISA workflows can quickly become a balancing act.
🔹Too concentrated? > Dilute and repeat.
🔹Too low? > Risk falling below the detection range.
🔹Too much variation? > More time spent troubleshooting.
SimpleStep Ignite™ ELISA combines greater sensitivity with a broader measuring range, helping you quantify both low- and high-abundance targets with fewer additional dilution steps.
Powered by chemiluminescent detection and recombinant antibody pairs, SimpleStep Ignite™ delivers reliable performance in a streamlined, single-wash workflow, with results in just 55 minutes.
Detect more across a wider range and make decisions sooner.
Learn more: www.abcam.com/en-us/products/elisa-kits-and-immunoassays/…
#elisa #chemiluminescence #assaydevelopment #biomarkers #drugdiscovery #abcam -
Abcam
@abcam
What are the big questions in immunometabolism right now, and where is the field heading next?
Our conference chairs share what they’re most excited to discuss at Immunometabolism Across Organs: From Tissue Niches to Systemic Networks, taking place in Boston on 14–15 September.
If you’re planning to attend or submit a short talk abstract, now’s the moment.
Deadline for early bird registration and short talk abstract submission: Friday 17 July
🔗Register here: events.abcam.com/event/Immunometabolism2026/home -
Abcam
@abcam
Attending AAIC today?
Stop by and meet Laurence Loï, Senior Product Manager at Abcam, who will be presenting her poster:
“Chemically peptide-ligated protein standards enable antibody validation and quantification of phosphorylated Tau in Alzheimer's disease samples.”
Laurence will be available during the lunch and afternoon breaks to discuss her work and answer your questions about antibody validation and Tau quantification in Alzheimer's disease research.
#aaic2026 #alzheimersresearch #tauresearch #neuroscience #abcam -
Abcam
@abcam
Ready to speed up your Alzheimer’s research?
Visit us in the Danaher booth 921 at AAIC for an introduction to the new SimpleStep Ignite™ ELISA, designed to deliver results 6× faster, in just 55 minutes, with fewer dilutions, greater sensitivity, and broader measuring range.
Talk times:
🔥Tuesday, July 14 — 11:15 am
🔥Wednesday, July 15 — 11:15 am
Discover how Ignite streamlines biomarker detection and accelerates Alzheimer’s research workflows.
#elisa #immunoassay #simplestepignite #alzheimersresearch #neuroscience #danaher #abcam -
Abcam
@abcam
Joining us at AAIC today?
Meet Antonella Galli, PhD, Director of Validation at Abcam, at Poster 1327 during the poster session from 3:30 to 4:15 PM.
Stop by to learn more about Abcam’s trusted antibody solutions for Alzheimer's research and chat with our validation expert about your research questions.
#aaic2026 #alzheimersresearch #neuroscience #abcam -
Abcam
@abcam
Alzheimer’s disease research depends on tools you can trust.
At AAIC 2026, we're showcasing how chimeric antibody technology and enhanced IHC validation help researchers study key Alzheimer’s targets with greater confidence. From multiplex staining to isoform-specific APOE4 detection, our focus is on delivering reliable, reproducible results that support meaningful discoveries.
Join us today at 3:30 in the Danaher booth 921 for a talk highlighting applications in neuroscience and assay development.
#aaic2026 #alzheimersresearch #neuroscience #antibodies #ihc -
Abcam
@abcam
Join Abcam as we help accelerate the pace of biomarker discovery and translational research with high-sensitivity immunoassays and trusted antibody solutions.
Here’s what not to miss:
➡️ Our Product Theater talk on SimpleStep Ignite™ ELISA
➡️ New scientific posters on phosphorylated Tau + antibody validation
➡️ In-booth insights all week
➡️ Discover your scientific innovator match with our AI photobooth
📍 Find us in the Danaher booth 921 and plan your visit -
Abcam
@abcam
Access new metabolic phenotypes with richer, single‑cell data.
From glycolysis to oxidative phosphorylation and lipid metabolism, Abcam’s flow‑validated antibodies enable metabolic pathway analysis at single‑cell resolution, helping you uncover immune phenotypes you couldn’t access before.
🔗Explore the portfolio: www.abcam.com/en-us/products/product-recommendations/acce…
#abcam #lifescienceresearch #antibodies #researchtools #scientificresearch #flowcytometry #flowcytometry #lifesciences #immunology #immunometabolism -
Abcam
@abcam
We’re heading to #aaic2026 as part of the Danaher family.
Discover how Abcam is accelerating biomarker discovery, from early research to translational impact.
What can you expect when you visit us?
✔ Faster, more sensitive immunoassays
✔ Trusted antibodies for reproducible results
✔ Real-world solutions for Alzheimer’s research challenges
Find us at Danaher booth 921
Find out more: events.abcam.com/AAIC2026 -
Abcam
@abcam
Thinking about joining us in Boston this September?
Hear from our conference chairs on what Immunometabolism Across Organs: From Tissue Niches to Systemic Networks is all about, who should attend, and what to expect.
📍 Boston, MA
📅 14–15 September 2026
⏰ Early bird registration + short talk abstract deadline: Friday 17 July
Secure your place: events.abcam.com/Immunometabolism2026 -
Abcam
@abcam
When you’re testing unknown samples or a mixture of samples, some can fall outside the assay’s measurable range on the first run. This can mean extra dilution or concentration steps, repeat testing, delayed results, and added cost.
SimpleStep Ignite™ ELISA is designed to support a smoother, more efficient workflow.
With up to 35× broader measuring range and 50× greater sensitivity, it increases the likelihood that more samples will be measurable first time - so you can test more sample concentrations in the same run, with fewer repeats and less hands-on time.
We compared reported C-peptide concentration values for 450 samples and found that all fell within the measuring range for SimpleStep Ignite™, highlighting its ability to support first-run success across a broad range of sample concentrations.
The result?
✔️Fewer repeat tests
✔️Simpler workflows
✔️Faster results
✔️Potential cost savings
Explore SimpleStep Ignite™ ELISA:
www.abcam.com/en-us/products/elisa-kits-and-immunoassays/…
#elisa #immunoassays #biomarkerresearch #biopharma #lifescienceresearch #abcam -
Abcam
@abcam
💡 A great day of ELISA innovation in Cambridge
Today, we delivered two engaging sessions showcasing our latest SimpleStep Ignite™ ELISA kits at GSK in Stevenage.
Across both sessions, attendees explored how our Ignite kits enable enhanced sensitivity, broader measuring ranges, and reliable results in under an hour – helping to streamline workflows and accelerate discovery.
Thank you to everyone who joined us for an insightful and interactive day.
For more information, visit: www.abcam.com/en-us/products/elisa-kits-and-immunoassays/…
#elisa #lifesciences #biotech #innovation #biopharma -
Abcam
@abcam
Boston, you’re about to get served (ice cream) 🍦
Join the Abcam team at Lab Scoops tomorrow at the J B Martin Conference Center for a complimentary cone and a chat about how we can better support your work.
👉 Sign up to receive a reminder: events.abcam.com/event/labscoops-boston/home -
Abcam
@abcam
Get consistent immunometabolism results with knock-out validated antibodies designed for challenging intracellular targets.
🔗Explore the portfolio: www.abcam.com/en-us/products/product-recommendations/acce…
#abcam #lifescienceresearch #antibodies #researchtools #scientificresearch #flowcytometry #flowcytometry #lifesciences #immunology #immunometabolism -
Abcam
@abcam
Next stop: Boston 🍦
Lab Scoops is heading to the Longwood Medical Area.
Take a break, grab a free scoop, and connect with the Abcam team supporting Harvard Medical School, Dana-Farber, Boston Children’s, and Mass General.
Share your insights, challenges, and ideas, and help shape how we support your science.
📍 J B Martin Conference Center
📅 June 30
🕒 1 pm-4 pm
👉 Sign up to receive a reminder, or just show up on the day: events.abcam.com/labscoops-boston -
Abcam
@abcam
Houston, what’s your flavor? 🍦
The Abcam team will be scooping up insights in exchange for ice cream tomorrow at John P McGovern Commons. Bring a colleague, take a break and help us shape how we support your work, from everyday workflows to bigger research goals.
👉 Sign up to receive a reminder events.abcam.com/event/labscoops-houston -
Abcam
@abcam
Sustainability update ♻️
We’re now delivering selected antibodies at ambient temperature in the US and Europe, using paper‑based, recyclable packaging without compromising quality.
This change means:
✅ Estimated 6.3+tons of EPS removed from ambient shipments each year
✅ >90% reduction in packaging weight (from ~55,000 lbs to ~5,000 lbs)
✅ Avoiding around 24 tons of excess packaging material each year
✅ 18+ tons of ice packs are avoided annually
Another step toward a more sustainable Abcam. For more information, check out this page: www.abcam.com/en-us/support/shipping-storage-support/ambi… -
Abcam
@abcam
From sample to results in just 55 minutes
Missed our live session? The on‑demand webinar on SimpleStep Ignite™ ELISA is now available.
Discover how this next‑generation chemiluminescent ELISA delivers faster turnaround, greater sensitivity, and a broader dynamic range, helping you quantify low‑ and high‑abundance targets in a single, streamlined workflow.
Hear directly from the scientists behind the technology as they explain how it fits into real‑world lab workflows and how you can start applying it today.
👉 Watch on demand now: www.abcam.com/en-us/webinars/simplestep-ignite-elisa -
Abcam
@abcam
Chimeric antigen receptor therapy (CAR‑T) has transformed treatment for blood cancers, but long‑term responses remain limited.
Join Dr Ellen King (KCL) on July 29 for a live webinar and discover:
✅ How the metabolism of CAR-T cells determines their persistence and anti-tumor efficacy
✅ Why only ~30% of patients experience durable responses
✅ How single‑cell approaches like Met‑Flow uncover functional metabolic states
✅ Strategies to identify predictive biomarkers and new therapeutic opportunities
📅 29 July | 3-4 pm GMT+1
🔗 Register now events.abcam.com/event/CARTCellTherapyWebinar2026
#cart #celltherapy #immunotherapy #immunometabolism #cancerresearch #webinar #abcam #kingscollegelondon -
Abcam
@abcam
We’re bringing Lab Scoops to Houston 🍦
Take a break, grab a free scoop, and share your insights with us.
Join us on campus for a relaxed ice cream social connecting researchers across MD Anderson, Baylor College of Medicine, UTHealth Houston, and Houston Methodist.
This isn’t just a treat; it’s your chance to shape how we support your work, from everyday workflows to bigger research goals.
📍 John P McGovern Commons, 6th Floor Meeting Room 1 & 2, 6550 Bertner Ave, Houston, TX 77030 USA
📅 June 23
🕒 Drop in anytime between 1 pm – 4 pm
👉 Sign up to receive a reminder, or just show up on the day events.abcam.com/event/labscoops-houston -
Abcam
@abcam
We’re excited to partner with @epicypher to help researchers unlock epigenomic insights with greater speed and confidence.
By combining our rigorously validated antibodies with the widely cited CUTANA™ ChIC/CUT&RUN platform, we’re addressing one of the biggest challenges in chromatin profiling: confidence in every reagent and every result.
Together, we’re enabling:
✔️More confidence in antibody performance
✔️Reliable, high-resolution epigenomic data
✔️Faster, more reproducible discoveries
Our goal is simple: remove barriers so you can focus on advancing research in gene regulation, biomarker discovery, and disease biology.
🔗 Explore what this partnership means for your work:
www.abcam.com/en-us/press-releases/abcam-epicypher-valida…
#epigenomics #chromatin #cutandrun #antibodyvalidation #lifesciences #abcam #epicypher -
Abcam
@abcam
Accelerate immunometabolism flow discovery
Get deeper insights from rare cell populations with a unique portfolio of flow-validated antibodies to 90% of key metabolic enzymes, developed in collaboration with Beckman Coulter Life Sciences. Drop-in ready for rapid panel expansion.
Explore the portfolio: www.abcam.com/en-us/products/product-recommendations/acce…
#abcam #lifescienceresearch #antibodies #researchtools #scientificresearch #flowcytometry #flowcytometry #lifesciences #immunology #immunometabolism -
Abcam
@abcam
Less searching. More progress.
MollAI, your AI-powered research assistant, is designed to help you find the right product for your experiment faster.
From antibodies to kits and tools, MollAI guides you to relevant options, offers intelligent recommendations, and helps you compare products with confidence.
Spend less time navigating the catalog and more time moving your research forward.
👉 Try MollAI: www.abcam.com/en-us/mollai
#mollai #abcam #lifescienceresearch #aiinscience #antibodies #researchtools #labefficiency #scientificresearch -
Abcam
@abcam
Come and learn about the advantages of using chimeric antibodies for building multiplex IHC and ICC panels and see how they can streamline your workflows.
📍 Poster session: Tumor Immunology
📅 Tuesday, June 9
🧬 Poster P-706
Stop by to explore the data and connect with our team.
#abcam #eacr2026 #cancerresearch #biomarkers #antibodies#Reproducibility #translationalresearch -
Abcam
@abcam
At #eacr2026, visit our poster to learn more about our enhanced validation program, which provides comprehensive data on the specificity and sensitivity of our recombinant antibodies.
📍 Poster session: Biomarkers in Tissue and Blood
📅 Tuesday, June 9
📋 Poster P-074
Stop by to see the data for TROP2 and speak with our IHC validation experts to find out more.
#abcam #eacr2026 #cancerresearch #biomarkers #antibodies #reproducibility #translationalresearch -
Abcam
@abcam
We’re pleased to announce the appointment of Dr. Kaveh Kahen as President of Abcam.
Dr. Kahen is a global leader in life sciences, bringing deep expertise in innovation, operational excellence, and business transformation. With leadership experience spanning Phenomenex, SCIEX, PerkinElmer, and Advion Interchim Scientific, he has a strong track record of driving growth and delivering value for customers.
As we continue to support researchers worldwide with trusted reagents and solutions, we’re excited for Kaveh to lead the next chapter of growth, innovation, and customer impact, because progress happens together.
Read more: www.abcam.com/en-us/press-releases/abcam-appoints-kaveh-k…
#abcam #leadership #lifesciences #innovation -
Abcam
@abcam
EIMN 2026 is fast approaching – join us in Luxembourg.
In just a few days, we’ll be heading to the European Immunometabolism Network (EIMN) Conference, and we’re looking forward to the insightful discussions and innovations driving this field forward.
Elena Loche will be at the Parc Hotel Alvisse, Luxembourg, from June 10–12. If you’re attending, she’d love to connect – whether you’re working in cancer, autoimmune, or metabolic disorder research, or exploring new directions in immunometabolism.
Alongside great conversations, don’t miss Elena’s presentation, “Accelerate immunometabolism flow discovery,” where key insights and approaches will be shared.
We’ll also be giving you the chance to win a free antibody during the event – so be sure to stop by and say hello.
If you’re interested in exchanging ideas or learning more about how we can support your research, we’d love to meet you.
See you in Luxembourg.
Learn more: www.abcam.com/en-us/products/product-recommendations/acce…
#eimn2026 #immunometabolism #cancerresearch #autoimmunediseases #metabolicdisorders #scientificcommunity -
Abcam
@abcam
📍 Heading to AFH 2026? Let’s meet in Nîmes.
We’re getting ready for the upcoming French Association of Histotechnology (AFH) Congress and are excited to connect with the community shaping the future of histotechnology.
From June 10–12, you can find our associates Delphine Ayache and Andrea Zàrrate at the H2 Congress Centre in Nîmes, France. If you’re attending, they’d love to chat about your current work, challenges and what you’re aiming to achieve in the lab.
We’re particularly looking forward to engaging with immunohistochemistry professionals interested in recombinant antibodies, conjugated antibodies and conjugation kits – and how these tools can support more reliable and efficient workflows.
Plus, don’t miss your chance to win antibodies each day of the event – be sure to stop by our stand for more details!
If you’re interested in advancing your IHC workflows or learning more about our solutions, come and say hello.
📅 Book a slot to connect with the team
👉 bookings.cloud.microsoft/book/MeetingswithAndrea@danaher.…
#afh2026 #histotechnology #immunohistochemistry #antibodies #scientificcommunity -
Abcam
@abcam
More insights, 6x faster
SimpleStep Ignite™ ELISA is designed to help keep research moving forward, delivering more insights, up to 6× faster than the industry standard, making SimpleStep Ignite™ the fastest chemiluminescent ELISA on the market.
With results in 55 minutes, 50× greater sensitivity, and up to 35× broader measuring range, SimpleStep Ignite™ ELISA helps you capture more data in a single experiment with less reruns. A simplified workflow with one incubation and one wash step reduces delays so you can get to the answer faster with confidence.
Explore SimpleStep Ignite™ ELISA www.abcam.com/en-us/products/elisa-kits-and-immunoassays/…
#simplestepignite #elisa #gettotheanswerfaster #highsensitivity #broadmeasuringrange #abcam -
Abcam
@abcam
Join Abcam at EACR 2026 in beautiful Budapest.
Visit us at booth 104 to connect with our on-site experts and find the tools you need to move your cancer research forward. From trusted antibodies to new solutions, we help you get results you can rely on.
Come and see what’s new.
👉 Book time with us: calendly.com/abcam-events/new-meeting -
Abcam
@abcam
📢 Save the date: #immunometabolism2026
Chaired by Luke O’Neill & Evanna Mills, this two-day meeting brings the community
together to explore how metabolites shape immune cell behavior across diverse organ
systems.
🗓️ Sept 14–15 | 📍 Boston
Full speaker list, call for abstracts & early‑bird discounts 👉
events.abcam.com/event/Immunometabolism2026 -
Abcam
@abcam
From PhD students to experienced researchers, MollAI is designed for scientists at every stage, supporting confident decision‑making throughout your research career.
“It asked the right questions and gave me information I was looking for.”
- PhD student, US
MollAI meets you where you are in your research journey, helping you move your work forward - faster.
👉 Try Abcam’s AI research assistant today: www.abcam.com/en-us/mollai
#mollai #researchers #lifesciences #aiinresearch #abcam #innovationinscience -
Abcam
@abcam
Ignite the pace of discovery.
55‑minute results, 50× greater sensitivity, and up to 35× broader measuring range. Built to help you quantify what others only detect, 6× faster than the industry standard.
Find out more: www.abcam.com/en-us/products/elisa-kits-and-immunoassays/… -
Abcam
@abcam
⏰ Today’s the day!
Join our live webinar at 11 am ET (May 19) to get a first‑hand look at SimpleStep Ignite™, our next‑generation chemiluminescent ELISA that takes you from sample to results in just 55 minutes.
If you’re looking to improve assay performance without changing how you work, don’t miss this session.
It’s not too late- secure your spot and join us live today!
👉 events.abcam.com/event/SSEIgniteWebinar-May26/home
PS. Can't make it? Register anyway to get notified when the on-demand version is available! -
Abcam
@abcam
⏳ Don't miss out - register today!
Discover how to move from sample to results in just 55 minutes in our upcoming live webinar on May 19 at 11 am ET, featuring SimpleStep Ignite™, our next‑generation chemiluminescent ELISA.
Whether you're aiming to streamline workflows or get more consistent performance from your assays, this session will show you what’s possible without overhauling your process.
Don’t miss out—reserve your place today 👉 events.abcam.com/event/SSEIgniteWebinar-May26/home
PS. If you can’t join live, register anyway and we’ll send you the on-demand recording as soon as it’s ready! -
Abcam
@abcam
What an incredible day yesterday at the Spatial Biology Symposium in Waltham, MA!
Together with Leica Microsystems, we brought the community together for a day full of insightful discussions on spatial proteomics and multiplexed imaging, hands-on lab tours, and valuable in‑person connections.
A huge thank you to our fantastic speakers and contributors who made this event so impactful:
Wayne Stallaert, Ph.D. | Emily Condiff, Ph.D. | Amy McCann | Kit-Yi Yam | Andrea Radtke, Ph.D. | Noah Herwood | Tracy Thomas | Kaitlynn McCay | Tim Ragan and our collaborators at Leica Microsystems.
We’re proud to support a space where innovation and collaboration continue to drive advances in life sciences and drug discovery.
🔬 Explore our spatial biology solutions to take your research further: www.abcam.com/en-us/products/product-recommendations/spat…
#spatialbiology #proteomics #lifesciences #drugdiscovery -
Abcam
@abcam
Ignite next-level efficiency.
We’re redefining ELISAs with up to 35× broader measuring range and 50× greater sensitivity, delivered in a single experiment with just one incubation and one wash step. Capture more usable data, faster, with fewer repeats.
🔗 Explore the range www.abcam.com/en-us/products/elisa-kits-and-immunoassays/…
#simplestepignite #singlewash #elisaworkflow #labefficiency -
Abcam
@abcam
Big news for reproducibility in science
We’re proud to be part of the team that has won the NIH Replication Prize Challenge. This award recognizes practical work that helps make biomedical research more reliable and easier to repeat.
A special thank you to our associates Hannah Cable, VP of New Product Development, and Ravindran Kumaran, Head of Collaborations, who both contributed to a report led by our partners at PETA Science Consortium International (PSCI). The report focuses on actionable, everyday steps to improve antibody reproducibility, helping turn shared commitments to rigor into consistent lab practice.
Thank you to the NIH and to all the collaborators involved for pushing the conversation on rigor and reproducibility forward.
Reproducibility matters. We’re excited to keep moving it forward, together.
🔗 Learn more about the Replication Prize:
commonfund.nih.gov/replication-initiative/news/announcing… -
Abcam
@abcam
Choosing a reagent isn’t just about performance - it’s also about timing and availability.
MollAI gives you immediate visibility into pricing and availability, so you can move from question to checkout faster to plan your experiments with confidence.
Keep your research moving. Try MollAI today: www.abcam.com/en-us/mollai
#labplanning #researchworkflows #mollai #abcam #scientifictools #efficiencyinscience -
Abcam
@abcam
⏰ Last chance to register!
The Abcam x @LeicaMicro Spatial Biology Symposium is happening next week (May 13) in Waltham, MA.
Don’t miss practical talks, lab tours & roundtable discussions focused on spatial proteomics and translational discovery—all free, but with limited space.
🎟 Register now: www.leica-microsystems.com/c/am/lsr-w/spatial-biology-sym…
#spatialbiology #proteomics #lifesciences #drugdiscovery -
Abcam
@abcam
We’re back at EACR!
We’re excited to be part of a meeting that brings together the global cancer research community to share breakthrough science, spark new ideas, and build meaningful collaborations. From basic discovery to preclinical and translational research, Abcam is proud to support scientists at every stage of the research journey.
Join us in Budapest, Hungary, and visit us at booth 104 to meet our team and discover how our rigorously validated antibodies, assays, and scientific expertise can help move your research forward.
Let’s connect, collaborate, and explore what’s next in cancer research.
Schedule a meeting here and let's talk science. 👉 calendly.com/abcam-events/new-meeting
#eacr2026 #cancerresearch #abcam #scientificdiscovery -
Abcam
@abcam
Ignite a whole new level of consistency.
We’re redefining ELISAs by using recombinant antibody pairs that deliver consistent performance batch after batch. See how SimpleStep Ignite™ ELISA helps connect more dots in your data.
🔗 Explore the range www.abcam.com/en-us/products/elisa-kits-and-immunoassays/… -
Abcam
@abcam
📍 CIMT 2026 is just around the corner. Let’s connect in Mainz.
In a few days, we’ll be heading to the 23rd Annual Europe’s Cancer Immunotherapy Meeting (CIMT). We’re really looking forward to the conversations and the science that drive this field forward.
Our associates Sinem Milanos and Marco Kirchenwitz will be at the Rheingoldhalle Congress Center, Mainz, from May 11–13. If you’re attending, they’d love to hear about what you’re working on and what questions you’re trying to answer.
We’ll also be sharing more about SimpleStep Ignite™ ELISA, designed to help you get from question to data faster. That means better sensitivity, a broader measuring range, and just one wash step in a 55‑minute assay.
If you’re interested in simplifying immunoassays, or you’re curious about where cancer immunotherapy is heading next, come and say hello.
📅 Book a time to connect: 👉 bookings.cloud.microsoft/book/MeetAbcamSinem@danaher.onmi…
See you in Mainz.
#cimt2026 #cancerimmunotherapy #elisa #immunoassays #abcam #scientificcommunity -
Abcam
@abcam
MollAI helps you turn uncertainty into action – guiding you to clear answers and relevant products faster.
Less searching. More progress. More confident next steps.
👉 Ask MollAI your next research question: www.abcam.com/en-us/mollai
#researchsupport #airesearchassistant #lifesciencetools #mollai #phdlife #abcam -
Abcam
@abcam
⏰ Two weeks to go — don’t miss out!
Our free, live webinar is almost here. On May 19, get a first‑hand look at SimpleStep Ignite™, our next‑generation chemiluminescent ELISA that takes you from sample to results in just 55 minutes.
Learn how SimpleStep Ignite™ delivers a stronger signal, lower background, and consistent quantification — all without adding complexity to your workflow.
If you’re looking to improve assay performance without changing how you work, this session is for you.
🎓 Live webinar | Free registration
📅 May 19
👉 Secure your spot now: events.abcam.com/event/SSEIgniteWebinar-May26/home
Spaces are limited — register today so you don’t miss this opportunity. -
Abcam
@abcam
⏰ Last chance to register!
The Abcam x @LeicaMicro Spatial Biology Symposium is happening next week (May 13) in Waltham, MA.
Don’t miss practical talks, lab tours & roundtable discussions focused on spatial proteomics and translational discovery—all free, but with limited space.
🎟 Register now: www.leica-microsystems.com/c/am/lsr-w/spatial-biology-sym…
#spatialbiology #proteomics -
Abcam
@abcam
Ignite the pace of discovery.
50× greater sensitivity, up to 35× broader measuring range, and results in 55 minutes. SimpleStep Ignite™ ELISA helps you connect more dots in your data.
Find out more: www.abcam.com/en-us/products/elisa-kits-and-immunoassays/…
#simplestepignite #elisa #nextgenelisa #highsensitivity #broadmeasuringrange #labefficiency #abcam -
Abcam
@abcam
With MollAI, you can explore links between targets, diseases, tissues, and products - all in one place. Whether you’re scoping a new research area or validating assumptions, MollAI speeds up decision-making by offering instant, intelligent recommendations.
“It did a good job of describing the actual science.”
- Postdoctoral researcher, US
MollAI doesn’t just help you find the right products, it helps move your research forward with confidence.
👉 Try MollAI today: www.abcam.com/en-us/mollai
#translationalresearch #targetdiscovery #biomedicalresearch #mollai #abcam #aiforscientists -
Abcam
@abcam
📍 Heading to CIMT 2026? Let’s connect in Mainz.
We’re excited to be at the 23rd Annual Europe’s Cancer Immunotherapy Meeting (CIMT) this May. It’s always exciting to see progress in innovative immunology research.
Our associates Sinem Milanos and Marco Kirchenwitz will be there from May 11–13 at the Rheingoldhalle Congress Center, Mainz. If you’re attending, they’d love to meet and talk about what you’re working on.
We’ll also be sharing more about our new SimpleStep Ignite™ ELISA, designed to help you move faster from question to data, with improved sensitivity, a broader measuring range, and only one-wash step, all in a 55-minute assay.
If you’re curious about simplifying immunoassays or just want to exchange ideas on where cancer immunotherapy is heading, come say hello.
See you in Mainz, book a time to connect here:
👉 outlook.office.com/book/MeetAbcamSinem@danaher.onmicrosof…
#cimt2026 #cancerimmunotherapy #elisa #immunoassays #abcam #scientificcommunity -
Abcam
@abcam
Ignite the pace of change.
We’re redefining ELISAs to deliver accurate results with a streamlined workflow that uses only one incubation and one wash step, in just 55 minutes.
That’s 6x faster than the industry standard, making SimpleStep Ignite™ the fastest chemiluminescent ELISA on the market.
🔗 Explore the range www.abcam.com/en-us/products/elisa-kits-and-immunoassays/… -
Abcam
@abcam
Less searching. More progress.
MollAI is your AI‑powered research assistant, designed to help you find the right product for your experiment - faster. Simply ask for help with what you’re working on, and MollAI guides you to relevant antibodies, kits, and tools based on your research needs.
Spend less time navigating product pages - and more time in the lab.
👉 Try MollAI: www.abcam.com/en-us/mollai
#mollai #lifescienceresearch #antibodies #labefficiency #aiinscience #abcam -
Abcam
@abcam
Join us for a free, live webinar on May 19 to learn more about SimpleStep Ignite™, our next-generation chemiluminescent immunoassay.
Hear directly from the scientist who developed the assay as they discuss how SimpleStep Ignite™ delivers a stronger signal, lower background, and consistent quantification, without additional workflow complexity.
🎓 Live webinar | Free registration
📅 May 19
👉 Register now: events.abcam.com/event/SSEIgniteWebinar-May26/home -
Abcam
@abcam
Save 50% on your first SimpleStep Ignite™ ELISA.
Get 55‑minute results, with 50× greater sensitivity and an up to 35× broader measuring range, using a simple single‑wash workflow.
Use code IGNITE50. Offer ends June 30, 2026.
🔗 www.abcam.com/en-us/campaigns/simplestep-ignite-elisa
#simplestepignite #elisa #labdeals #researchtools #abcam -
Abcam
@abcam
Don’t let AACR end without one more great poster. If your work relies on
high‑quality, rigorously validated antibodies in oncology or TROP2‑driven
pathways, stop by and see how our enhanced validation approach drives
more reproducible, trustworthy results.
✅ Learn what robust antibody validation really looks like
✅ Chat with our scientists about strengthening your own workflows
✅ One more poster, one more dose of great science
🔗Join us: lifesciences.danaher.com/us/en/events/aacr2026/aacr-2026-…
#aacr2026 #cancerresearch #antibodyvalidation #trop2
#reproducibleresearch -
Abcam
@abcam
The countdown is on for the Abcam x Leica Spatial Biology Symposium⏳
Hear practical talks on spatial proteomics & multiplexed imaging, plus present your own work in the poster session.
🧪 Expert talks | 🔬 Lab tours | 🤝 Networking
🎟 Explore the full program and register now: go.leica-ms.com/SpatialBiologySymposium2026
#spatialbiology #proteomics #lifesciences #drugdiscovery -
Abcam
@abcam
AACR friends — this one’s a must‑see!
Stop by our chimeric antibody poster, jump into the discussion, and
leave inspired. Adding to the excitement, the poster is
presented by Will Howat, who recently received a CiteAb
Award for Significant Individual Impact.
Come and meet Will and the team.
🔗Join us: lifesciences.danaher.com/us/en/events/aacr2026/aacr-2026-…
#aacr2026 #chimericantibodies #oncologyresearch -
Abcam
@abcam
Ignite a deeper level of insight.
We’re redefining ELISAs, delivering up to 35x broader measuring range and 50x greater sensitivity in just 55 minutes, with only one incubation and one wash step.
Designed to help you capture more usable insights from every experiment, SimpleStep Ignite™ ELISA keeps your research moving forward with fewer delays and fewer reruns.
🔗 Explore SimpleStep Ignite™ ELISA: www.abcam.com/en-us/products/elisa-kits-and-immunoassays/…
#simplestepignite #elisa #highsensitivity #broadmeasuringrange #chemiluminescentelisa -
Abcam
@abcam
Are you at AACR? Come say hi and dive into p53 science with us.
If you’re exploring PTMs, tumor suppressor pathways, or building more sensitive and quantitative assays, this is a poster you’ll want to catch.
📍Worth the detour between sessions.
Join us: lifesciences.danaher.com/us/en/events/aacr2026/aacr-2026-…
#aacr2026 #postersession #reproducibleresearch -
Abcam
@abcam
☕ Fuel your day. Power your research.
Swing by Booth 722 at AAI for a complimentary caffeine
boost and learn more about the tools that boost your
experiments, too.
Because science runs on good ideas…and good coffee.
Join us today: events.abcam.com/event/immunology2026
#immunology2026 #aai2026 #aaimeeting #americanassociationofimmunologists
@emilie_sto -
Abcam
@abcam
Exploring the posters at #immunology2026? 🔎
Stop by poster 579 to see our work on enhanced neutrophil
depletion in lung tumor models with our in-house expert,
@emilie_sto Emilie Stolarczyck!
Join us: events.abcam.com/event/immunology2026
#immunology2026 #aai2026 #aaimeeting #americanassociationofimmunologists -
Abcam
@abcam
So many posters to see, so little time! ⌛
If TREM1 research is on your checklist for
#immunology2026, catch JK’s poster presentation today
at 2:30 pm.
Join us: events.abcam.com/event/immunology2026 -
Abcam
@abcam
🔥 Checkpoint biology, accelerated.
See our new SimpleStep Ignite™ immunoassay panel data presented by Mandy Lund at #immunology2026.
Check it out now: events.abcam.com/immunology2026 -
Abcam
@abcam
Introducing SimpleStep Ignite™ ELISA, your new route to faster insights.
Up to 35× broader measuring range and 50× greater sensitivity compared to traditional colorimetric ELISAs, helping reveal signals others may miss.
Explore SimpleStep Ignite™ ELISA: www.abcam.com/en-us/products/elisa-kits-and-immunoassays/…
#simplestepignite #elisa #highsensitivity #broadmeasuringrange #abcam -
Abcam
@abcam
Don’t miss out 🟦
At #immunology2026, spark the right connections and accelerate discovery beyond the show floor. Join us tonight at Spinnovate - grab your paddle for ping pong, great conversation, and ideas that move fast. 🏓✨
⚠️ Limited places available -reserve your complimentary ticket now
P.S. A little friendly rivalry could unlock a surprise that gives your research a competitive edge 👀💡
events.abcam.com/event/immunology2026/spinnovate -
Abcam
@abcam
AACR is almost here and we’re bringing something new. Stop by Danaher booth 4217 to get an early look at our latest tools designed to advance cancer research.
Let's plan to meet: lifesciences.danaher.com/us/en/events/aacr2026/aacr-2026-…
#aacr2026 #discoverwhatsnew #innovationalert #danaher -
Abcam
@abcam
Be there, or be square 🟦
This year at #immunology2026, connect the dots faster and ignite the pace of discovery beyond the tradeshow floor. Book your free place at Spinnovate and connect with us this Thursday for ping pong, great company, and ideas that move fast. 🏓💫
⚠️ Limited spots available – book your complimentary ticket now
P.S. A little friendly competition might just land you a surprise that gives your research an extra edge 👀✨
events.abcam.com/event/immunology2026/spinnovate
#spinnovate #abcam #immunology #lifescience #biotech #scientificevents #researchcommunity #networkingevent #innovationinscience #tradeshowlife -
Abcam
@abcam
Heading to #immunology2026? Make sure these are on your must‑see list.
If you’re looking for new tools to accelerate your research, cutting‑edge data, and real conversations with experts who get your science, we’ve got you covered. Don’t miss:
🔬 Exhibitor workshop: High‑sensitivity biomarker detection with Ivan Zanoni, Boston Children’s Hospital
🧪 Scientific posters: Checkpoint inhibitor quantification, enhanced antibody validation, and immuno‑oncology models
📍 In‑house experts at Booth 722: Ready to dig into your challenges and share what’s new
Plus, don’t miss Spinnovate, the ping pong social where ideas spark, conversations ignite, and innovation moves faster 🏓💫
Heads up: Bring your game (and your curiosity). Spinnovate attendees will have a chance to receive a surprise that could give their research a serious boost 👀✨
👉 Explore everything we’re doing at AAI 2026 here: events.abcam.com/event/immunology2026/home
See you there - let’s move immunology forward.
#immunology #abcam #danaher #researchaccelerated #aai #immunooncology #biomarkers -
Abcam
@abcam
Ignite the pace of discovery
Results in 55 minutes, insights delivered 6x faster, 50x greater sensitivity and up to 35x broader measuring range. SimpleStep Ignite™ ELISA keeps research moving forward.
Explore SimpleStep Ignite™ ELISA: www.abcam.com/en-us/products/elisa-kits-and-immunoassays/…
#simplestepignite #elisa #gettotheanswerfaster #highsensitivity #broadmeasuringrange #abcam -
Abcam
@abcam
AAI 2026, here we come!
Great science happens when the right connections are made. Join us at Booth 722 to find out how our high-sensitivity SimpleStep Ignite™ ELISA kits and flow cytometry antibodies drive faster, more reliable insights.
Explore everything we’re doing (including THE social event of this year’s show) here: events.abcam.com/immunology2026
#immunology2026 #aai2026 #immunology2026 #immunologyresearch #flowcytometry #elisa #abcam #labinnovation -
Abcam
@abcam
We’re pleased to announce the launch of SimpleStep Ignite™ ELISA, our next‑generation chemiluminescent immunoassay.
SimpleStep Ignite™ ELISA delivers results in 55 minutes, combining 50× greater sensitivity with up to 35× broader measuring range, enabling researchers to generate faster, higher‑quality decisions without compromising data integrity.
Designed to support discovery and preclinical workflows, SimpleStep Ignite™ ELISA helps researchers reduce reruns, streamline workflows, and move from results to decisions faster.
📄 Read the full press release: www.abcam.com/en-us/press-releases/abcam-launches-simples…
#abcam #simplestepignite #elisa #productlaunch #lifesciences -
Abcam
@abcam
We’re heading back to AACR 2026 and can’t wait to connect with you! This year, we’re excited to bring our newest innovations to the conference floor.
Visit us at Danaher booth 4217 to:
• Explore our latest products designed to power cutting‑edge cancer discovery
• Get hands‑on insights into tools that support high‑quality, reproducible research
• Speak directly with our scientific experts or book a dedicated time here
👉 calendly.com/abcam-events/book-time-with-abcam-at-aacr-bo…
Discover how partnering with us can help accelerate your next breakthrough. Together, we’re advancing cancer research.
#aacr2026 #cancerbiology #immunooncology #scientificdiscovery #dahaner -
Abcam
@abcam
Introducing InflammaZoom: a global webinar series bringing the innate immunity community together.
Launched in June 2020 by Professor Clare Bryant (Chair of the Cambridge Immunology Network), InflammaZoom was created to ensure that outstanding science in innate immunity and inflammasome biology continued to be shared - even when the world went virtual.
Since then, it has grown into an international platform where immunologists connect, exchange ideas, and keep important scientific conversations moving forward.
Hear inspiring talks from Rachel Lai (Imperial College London, UK)) and Jueqi Chen (University of Chicago, USA) and take part in meaningful discussions with peers across the globe.
👉 Register for free now:
events.abcam.com/event/Inflammazoom2026/home
#inflammazoom #innateimmunity #immunology #inflammasome #lifesciences #webinarseries #scientificcommunity #abcam -
Abcam
@abcam
This August, join us in Munich for the Summer School on Chromatin Biology - a two‑week, immersive, hands‑on program at the forefront of chromatin and epigenetics research.
Dive into the field through:
◉ Expert‑guided hands‑on training
◉ Data analysis and bioinformatics
◉ Daily lectures from internationally recognized leaders
Learn alongside peers from around the world, exchange ideas, and build lasting scientific connections while advancing your research skills.
Applications close April 18. Apply now: events.abcam.com/event/HelmholtzSummerSchool2026/summary
#chromatinbiology #epigenetics #summerschool #scientifictraining #lifesciences #molecularbiology #bioinformatics #researchtraining #munich #earlycareerresearchers -
Abcam
@abcam
Less searching. More progress.
MollAI provides instant, intelligent product recommendations that support confident decision‑making to move your research forward, faster.
Start your chat: www.abcam.com/en-us/mollai
#abcam #scientificresearch #aiinscience #digitalinnovation #researchtools -
Abcam
@abcam
Introducing MollAI - your new AI assistant.
Find the right products faster with instant, intelligent guidance.
With MollAI you can:
◉ Navigate our 80k+ portfolio with AI powered search
◉ Compare products tailored to your precise needs
◉ Get expert recommendations within seconds
◉ Choose the right solution with confidence
Start your chat: www.abcam.com/en-us/mollai
#abcam #aiinscience #lifesciences #biotechnology #scientificresearch -
Abcam
@abcam
⏳ Live webinar today at 4pm GMT!
Join our free webinar on the 4P’s of IHC Validation and learn how to avoid the pitfalls that compromise spatial biology results.
📅 March 24
🕓 4pm-5pm GMT
Save your spot 👉 events.abcam.com/IHCValidationWebinar
Can’t make it? Register anyway and we’ll notify you when the on-demand version is available.
#abcam #spatialbiology #immunohistochemistry #antibodyvalidation #scientificwebinar -
Abcam
@abcam
Join us on March 26 for our next Digital Cell Cycle Club featuring keynote speaker Scott Kenney from Memorial Sloan Kettering Cancer Center.
Be a part of the conversation where researchers connect and inspire new collaborations within the global cell cycle field.
Register for free Digital Cell Cycle Club March 2026: events.abcam.com/event/CellCycleClub2026/home -
Abcam
@abcam
⏰Tomorrow!
Our IHC Validation webinar goes live tomorrow, and it’s packed with practical insights to help you boost reproducibility and avoid common pitfalls.
You’ll learn how to prepare samples correctly, optimize assay performance, ensure predictability, and protect your spatial biology workflows from avoidable errors.
Join us live to learn directly from the experts — or register to get the on-demand recording.
📅 March 24
🕓 4pm GMT
🎟️ Free registration — tap the link below
events.abcam.com/event/IHCValidationWebinar/home
#spatialbiology #immunohistochemistry #antibodyvalidation #scientificwebinar -
Abcam
@abcam
One clone. Multiple species. Consistent, flexible detection.
Explore the versatility of Abcam’s Chimeric Antibodies at AD/PD 2026.
Join us today at 10:45 in the Danaher booth (15A) for an in‑booth talk highlighting applications in neuroscience and assay development.
👉 Find out more: lifesciences.danaher.com/us/en/events/adpd2026.html
#adpd2026 #antibodies #chimericantibodies #immunodetection #neuroscienceresearch #assaydevelopment #reproducibility #lifesciences #abcam #danaher -
Abcam
@abcam
Ready to speed up your neurodegeneration research?
Visit us in the Danaher booth (#15a) at AD/PD for an introduction to the new SimpleStep Ignite™ ELISA - designed to deliver results 6× faster, in just 55 minutes, with fewer dilutions and enhanced sensitivity.
Talk times:
🔥Wednesday, March 18 — 10:45 am
🔥Friday, March 20 — 1:45 pm
Discover how Ignite streamlines biomarker detection and accelerates Alzheimer’s and neurodegeneration research workflows.
#adpd2026 #elisa #immunoassay #simplestepignite #alzheimersresearch #neuroscience #danaher #abcam -
Abcam
@abcam
We’re honored to be recognized in the 2026 @CiteAb Awards 🎉
🏆 Winner - IHC Supplier of the Year Neuroscience
🌟 Winner - Significant Individual Impact Award: Dr. Will Howat
🎖️ Highly Commended – Phospho Antibody Supplier
Thank you to our teams and the researchers who trust our tools every day. 🙌
Read more: www.abcam.com/en-us/press-releases/abcam-honored-at-2026-…
#lifescience #ihc #neuroscience, #citeabawards -
Abcam
@abcam
Step into the future of chromatin biology this summer.
Embark on an immersive journey into state‑of‑the‑art chromatin biology. Advance your knowledge through this applied course featuring ATAC‑seq, ChIP‑seq, ChIC/CUT&RUN‑seq, CUT&Tag‑seq, and in‑depth bioinformatics analysis.
This August, join us in @hemholtz Munich for a two‑week, hands‑on deep dive into the world of cutting‑edge science.
Why you’ll want to be there:
• Hands‑on learning at the forefront of chromatin research
• A personalized, small‑cohort environment with real mentorship and interaction
• Collaborative, community‑driven training with peers from around the globe
• Expanded professional connections through access to leaders in chromatin and epigenetics
This is your chance to grow, experiment, connect, and step boldly into the next stage of your scientific journey.
Only 14 spots available - apply by March 29!
Sign up here: events.abcam.com/event/HelmholtzSummerSchool2026/summary
#helmholtzmunich #chromatinbiology #epigeneticsresearch #genomics hashtag #ngs #bioinformatics #lifesciences #scientifictraining #atacseq #chipseq -
Abcam
@abcam
Explore Abcam’s #adpd2026 posters 🧠✨
We’re sharing new data in antibody validation, spatial proteomics, and assay innovation in four posters at AD/PD — all designed to support deeper insights into neurodegenerative disease.
Swipe to learn more about our four featured posters, including
✦ APOE4 case study of enhanced validation
✦ pTau quantification using peptide‑ligated standards
✦ Chimeric antibodies in low‑multiplex assays
✦ AI‑powered spatial proteomic mapping in AD
Join us at AD/PD 2026 in the Danaher booth (#15a) to dive deeper and meet the team. See you there! 👋🔬
#adpd2026 #scientificposters #neuroscience #alzheimersdisease #antibodyvalidation #neuroresearch #lifescienceresearch #abcam -
Abcam
@abcam
Today, we’re also spotlighting Amy McCann, Senior Director of Research Solutions at Abcam, whose career sits at the powerful intersection of STEM, business strategy, and customer impact.
Amy’s path, from early roles at Cytiva and Revvity to leading portfolios across drug discovery, NGS, and spatial biology, shows how stepping beyond traditional expectations can unlock new opportunities. Along the way, the advocacy of a strong ally encouraged her to share her perspective more confidently, shaping the leader she is today.
With executive leadership certifications from Bentley University and the Yale School of Management, Amy continues to champion environments where diverse voices are heard and valued.
✨ “Working at the intersection of STEM and business, there are far fewer women’s voices. It’s important to find advocates and mentors. Realize you have an opportunity to be heard and share your often unique perspective. Commit to paving the way for our daughters and sons.”
#careerjourneys #belongingatwork #leadershipdevelopment #givetogain #iwd2026 #womeninscience -
Abcam
@abcam
As we celebrate the diverse career journeys that enrich our global community during International Women’s Day, we’re highlighting Junli Yu, Vice President of the Antibody Development Platform and Hangzhou Site Head at Abcam.
From her postdoctoral work at Memorial Sloan Kettering Cancer Center to leadership roles spanning drug development, diagnostics, and life sciences, her cross‑disciplinary path reflects courage, adaptability, and a commitment to creating environments where teams can do their best work. Today, she leads teams responsible for developing hundreds of high‑quality monoclonal antibodies each year, contributing to breakthroughs across research and healthcare.
✨ “Keep positive and just do it.”
A guiding approach that continues to inspire collaboration and progress across our organization.
#careerjourneys #belongingatwork #lifesciences #leadership #innovation #givetogain #iwd2026 #womeninscience -
Abcam
@abcam
As we recognize the many paths that shape meaningful work during International Women’s Day, we’re proud to spotlight Suzanne Brewerton, Director of Applications and Automation at Abcam, whose “squiggly career” highlights how diverse experiences strengthen a sense of belonging and innovation across our organization.
From her Cambridge PhD to roles in bioinformatics, global pharma, and start‑ups, Suzanne has shown how curiosity, continuous learning, and stepping beyond comfort zones can accelerate both personal growth and scientific discovery. Today, she leads teams transforming how digital and data are used to enable faster, smarter R&D.
✨ “Say yes to opportunities outside your comfort zone — that’s where the real learning and real joy lie.”
#careerjourneys #belongingatwork #digitalinnovation #ai #leadership #givetogain #cbctalentprogramme #iwd2026 #womeninscience #squigglycareer -
Abcam
@abcam
Avoid common pitfalls in IHC validation — Join our free webinar on March 24, 4 pm GMT
The success of your spatial assay starts with well‑validated IHC antibodies, and it’s worth exploring what it really takes to make them truly reliable.
Join Drs Will Howat and Silvia Sbacchi as they break down the four pillars of successful IHC validation, including how to prepare your materials, ensure consistent performance, build predictability into your workflow, and avoid the common pitfalls that can compromise your spatial experiments.
Register for free: events.abcam.com/event/IHCValidationWebinar
#spatialbiology #immunohistochemistry #antibodyvalidation #scientificwebinar -
Abcam
@abcam
Meet Abcam at AD/PD 2026 — advancing neuroscience together
Find us at the Danaher booth (#15a), where we’re partnering with Beckman Coulter Diagnostics to showcase tools accelerating neurodegenerative disease research and the future of diagnostic innovation.
Stop by to explore how Abcam is empowering neuroscience breakthroughs with:
🔥 SimpleStep Ignite™ ELISA, results in 55 min
🔥 Imaging antibodies to >95% of core AD targets
🔥 >4,900 knockout validated antibodies
🔗Learn more: lifesciences.danaher.com/us/en/events/adpd2026.html.html
#adpd2026 #neuroscienceresearch #alzheimersresearch #neurodegeneration #danaher #abcam #beckmancoulterdiagnostics -
Abcam
@abcam
Unlock your potential in chromatin biology with our two-week summer school, held at Helmholtz Munich on August 17-29.
Our scientific organizers from Epigenetics @HelmholtzMunich, Robert Schneider, Maria-Elena Torres-Padilla, and Aloys Schepers, have put together a fantastic faculty of experts who will guide you through hands-on lab training and inspire you with daily lectures.
Apply by March 29 to be considered for one of the 14 places available, including two sponsored spots reserved for students from low-income countries. Please note that sponsorship applications are due by February 27.
Don’t just take our word for it – here’s what previous students thought 👉events.abcam.com/event/HelmholtzSummerSchool2026/testimon…
#chromatinbiologysummerschool2024 #careerdevelopment #researchskills #epigenetics -
Abcam
@abcam
Cell Cycle Club is back for 2026!
Join us on March 26 as we bring together researchers from around the world for an informal forum to share novel research findings, exchange ideas, and foster new collaborations within the cell cycle research community.
Opportunities for short talks and breakout sessions-submit your abstract by March 13 and join the conversation.
Register for free: events.abcam.com/event/CellCycleClub2026/home -
Abcam
@abcam
His-tag assays reimagined.
Discover how CaptSure™ technology powers our competitive SimpleStep ELISA® for polyhistidine tags—delivering efficiency and accuracy for your workflows.
🔗Learn more: lifesciences.danaher.com/us/en/events/slas2026.html -
Abcam
@abcam
Quantifying small molecules and PTMs doesn’t have to be complex.
Our SLAS 2026 poster reveals how a 90-minute, one-wash SimpleStep ELISA® streamlines workflows without compromising accuracy.
🔗Learn more: lifesciences.danaher.com/us/en/events/slas2026.html -
Abcam
@abcam
High-throughput screening made simple.
At SLAS 2026, we’ll show you how SureFire® and SimpleStep ELISA® combine speed, sensitivity, and precision for drug discovery research.
Don’t miss this deep dive into next-gen immunoassays.
🔗Learn more: lifesciences.danaher.com/us/en/events/slas2026.html -
Abcam
@abcam
High-throughput screening made simple.
At SLAS 2026, we’ll show you how SureFire® and SimpleStep® ELISA combine speed, sensitivity, and precision for drug discovery research.
Don’t miss this deep dive into next-gen immunoassays.
🔗Learn more: lifesciences.danaher.com/us/en/events/slas2026.html -
Abcam
@abcam
We’re heading to SLAS 2026!
Find Abcam at the Danaher booth (#2108) and discover how SimpleStep® ELISA kits simplify your workflow with fast, one-wash assays.
🔗Learn more: lifesciences.danaher.com/us/en/events/slas2026.html -
Abcam
@abcam
We are proud to be part of #ligand-AI, a new @IHIEurope bringing together global partners to accelerate AI-driven drug discovery through open science. The consortium will create large, open datasets of protein–ligand interactions to help build predictive AI models for thousands of human proteins.
🔗Learn more at www.abcam.com/en-us/press-releases/abcam-joins-the-innova…
#target2035 #ligandai #ihifunded #horizoneurope #openscience #drugdiscovery #ai #machinelearning #fairdata #opendata #lifesciences #publicprivatepartnership #healthinnovation -
Abcam
@abcam
We’re excited to be at the 11th annual Festival of Genomics & Biodata in London on January 28-29. We believe the scientific community can go further, faster when we go there together.
Visit us at booth #70 to learn how Abcam can help accelerate your discoveries with cutting-edge solutions.
📆 Let’s talk Science- schedule a meeting here: calendly.com/abcam-events/book-time-with-abcam-at-festiva…
See you at The Festival! -
Abcam
@abcam
InflammaZoom is back for 2026! Kick off the year with a deep dive into innate immunity and inflammasome biology. Register once and unlock access to every session all year long — your all-access pass to cutting-edge inflammation research.
Join us on January 19, 2026, from 1:00 pm - 2:00 pm GMT and hear from:
✔Katia Cosentino (University of Modena and Reggio Emilia, Italy)
✔Tanita Wein (Weizmann Institute of Science, Israel)
Register now: events.abcam.com/event/Inflammazoom2026/home -
Abcam
@abcam
Accelerate your spatial biology research with tools tested by experts.
Explore our new spatial biology antibody database, featuring clones tested across a range of platforms.
Learn more: www.abcam.com/en-us/products/product-recommendations/spat… -
Abcam
@abcam
Premium quality. More accurate results.
Reliable results start with tools you can trust.
That’s why our recombinant monoclonal
antibodies are extensively validated to
ensure specificity - helping you move your
research forward, faster.
Explore the range www.abcam.com/en-us/products/primary-antibodies/monoclona… -
Abcam
@abcam
Keep your IHC and ICC workflows running smoothly with our everyday imaging essentials.
From antibodies to accessories, our imaging lab essentials offer everything you need to support consistent, high-quality results in your experiments.
Explore our range and find out how we can help you detect a broad range of cellular targets, including structural markers, organelles, cell fate markers, and key targets that drive complex disease phenotypes: www.abcam.com/en-us/products/product-recommendations/imag… -
Abcam
@abcam
Find what you need to speed up your Alzheimer's disease
research.
This includes antibodies to 95% of core AD genes validated in
imaging applications with human samples.
Explore our extensive portfolio of monoclonal and
conjugated antibodies, delivering reliable and reproducible
results from your first experiment.
www.abcam.com/en-us/products/product-recommendations/alzh… -
Abcam
@abcam
🚀 New panel builder to supercharge your flow cytometry experiments!
Design optimized multicolor panels with our flow cytometry panel builder and visualize fluorophore spectra in real time with our spectra viewer.
🔧 Build smarter panels
🔬 Compare spectra with precision
🤝 Access our catalog of fluorescent conjugates
Explore now:
🔗 Panel builder: www.abcam.com/en-us/technical-resources/applications/flow…
🔗 Spectra viewer: www.abcam.com/en-us/technical-resources/applications/flow… -
Abcam
@abcam
🔥 InflammaZoom is back! 🔥
Join us on December 15 from 1:30–2:30 PM GMT for a deep dive into innate immunity and inflammasome biology.
Hear from leading experts Siddharth Balachandran (Fox Chase Cancer Center, United States) and Marcus Taylor (Max Planck Institute for Infection Biology, Germany).
Don’t miss the opportunity to expand your knowledge and connect with the community!
Register now: events.abcam.com/event/Inflammazoom2025/home
#inflammazoom #innateimmunity and #inflammasome biology -
Abcam
@abcam
Thanks to Arindam Bose from Leica Microsystems for kicking off our tech talks this afternoon! His talk, "Decoding AD: spatial proteomics via multiplex immunostaining and AI" was incredibly insightful and we had a fantastic turn out.
Catch the next one at booth #2221 tomorrow: "Multiplex made easy: one clone, many species" at 11.30am.
#sfn25 -
Abcam
@abcam
Calling all AD researchers at SfN! Head to poster position D22 and speak to our Director of Validation, Antonella, about how our chimeric antibodies can move your AD research forward 🧠
-
Abcam
@abcam
Heading to SfN 2025 in San Diego?
Visit booth #2221 and step into our Neuro Nook: a hub for thought-provoking sessions that spark discovery. Each day we’re hosting a different talk featuring insights from neuroscience experts and innovators, including talks on multiplex, Alzheimer’s disease, and more. Connect, share ideas, and help move neuroscience forward one conversation at a time.
See you there 👋#sfn25 -
Abcam
@abcam
One bottle of InstantBlue® Coomassie Protein Stain (ab119211) is sold every 9 minutes.
Why? Because scientists love its speed, sensitivity & simplicity.
✅ Stains in just 15 minutes — no destain needed.
Swipe through honest reviews from researchers who rate it exceptionally high.
🔗 www.abcam.com/en-us/products/reagents/instantblue-coomass…
#proteinstain #lablife #biotech #instantblue #coomassie #lifescience -
Abcam
@abcam
It’s that time again… where science meets innovation at SfN 2025! 🙌
We’re thrilled to be part of this year’s Society for Neuroscience Annual Meeting, taking place in San Diego, CA, from November 16-19.
As the premier global event for neuroscientists, SfN is where emerging science is unveiled, collaborations are sparked, and the latest tools and technologies take center stage. We’ve got a lot in store this year–so be sure to swing by booth #2221 and join the fun 😎
Here’s what’s happening:
✨ Expert-led poster sessions – Five sessions throughout the meeting, featuring fresh research and insights from our team
🧠 Tech Talks in the Neuro Nook – In-booth discussions on cutting-edge tools shaping the future of neuroscience
🌐 Full schedule available here → events.abcam.com/neuroscience2025
Whether you're here to learn, connect, or collaborate, we can’t wait to meet you and explore what’s next in neuroscience.
#sfn2025 #neuroscience -
Abcam
@abcam
Last night’s #abcamhalloween Social was a frightfully good time! 🎃👻
From pumpkin carving and candle decorating to a Murder Mystery showdown, our teams brought the spooky spirit to life at Molly’s.
Costumes, creativity, and community!
Thanks to R&D, IHM & Logistics for hosting.
#halloween2025 #lifeatabcam #officefun -
Abcam
@abcam
🎉 Heading to SITC 2025? Let’s connect! Stop by booth #705 (inside Leica Biosystems) to explore how we can support your research with trusted tools and expert insights.
As a thank you for your continued partnership and dedication, please join Abcam and @LeicaBio on Friday, November 7, from 7:00-9:00 pm at our customer appreciation event. Enjoy an evening of live music, complimentary appetizers, drinks, and great company.
📍 Bobby McKey’s Dueling Piano Bar
📌 172 Fleet Street, National Harbor, MD 20745
👉 Register for free via the link in our bio -
Abcam
@abcam
Accelerate biomarker discovery with confidence and clarity.
Biomarker research is advancing rapidly, and your tools should keep pace. At Abcam, our SimpleStep ELISA® Kits are engineered to deliver speed, precision, and efficiency, helping you streamline your workflows and generate high-quality data faster.
We’ve partnered with @moldev to help you get started:
✔ Save up to 50% on our SimpleStep ELISA® Kits.
✔ Save up to 20% on Molecular Devices’ SpectraMax® i3x Multi-Mode Reader.
Whether you're optimizing throughput or improving reproducibility, our solutions are designed to move your research forward.
Learn how to optimize your workflow and redeem offers here: info.moleculardevices.com/en-us/ppc/br/accelerate-biomark… -
Abcam
@abcam
🧠 Accelerate your Alzheimer's research with confidence
Discover Abcam’s curated portfolio of gold-standard recombinant antibodies and sensitive ELISA kits, validated in AD patient samples and optimized for Tau, Beta-amyloid, and other key targets.
✅ Generate 300% more data from precious samples with 384-well SimpleStep ELISA® kits
✅ Explore conformation-specific Tau antibodies and matched pairs
✅ Rely on award-winning batch-to-batch consistency
However you’re studying Alzheimer’s, we’ve got everything you need in one place.
🔗 Browse the full collection now: www.abcam.com/en-us/products/product-recommendations/alzh… -
Abcam
@abcam
Did you know that we offer over 3,000 recombinant antibodies in 20 µL trial sizes?
Whether you're optimizing your assay or exploring new targets, our trial sizes give you the flexibility to test before you commit, saving time, resources, and budget.
Explore the full range and find the perfect fit for your research: www.abcam.com/en-us/technical-resources/product-overview/… -
Abcam
@abcam
🚨 Live #immunology webinar 20th October at 2:00 pm BST 🚨
Tune in on Monday to hear from James Murphy (WEHI) and Jonathan Maelfait (VIB-UGent Center for Inflammation Research) at #inflammazoom, our free webinar series on #innateimmunity and #inflammasome biology.
Register for free: events.abcam.com/event/Inflammazoom2025/home -
Abcam
@abcam
Thank you to everyone who attended Mapping Biology to Transform Cancer Therapeutics last week⭐
The conference featured a brilliant lineup of speakers working at the forefront of spatial biology, systems biology, and translational oncology, focusing on four pillars:
🎯Targeting immune and lymphatic landscapes
🔍Spatial and functional atlases for cancer discovery
🧪Charting cell death for cancer targeting
Navigating regulatory networks for predictive biology
A huge shoutout and thank you to our fantastic host Jessalyn Ubellacker, Assistant Professor in the Department of Molecular Metabolism at the Harvard T. H. Chan School of Public Health. It was a real pleasure! -
Abcam
@abcam
Join us for our Digital Cell Cycle Club on October 15, a global forum for sharing cutting-edge research, sparking new ideas, and building collaborations across the cell cycle community.
This time, we’re excited to be joined by keynote speaker Christine Jacobs-Wagner, HHMI Investigator and Professor at Stanford University.
Register now for free: events.abcam.com/event/cellcycleclub/home -
Abcam
@abcam
Heading to SITC 2025? Abcam and Leica Biosystems are teaming up to deliver trusted antibody solutions that are seamlessly integrated into your staining workflow. Visit us at booth #705, then join us Friday night, November 7, for an evening of celebration – our way of saying thank you for your partnership in advancing science.
🎹 Bobby McKey’s Dueling Piano Bar
📍 172 Fleet Street, National Harbor, MD 20745
Enjoy complimentary appetizers, drinks, and an unforgettable show in the company of fellow researchers.
Register for free at events.abcam.com/event/SITC2025 -
Abcam
@abcam
Planning an IHC experiment? We’ve got you covered from start to finish.
Download our comprehensive IHC guide for expert tips on tissue processing, antibody selection, detection methods, controls, antigen retrieval, and troubleshooting: www.abcam.com/en-us/technical-resources/guides/ihc-guide -
Abcam
@abcam
InflammaZoom is back on October 20. Tune in from 2:00 to 3:00 PM BST for a deep dive into innate immunity and inflammasome biology.
Hear from James Murphy (WEHI, Melbourne, Australia) and Jonathan Maelfait (VIB-UGent, Ghent, Belgium).
Register now: events.abcam.com/event/Inflammazoom2025/home
#inflammazoom #innateimmunity #inflammasomebiology -
Abcam
@abcam
A new chapter for Abcam’s Shanghai office ⭐
At the beginning of September, Abcam’s commercial team in Shanghai officially joined sister company @Cytiva at the GE Science Park in Shanghai – a milestone that brings our teams closer together and strengthens collaboration across the Danaher family.
We marked the occasion with a warm lunchtime gathering, joined by colleagues from Abcam, @Cytiva, and Danaher China. It was more than a move – it was a celebration of shared purpose, connection, and the exciting possibilities ahead. -
Abcam
@abcam
Western blotting may be 40+ years old, but it’s still unlocking answers in research today.
In our on-demand webinar, we walk you through the western blot process, including how to choose the right samples, select proper controls, and pick the best-suited antibodies. Watch it now: www.abcam.com/en-us/webinars/western-blotting-at-40 -
Abcam
@abcam
Our troubleshooting guide will help you to find solutions for common problems in IHC, such as high background, no staining, and non-specific background. Get back on track in no time with expert support, high-quality antibodies, and streamlined workflows. www.abcam.com/en-us/technical-resources/applications/immu…
-
Abcam
@abcam
Watch our on-demand webinar for tips and techniques needed to overcome common IHC and ICC staining challenges covering single and multiple labels. Get it here: www.abcam.com/en-us/webinars/ihc-and-icc-staining-using-s…
-
Abcam
@abcam
We've pulled together an easy-to-follow guide to help you find the stains most suited to your experiment. Find out what special stains are used for, what to do if your primary antibody is visualized with a chromogen, and more 👉 www.abcam.com/en-us/products/selection-guides/ihc-stains-…
-
Abcam
@abcam
🗓️ Join us on Oct 6 at Harvard Medical School for Mapping Biology to Transform Cancer Therapeutics, a dynamic, free conference spotlighting an exceptional lineup of speakers who each bring unique insights that are shaping the future of #cancertherapeutics.
🔗 Register free: -
Abcam
@abcam
🧬 Cell Cycle Club returns Oct 15
A global forum to share cutting-edge research, spark ideas & build collaborations.
💬 Host a breakout or give a short talk
📅 Submit your abstract by Oct 3
✅ Click the link to register for free now: events.abcam.com/event/cellcycleclub/home
#cellcycleclub #cellbiology #scientificcommunity #researchcollaboration -
Abcam
@abcam
We have a wealth of resources available to assist you in key workflows, like our IHC-P protocol: curated by our in-house experts to guide you from sample preparation to detection. See the protocol here: www.abcam.com/en-us/technical-resources/protocols/ihc-wit…
-
Abcam
@abcam
Today is #worldalzheimersday.
Over 55 million people live with dementia globally, with 10 million new cases each year.
At Abcam, we support researchers with tools to uncover the biology of Alzheimer’s and drive breakthroughs in neurodegenerative disease. Together, we can advance science.
Learn more: www.abcam.com/en-us/technical-resources/research-areas/ne…
For more info about World Alzheimer’s day, visit www.alz.org/about/awareness-initiatives/world-alzheimers-day
#neuroscience #alzheimersresearch #abcam -
Abcam
@abcam
Follow our easy-to-use western blot protocol for a step-by-step guide to mastering the technique, powered by high-quality antibodies from our lab essentials range, offering exceptional value without compromising performance.
Explore now: www.abcam.com/en-us/technical-resources/protocols/western… -
Abcam
@abcam
At #abval2025, Abcam’s Joyce & Matthew showed how knockout cell lines are enhancing antibody validation.
Targeted gene editing = more reliable results, backed by robust data.
🔬 Science driving reproducibility.
@CiteAb @UniofBath -
Abcam
@abcam
Did you know that we recently reduced prices across our catalog?
This includes reductions on 80% of our top-rated monoclonal and polyclonal antibodies, so you can get the same trusted quality at a lower price. Find out more: www.abcam.com/en-us/technical-resources/product-overview/… -
Abcam
@abcam
We had a brilliant time at today’s #antibodysymposium in Cambridge.
✅ 5 expert talks
✅ Panel discussion
✅ Networking lunch
Thanks to all our speakers from @abcam, @mcgillu, @AstraZeneca & more for sharing insights on antibody selection & validation.
#reproducibleresearch #lifesciences #abcamevents -
Abcam
@abcam
Present your research at #mappingbiologytotransformcancertherapeutics2025 this October at Harvard Medical School. Submit your abstract and register for free admission by Sept 25 👉 events.abcam.com/event/mappingbiologytotransformcancerthe….
-
Abcam
@abcam
Science moves faster when we move forward together. To support researchers facing financial pressures across the industry, we’re reducing prices on thousands of products – including antibodies at up to 67% off.
www.abcam.com/en-us/technical-resources/product-overview/… -
Abcam
@abcam
Brush up on the ins and outs of western blot, including recipes for buffers and stock solutions, recommended controls, sample preparation, and more in our complete guide. Get your guide here: www.abcam.com/en-us/technical-resources/guides/western-bl…
-
Abcam
@abcam
Consider your imaging workflows covered with our lab essentials rage: a collection of everything you need for IHC and ICC in one place. This includes common markers like our Anti-Histone H3 antibody - Nuclear Marker and ChIP Grade (ab1791). www.abcam.com/en-us/products/product-recommendations/imag…
-
Abcam
@abcam
🔬 Reliable Results, Every Time
Our ELISA kits come fully equipped with everything you need to detect and quantify antigens in biological samples - no guesswork, no hassle. Built on high-quality matched antibody pairs, they deliver consistent, reproducible results you can trust.
💡 Ready to simplify your assays? Explore our ELISA kits today. www.abcam.com/en-us/products/elisa-kits -
Abcam
@abcam
Manifesting a productive week for you 👊 🚀
-
Abcam
@abcam
This year at EACR, we were delighted to connect with many of our customers, gaining insights into their research and how they use Abcam products. Here, Serena Tondi from the Candiolo Cancer Institute shares her research on orthotopic pancreatic cancer and how Abcam products helped her analysis.
“I'm Serena Tondi, a postdoctoral researcher at the Candiolo Cancer Institute in Turin.
My research mainly focuses on pancreatic cancer, specifically on immune therapies. I developed an orthotopic pancreatic cancer model in mice, and I treat these tumors with different immune therapies, mainly CAR T cells. The goal is to reprogram the tumor microenvironment to improve the efficacy of CAR T cell therapy and create a more immuno-permissive environment.
I use Abcam products during the analysis phase after tumor explant. At the end of the experiment, I remove the tumor and perform two types of analysis: flow cytometry on one side, and on the other, I use Abcam antibodies to stain tissue sections for immunofluorescence.
I choose Abcam antibodies because, in my experience, they’ve provided the best performance. I’ve used antibodies targeting immune cell populations, especially the directly conjugated ones. After the analysis – particularly after acquisition – the image quality was excellent, and the product quality overall convinced me to keep using them.
I have no negative feedback – so far, my experience has been very positive. I've used a small panel of antibodies, but my plan is to expand that panel for immunofluorescence and hopefully work more closely with you to build it out using additional antibodies.” -
Abcam
@abcam
Join us in Boston this October for a 1-day conference dedicated to #mappingbiology to transform #cancertherapeutics. Registration is now open - visit the website to explore topics, confirmed speakers, and talk opportunities! abcam.me/mappingbiology2025
#mappingbiologytotransformcancertherapeutics2025 -
Abcam
@abcam
Ever felt overwhelmed by antibody product data? 🧬
You’re not alone. Product data pages (PDPs) are full of useful info – but decoding them can feel like solving a puzzle. The trick? Knowing what to look for and where to ask questions.
👉 Want to make smarter antibody choices?
Check out our quick guide to mastering PDPs and take the stress out of your search for the perfect antibody. www.abcam.com/en-us/stories/articles/how-to-read-antibody… -
Abcam
@abcam
Spend less time searching and more time discovering with our comprehensive antibody solutions. Designed to streamline your imaging workflow, our extensive catalog of reagents – validated in primary cell cultures and disease samples – enables you to simplify your workload and accelerate your research.
Discover how we can simplify your AD research now: www.abcam.com/en-us/technical-resources/research-areas/ne… -
Abcam
@abcam
This year at EACR, we were delighted to connect with many of our customers, gaining insights into their research and how they use Abcam products. Here, Berina from the Candiolo Cancer Institute shares her research on pancreatic cancer and how Abcam antibodies were used to identify CTCs:
“My name is Berina Sabanovic, and I work at Candiolo Cancer Institute on pancreatic cancer. I’m isolating circulating tumor cells to identify cancer stem cells within this population. After positive identification, I perform single-cell RNA sequencing to discover novel targets that could support the development of personalized medicine.
I’ve used Abcam antibodies for identifying CTCs. I worked with a panel of four antibodies, which helped pinpoint my population of interest – thanks to Abcam’s broad portfolio, especially their directly conjugated options. Since I needed four antibodies, the fluorochromes had to be spaced far apart, and Abcam’s catalog made that possible.
My experience with Abcam has been very positive – both with this project and past ones. And whenever I’ve needed help with troubleshooting or contacted a specialist, the responses were always fast and relevant. So, keep up the great work. Thank you!”
If you ever need support troubleshooting your experiment, our specialists are here for you - every step of the way. Because in science, the work never stops, and neither do we. -
Abcam
@abcam
Save time, effort and money by choosing and validating the right antibody. Bringing together thought leaders from academia and industry, join us for a live symposium that explores practical solutions for finding and using antibodies to support robust and reproducible scientific research.
Register here: events.abcam.com/event/abcam_ycharos_symposium/summary -
Abcam
@abcam
Get antibodies that work first time, every time. Our enhanced IHC validation standard goes above and beyond. We validate up to 400 tissue cases for some of our best recombinant antibodies.
www.abcam.com/en-us/stories/articles/ihc-enhanced-validation -
Abcam
@abcam
With our lab essentials range, you can get everything you need for western blot in one place. This includes our Anti-mCherry antibody, rated 5* by customers. Discover our lab essentials, including tags and loading controls, here: www.abcam.com/en-us/products/product-recommendations/stai…
-
Abcam
@abcam
Starting a new lab is no small feat, especially when you’re on a tight timeline. When Nūmi® reached out with an urgent request – needing products and support to open a brand new lab – our French-speaking Customer Service team acted fast. Within hours, we activated a new lab discount, walked them through onboarding, and placed the order.
In less than 48 hours, their products arrived, thanks to a coordinated effort by 8 team members across 3 countries, spanning Planning, Manufacturing, Supply Chain, Logistics, and Customer Service. Fluent in French and English, our cross-functional team worked seamlessly to deliver.
Eugénie Pezé-Heidsieck, Co-founder & CTO at Nūmi, shared:
“Je n’ai jamais vu un tel support client, mille mercis pour votre aide, vraiment.”
(“I’ve never seen such amazing customer support - thank you so much for your help, truly.”)
💡 Exceptional service is what we strive for, because progress happens together, and we're passionate about helping scientists succeed.
If you're launching a lab or navigating grants, our new lab discount could be just what you need. We’re ready to support your research: www.abcam.com/en-us/offers-and-initiatives/new-lab-program
In less than 48 hours, their products arrived, thanks to a coordinated effort by 8 team members across 3 countries, spanning Planning, Manufacturing, Supply Chain, Logistics, and Customer Service. Fluent in French and English, our cross-functional team worked seamlessly to deliver.
Eugénie Pezé-Heidsieck, Co-founder & CTO at Nūmi, shared:
“Je n’ai jamais vu un tel support client, mille mercis pour votre aide, vraiment.”
(“I’ve never seen such amazing customer support - thank you so much for your help, truly.”)
💡 Exceptional service is what we strive for, because progress happens together, and we're passionate about helping scientists succeed.
If you're launching a lab or navigating grants, our new lab discount could be just what you need. We’re ready to support your research: www.abcam.com/en-us/offers-and-initiatives/new-lab-program -
Abcam
@abcam
From imaging antibodies covering 95% of core Alzheimer’s disease targets to expert-backed resources and guidance, we bring you complete research solutions. Discover our resources now, including marker guides, pathways, and more.
Neural Markers Guide: go.myabcam.com/neural-markers-guide
Alzheimer's interactive pathway: go.myabcam.com/alzheimers-interactive-pathway
Alzheimer’s hub page: Alzheimer's Disease Research Tools: www.abcam.com/en-us/products/product-recommendations/alzh… -
Abcam
@abcam
As costs rise across the industry, researchers are under increasing pressure to do more with less. That’s why we’re lowering prices on thousands of our most in-demand antibodies – so you can stay on track and on budget. Learn more: www.abcam.com/en-us/technical-resources/product-overview/…
-
Abcam
@abcam
When every sample matters, choose antibodies built for reproducibility and reliability. Independent testing by YCharOS in 2024 shows our precision antibodies achieve a 63% higher success rate on average compared to competitors.
Dig into the numbers here: www.abcam.com/en-us/stories/articles/ycharos-results-of-a… -
Abcam
@abcam
Alzheimer’s disease begins long before symptoms appear - often up to 20 years prior.
Despite this, most diagnoses still occur only after cognitive decline becomes evident and irreversible. Today, biomarkers are changing that trajectory.
By enabling earlier detection and offering deeper molecular insights, biomarkers are revolutionizing Alzheimer’s research, diagnosis, and patient care.
Learn why biomarkers matter: www.abcam.com/en-us/stories/articles/biomarkers-in-alzhei… -
Abcam
@abcam
We’re committed to remaining your go-to for high-quality antibodies, which is why we’ve reduced prices on thousands of our most in-demand products, with 80% of our most popular monoclonal and polyclonal antibodies now available at new lower prices. www.abcam.com/en-us/technical-resources/product-overview/…
-
Abcam
@abcam
Find what you need to speed up your Alzheimer's disease imaging experiments. This includes antibodies to 95% of core AD genes validated in imaging applications with human samples.
Discover our antibodies now, including chimeric, conjugated, and recombinant antibodies for batch-to-batch consistency. Learn more: www.abcam.com/en-us/products/product-recommendations/alzh… -
Abcam
@abcam
Drive 25% higher success in WB and ICC when using Abcam’s recombinant rabbit monoclonal antibodies made using our RabMab® technology. Learn more: www.abcam.com/en-us/stories/articles/ycharos-results-of-a…
-
Abcam
@abcam
Attending AAIC 2025 in Toronto?
Visit Abcam at one of Beckman Coulter’s educational symposia!
📅 Don’t miss out—register now: www.beckmancoulter.com/en/learning-and-events/events/aaic… -
Abcam
@abcam
We’re excited to share that our Labs and Logistics teams have officially achieved a platinum My Green Lab certification! 🌟
My Green Lab is a non-profit organization with a mission to build a global culture of sustainability in science. They are dedicated to promoting safe, sustainable practices in research laboratories, while still preserving the integrity of the science.
My Green Lab covers 14 sustainable topic areas such as infrastructure energy, waste, resource management, cold storage, plug load, water, travel, purchasing etc.
Here’s Matt to tell us more! -
Abcam
@abcam
Introducing our Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker: highly cited, rated 5* by customers, and now available at a reduced price as part of our lab essentials range along with many other common markers. Discover more here: www.abcam.com/en-us/products/product-recommendations/imag…
-
Abcam
@abcam
We’re proud to share that our Cambridge UK site holds a Human Tissue Authority (HTA) licence. This is a fantastic achievement and a testament to the dedication of our HTA team (pictured) and all associates working with human biological materials.
Holding a HTA licence allows us to store and use human biological samples for research, provided we meet regulatory standards. These standards are regularly monitored by the HTA to ensure full compliance.
Under our HTA licence, we use human biological materials (blood, tissue, cells) to validate antibodies through techniques such as:
- Immunohistochemistry (IHC)
- Western blot
- Immunocytochemistry (ICC)
- Flow cytometry
👏 A huge thank you to our HTA team and everyone involved! -
Abcam
@abcam
Rest assured in the quality of your antibodies. Ranked first in independent validation studies by YhcarOs in 2024. Learn more here: www.abcam.com/en-us/stories/articles/ycharos-results-of-a…
-
Abcam
@abcam
🌈 This June, Abcam celebrated #pridemonth with vibrant events, heartfelt conversations, and a deep commitment to inclusion. From tie-dye and drag bingo to powerful safe-space talks and stories of allyship, we honored the LGBTQ+ community with pride and purpose.
Inclusion isn’t just a value - it’s a practice. Thank you to all our associates who made this month meaningful. We’re proud to continue building a workplace where everyone feels seen and supported. 🏳️🌈 -
Abcam
@abcam
📚 Be part of our Cell Cycle Conference, where innovation meets collaboration within the #cellcycle research community. This half-day event features keynote speaker Professor Susana Godinho from (@QMUL.) Register now to join us at @TheCrick in London or online on July 15:
-
Abcam
@abcam
"We can explore the patterns in patients' tumors that are linked to response or resistance to therapy and, ultimately, determine how to build translational, predictive signatures that can be applied in the clinic."
Our interview with Arutha Kulasinghe, Associate Professor and Principal Research Fellow, Clinical-oMx Lab, University of Queensland, was truly fascinating; he shared his insights into the computational challenges of spatial biology, the power of AI-driven insights, and the exciting potential to democratize spatial tools.
Read the full article here: www.abcam.com/en-us/stories/articles/aacr-interview-serie… -
Abcam
@abcam
Things you may not know about Abcam Scientific Support...
We operate in:
Cambridge, UK / Amsterdam, NL / Boston, MA / Eugene, OR / Shanghai, CN / Singapore, SG / Tokyo, JP
We speak:
English / German / French / Spanish / Chinese / Japanese
All this with 24/5 English Speaking support. That’s 24 hours a day for 5 working days a week. We know science doesn’t sleep, which is why we’re committed to support you every step of the way. -
Abcam
@abcam
We’re thrilled to be at #aaic2025 in Toronto, Canada! 🧠🧪🔬
Visit us at Booth #1146 to power up your research and explore new ways to advance the field.
#neuroscience #alzheimers #parkinsons
events.abcam.com/AAIC2025 -
Abcam
@abcam
Last Wednesday, our U.S. teams came together to celebrate Juneteenth – the newest federal holiday marking June 19, 1865, when the last enslaved African Americans in Galveston, Texas, learned of their freedom.
Juneteenth is a time to reflect, honor Black history and culture, and recommit to a more inclusive future.
This year, we proudly co-hosted events with Danaher’s Black + Friends ARG and HOPE, Abcam’s Multicultural ERG, creating space for storytelling, cultural connection, and community joy.
From heartfelt personal stories to sweet treats in Waltham and a cookout-themed Happy Hour in Eugene, we’re grateful to everyone who joined us in honoring this important day and helped make a difference.
#juneteenth -
Abcam
@abcam
Whether you're working in IHC or ICC, we've got you covered with our lab essentials range 🧪 This includes antibodies to common markers, like our Anti-Iba1 antibody [EPR16588], now available at a lower price. Find your essentials 👉 www.abcam.com/en-us/products/product-recommendations/imag…
-
Abcam
@abcam
At #aacr25, we had the privilege of interviewing five fantastic scientists, gaining valuable insights into their world, emerging industry trends, and their vision for the future of cancer research.
"A few years ago, we didn’t have these tools – or rather, we did, but at a much lower plex, meaning we could only analyze one marker at a time. Back then, we called it microscopy."
The second interview in our series is with Anand Jeyasekharan, a medical oncologist at the National University of Singapore. Here we explore how principles from ecology and meteorology offer fresh insights into studying cancer, and the critical need for standardization and optimization in emerging clinical technologies.
Read the full interview here: www.abcam.com/en-us/stories/articles/aacr-interview-serie… -
Abcam
@abcam
Discover a newly developed and validated antibody panel, tested across four distinct human tissue types.
When integrated with the Cell DIVE™ multiplexed imaging platform, this panel enables in-depth analysis of cell-cell interactions and multi-marker colocalization, offering powerful insights into the cellular landscape of inflammatory diseases.
View the application note here: docs.abcam.com/pdf/immunology/highly-multiplexed-ihc-appl… -
Abcam
@abcam
🧬Join us for our next #cellcycleclub Conference @thefranciscrickinstitute in London or online on July 15. 👉👉Short talks and posters welcomed at events.abcam.com/cellcycleclub
-
Abcam
@abcam
At #aacr25, we had the privilege of interviewing five fantastic scientists, gaining valuable insights into their world, emerging industry trends, and their vision for the future of cancer research.
"To ensure high-quality antibodies for all our target molecules, Abcam was the most obvious choice. Their extensive catalog and reliability make them a great fit for our research.”
In our third interview, Professor Itay Tirosh from the Weizmann Institute of Science shared insights into his research on tumor cell diversity, the rising prominence of spatial technologies in cancer analysis, and his collaboration with Abcam to enhance spatial proteomics for a deeper understanding of tumor ecosystems.
Read the full interview here: www.abcam.com/en-us/stories/articles/aacr-interview-serie… -
Abcam
@abcam
Get our top-rated Anti-beta Actin antibody [mAbcam 8226] - Loading Control (ab8226), and have confidence that you're getting exceptional value. Learn more here: www.abcam.com/en-us/products/product-recommendations/stai…
-
Abcam
@abcam
As research continues to untangle the molecular pathways that drive Alzheimer’s disease (AD), the serotonin system has emerged as a key player. Read what we know so far here: www.abcam.com/en-us/stories/articles/alzheimers-and-5ht1b
-
Abcam
@abcam
📚 Explore the #cellcycle Conference program featuring keynote speaker Professor Susana Godinho from Queen Mary University of London (@officialqmul). This half-day event is free to attend – register now to join us at @TheCrick or online on July 15 👉👉 events.abcam.com/cellcycleclub
-
Abcam
@abcam
Attending EACR this year? Meet with us to learn more about how our vast range of recombinant antibodies, assay kits, cell lines and proteins can help your #cancer research move forward!
🌟 Stop by our booth #99 to chat with our onsite experts
🌟 Pre-book a meeting with us so we can discuss your research needs and support you to go further, faster
To learn more about what we’re up to at #eacr2025, visit our EACR resource hub 👉 events.abcam.com/EACR2025
#oncology #antibodies #spatialbiology #immunoassays #multiplexihc -
Abcam
@abcam
A huge thank you to Jessalyn Ubellacker, Assistant Professor in the Department of Molecular Metabolism at the Harvard T.H. Chan School of Public Health, for taking the time to meet with us at #aacr25!
Here, Jessalyn shares why it’s an exciting time to be working in lymphatic research – learn more about this fascinating area of cancer research, her lab's work on metabolic vulnerabilities and cancer metastasis, how advancements in metabolic profiling are opening new possibilities for understanding cancer progression and so much more in her full interview, available here: www.abcam.com/en-us/stories/articles/aacr-interview-serie… -
Abcam
@abcam
Starting a new lab or navigating the grant process can be challenging. At Abcam, we understand this firsthand, which is why we offer a variety of programs designed to support new labs. One of our standout offerings is the new lab discount, a valuable resource you won't want to miss. Terms and conditions apply.
www.abcam.com/en-us/offers-and-initiatives/new-lab-program -
Abcam
@abcam
Using our website's powerful search tools can make searching for the right reagents a breeze. Here’s Hannah from Abcam Scientific Support to show you how to save time and get back to your research.
-
Abcam
@abcam
Attending #eacr2025 this year? Visit us at booth #99 to learn more about how our vast range of recombinant antibodies, assay kits, cell lines and proteins can help your #cancer research move forward.
events.abcam.com/event/EACR2025
#oncology #antibodies #spatialbiology #immunoassays #multiplexihc -
Abcam
@abcam
Earlier this week, 15 dedicated Abcammers at our Waltham site came together to make a difference - one bag of trash at a time.
As part of Abcam’s One Day volunteer program, the team spent their day cleaning up a two-mile stretch along the Charles River, collecting large bags of litter and leaving the area cleaner and more inviting for the community.
Our One Day program empowers Abcam colleagues to volunteer and give back to their communities. Each colleague receives a full day’s worth of volunteer hours to support causes they care about.
Whether it’s cleaning up a local park, helping at a food bank, or supporting a charity, One Day gives us the opportunity to make a meaningful impact. 💚 -
Abcam
@abcam
Our #1 cited (CiteAb) Anti-Glutathione Peroxidase 4 antibody [EPNCIR144] is now available at a new lower price✨ Our lab essentials range is a curated collection of high-quality antibodies and accessory products to streamline your imaging workflows. Find everything you need here 👉 www.abcam.com/en-us/products/product-recommendations/imag…
-
Abcam
@abcam
🧠 May is Brain Tumor Awareness Month.
#glioblastoma (GBM) makes up 48% of all primary malignant brain tumors and can affect anyone, regardless of age, gender, or background. Despite first being identified in the 1920s, there are still only four FDA-approved treatments, and its causes remain largely unknown.
At Abcam, we're committed to supporting GBM research by providing the tools needed to accelerate discovery in this key area.
Download our interactive GBM pathway and dive into the complex signaling involved in glioblastoma and discover trusted, high-quality antibodies for your research.
#braintumorawarenessmonth #gbm #neurooncology #cancerresearch #glioblastomaawareness -
Abcam
@abcam
Great to have @StanStrawbridge with us at our Cambridge office today!
Stanley E. Strawbridge
@StanStrawbridge
Thanks to Anne Wiblin and the team @abcam for the invitation to share and discuss my research today! #stemcells #development
-
Abcam
@abcam
Join us tomorrow for two exciting talks in this hour-long session from leaders in #inflammasome research: events.abcam.com/event/Inflammazoom2025/home
🔹 Ana Tapia Abellán, PhD (Univ. of Tübingen / Santa Lucia Hospital)
The two parallel NLRP3 activation pathways: MTOC-dependent and MTOC-independent: an update
🔹 Prof. Alexander Weber, PhD (Univ. of Tübingen)
NLRP3 directly senses intracellular potassium ions
Registration is free and includes:
✔️ Reminders for future live sessions
🎥 Year-round access to recordings
🌍 A global network focused on #innateimmunity
#immunology #cellbiology #inflammazoom -
Abcam reposted
Abcam
@abcam
Attending #pegsummit this week in Boston MA? Join our Director of Antibody Development, Jayne Hammersley, to explore the development and validation of high performing #ihc antibodies for #oncology research in her lunch and learn presentation on May 14.
Learn more about Jayne’s talk here 🎤👉events.abcam.com/event/PEGS-Boston-Summit/summary -
Abcam
@abcam
The next #inflammazoom webinar is coming up on May 19, 2025 🙌
Join us for two exciting talks in this hour-long session from leaders in #inflammasome research: events.abcam.com/event/Inflammazoom2025/home
🔹 Ana Tapia Abellán, PhD (Univ. of Tübingen / Santa Lucia Hospital)
The two parallel NLRP3 activation pathways: MTOC-dependent and MTOC-independent: an update
🔹 Prof. Alexander Weber, PhD (Univ. of Tübingen)
NLRP3 directly senses intracellular potassium ions
Registration is free and includes:
✔️ Reminders for future live sessions
🎥 Year-round access to recordings
🌍 A global network focused on #innateimmunity
#immunology #cellbiology #inflammazoom -
Abcam
@abcam
Attending #pegsummit this week in Boston MA? Join our Director of Antibody Development, Jayne Hammersley, to explore the development and validation of high performing #ihc antibodies for #oncology research in her lunch and learn presentation on May 14.
Learn more about Jayne’s talk here 🎤👉events.abcam.com/event/PEGS-Boston-Summit/summary -
Abcam
@abcam
Trust in your results and reproducibility is paramount in life science research. Unfortunately, poor quality reagents still impact the field, with around 20% of protein studies using ineffective antibodies (Ayoubi, 2023).
Since 2020, Abcam has partnered with YCharOS (pronounced ‘Icarus’), an independent open-science organization, to verify the quality and consistency of our recombinant antibodies. We're proud to share that the results speak for themselves! Discover more here: www.abcam.com/en-us/stories/articles/ycharos-results-of-a… -
Abcam
@abcam
Looking for on-demand scientific support? With over 25 years of experience, we’re scientists who tailor our support to your experimental needs.
-
Abcam
@abcam
We’re proud to play a key role in scientific discovery across the globe. Community is at the heart of everything we aspire to achieve.
Take it from strategic account manager, James: “I’m inspired to serve the greater research community here.” 🌟
If you’re looking for the kind of workplace that fulfils the life science community, get in touch! Check out our careers page here: corporate.abcam.com/careers/ -
Abcam
@abcam
🚨 #bostoninteractivegliagroup returns for its annual conference this May with chairs Dorothy Schafer and Travis Faust @UMassChan and will feature keynote speaker Francisco Quintana @brighamandwomans! Learn more here 👉 events.abcam.com/event/Boston-Interactive-Glia-Group
#glialcellresearch #bigg2025 #neuroinflammation #neurodegeneration -
Abcam
@abcam
Introducing IgG2c Ly6G [1A8], a chimeric recombinant antibody developed by Dr. Emilie Stolarczyk, Dr Tatyana Chtanova and team. This breakthrough enhances neutrophil depletion in vivo, extending depletion periods and reducing injection frequency.
🔬 Key benefits:
- Extended neutrophil depletion
- Reduced injection frequency
- Enhanced experimental protocols
Kudos to the team for this game-changing innovation! Come hear about this game-changing discovery at AAI, Sunday, May 4. 🌟
#immunology #aai2025 -
Abcam
@abcam
Your western blot workflow just got simpler ✅ Get top antibodies for western blot staining at exceptional value, like our Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602). Now available for a new lower price. Discover more here: www.abcam.com/en-us/products/product-recommendations/stai…
-
Abcam
@abcam
Attending #aacr25? Catch our spotlight theater talk on April 29, 10am to hear from Itay Tirosh (Weizmann Institute of Science) share his insight into spatial proteomics of cell states and extracellular matrix in glioma and carcinoma.
#oncology #spatialbiology #antibodies -
Abcam
@abcam
Our Mission Support team is built of experts in the products we offer. If you’re unsure which product is best for your research, they’re here to provide guidance, answer your questions, and help you choose the ideal reagent or kit with confidence.
-
Abcam
@abcam
The integration of AI into drug discovery is transforming the pharmaceutical world. These cutting-edge tools are opening exceptional opportunities, such as speeding up the process of developing new medications, cutting down on costs, and boosting the chances of success for those new drugs hitting the market. However, this journey also faces challenges that need to be addressed to fully understand their potential.
In our article, we discuss the challenges, opportunities, strategies, and prospects of AI in drug discovery. Read it here 👉 www.abcam.com/en-us/stories/articles/beyond-the-lab-how-a… -
Abcam
@abcam
We’re big on development at Abcam. As we continue to grow, our people grow with us through challenging, impactful work, with the freedom to be curious and creative.
Brooke, Laboratory Support Manager, loves this about working here: “I can bring my whole self to work and use my skillset to its fullest”. 🌟
If you’re looking for an environment where you can reach your full potential, we want to hear from you! Check out our careers page here: jobs.danaher.com/global/en/abcam -
Abcam
@abcam
Attending #aacr2025 this year? Visit us at Danaher booth #3108 to learn more about how our vast range of recombinant antibodies, assay kits, cell lines and proteins can help your #cancer research move forward.
lifesciences.danaher.com/us/en/events/aacr2025/abcam-aacr…
#oncology #antibodies #spatialbiology #immunoassays #multiplexihc -
Abcam
@abcam
Meet Anna, our research areas scientific lead for metabolism 🌟 We sat down with Anna to find out a bit more about her journey through the world of research, her discoveries in the role of stem cells in cancer, and her thoughts on the future of stem cell research.
Read the full article here: www.abcam.com/en-us/stories/articles/an-interview-with-dr… -
Abcam
@abcam
With over 30 PhD-qualified scientists, we offer expertise across multiple research areas, product types, and applications. 🚀
Unlock the full potential of your research and achieve faster results with our dedicated support. -
Abcam
@abcam
Our top ICC/IHC antibodies are now available for a new lower price 🔬 This includes Anti-NeuN [EPR12763] (ab177487) which has over 1,000 citations (CiteAb) and is recombinantly manufactured for batch-to-batch consistency. Get yours now: www.abcam.com/en-us/products/product-recommendations/imag…
-
Abcam
@abcam
We’re thrilled to share that we’ve been recognized for the 11th year running by CiteAb, this year winning the Antibody Supplier Succeeding in Genetics Research, and receiving ‘highly commended’ in Recombinant Antibody Supplier of the Year 🥳
Learn more: www.abcam.com/en-us/press-releases/abcam-wins-antibody-su… -
Abcam
@abcam
The future is recombinant 💪
We’ve been leading the recombinant revolution for the last ten years. In this time, the use of monoclonal antibodies has overtaken polyclonals in the research antibody market.
Recombinant antibodies have significant benefits over polyclonals, such as batch-to-batch consistency, confirmed specificity, and ease of scalability, to name a few. Read our article to learn more about why recombinant is the way forward 🙌 www.abcam.com/en-us/stories/articles/the-future-is-recomb… -
Abcam
@abcam
When a customer at Cancer Research UK (CRUK) told us they had two weeks until their grant expired, our sales team rallied our associates from across the globe to deliver and surpass customer expectations.
Our sales support team placed the order for CRUK, all the while communicating with our demand management team on the customers’ requirements.
Our China office was the only site with the required materials, so the logistics team got on it instantly. After identifying opportunities for acceleration, multiple departments across the globe came together to drive our system and physical logistics flow.
This included expedited aliquoting, prioritized warehousing, manual internal transfer and stock allocation, as well as early preparation of export documents and customs approval.
48 hours and 12,000 miles later, CRUK’s order arrived at our UK offices at 9.20am. Our UK logistics team quickly identified and stocked the units as a priority.
The order was picked, packed and finally walked over in person to our customer at Cancer Research UK on the Biomedical Campus in Cambridge, and delivered at 12:15pm, just under three hours after arriving at Abcam.
Great customer service is the heartbeat of a business, creating loyal customers and unforgettable experiences. We’re proud to have been able to support CRUK with our unparalleled commitment to teamwork and efficiency, proving that progress truly happens together. -
Abcam
@abcam
🎓 Just finished your PhD?
Congratulations on this monumental achievement! 🎉 But once all the celebrations (of which there should be many!) are over, you might be left wondering, “what next?”.
We caught up with Pedro on navigating the diverse career paths for PhD graduates, from academia to industry, entrepreneurship, and beyond. Whether you're looking to continue your research, innovate in the corporate world, or start your own venture, we've got the insights to help you navigate your journey.
Click here to read the full article: www.abcam.com/en-us/stories/articles/so-youve-finished-yo… -
Abcam
@abcam
Attending #adpd2025?
Be sure to check out poster 441 on April 2, 8am-10am, presented by Will Howat, VP of Validation and Technical Quality at Abcam, to learn about how Abcam’s BioQC methods provide researchers with reliable, reproducible and consistent results they can count on 🌟✅
events.abcam.com/event/ADPD2025/summary
#neuroscience #alzheimers #parkinsons -
Abcam
@abcam
We’re thrilled to be at #adpd2025 this week in Vienna, Austria! 🧠🧪🔬
Visit us at Booth #01 to power up your research and explore new ways to advance the field.
events.abcam.com/event/ADPD2025/summary
#neuroscience #alzheimers #parkinsons -
Abcam
@abcam
Download our new interactive glioblastoma pathway to explore the complex signaling pathways implicated in glioblastoma pathology and discover premium antibodies to move your research forward: go.myabcam.com/glioblastoma-interactive-pathway
-
Abcam
@abcam
Since the beginning of his career, British clinical scientist Michael Stratton has made dozens of contributions to the field of cancer genetics, including leading the team that identified and mapped the BRCA2 gene in the 1990s.
Michael founded the Cancer Genome Project, where he discovered genetic mutations contributing to skin cancer and conducted ground-breaking work on DNA damage and repair in cancer cells. This work has been pivotal in identifying cancers and developing ways to prevent them.
At Abcam, we believe that breakthroughs made by one of us empower us all.
#progresshappenstogether #behindthebreakthroughs -
Abcam
@abcam
Get your lab essentials from Abcam at a new lower price. Premium quality. Exceptional value. Seamless workflows. Learn more here 👉 lifesciences.danaher.com/us/en/research-areas/loading-con…
-
Abcam
@abcam
March 24 marks World Tuberculosis (TB) Day. Since 2000, global efforts have saved 79 million lives from TB – while this is a fantastic achievement, in 2023 alone, 1.25 million people died from TB and 30,000 more fall ill every day from this preventable and curable disease.
This year, the World Health Organization are encouraging world leaders to commit, invest and deliver:
✅ Commit to fully funding TB programs, implementing WHO guidelines, and strengthening national strategies.
💰 Invest in research, innovation, and access to life-saving TB prevention and care.
🚀 Deliver by scaling up early detection, diagnosis, and treatment—especially for drug-resistant TB.
Progress is happening – 8.2 million people received TB treatment in 2023, but we must do more to close the global gap. Together, we can end TB.
Learn more: www.who.int/campaigns/world-tb-day/2025
#worldtbday #endtb #commitinvestdeliver -
Abcam
@abcam
This week the Abcam Women’s Network Employee Resource Group (ERG) had the pleasure of streaming a talk from the National Conference for Women delivered by Dr. Sue Varma on Practical Optimism: How to Create a Healthier Relationship with Work.
In this session Dr. Varma demonstrated how to have a healthier relationship with work, using her eight pillar strategy to create a work-life balance filled with joy and purpose for a more successful and fulfilling career.
We’re proud that Abcam continues to empower our associates across our business to be their authentic selves.
#abcamwomensnetwork #dei #nationalconferenceforwomen -
Abcam
@abcam
Our 20 µl trial size antibodies mean you can easily test your antibody or perform pre-screening before committing to a larger quantity. Look for the 20 µl tag on our product search results, or find out more here: www.abcam.com/en-us/technical-resources/product-overview/…
-
Abcam
@abcam
JK is back, this time with our Anti-Histone H3 antibody – proficient in various applications, just like you ✨
Get it now at a reduced price and keep moving your research forward.
www.abcam.com/en-us/products/primary-antibodies/histone-h… -
Abcam
@abcam
🌟 Meet Josie, our Head of Talent Development 🌟
At Abcam, we believe in fostering growth and development for all our employees. Whether you're looking to move around the business and try different roles or grow within your current team, we provide the support and mentorship you need to thrive.
Josie, our Head of Talent Development, shares her experience: “We’re free to share ideas, experiment, and grow in ways that matter to us.”
We’re a fast-paced environment, and we want our people to grow as our business grows. Which is why, no matter which department you’re in, you have the opportunity to develop your career, tailored to your specific aspirations.
If this sounds like the kind of environment where you’d thrive, we’d love to hear from you. Click the link to learn more about joining Abcam and view our current vacancies.
jobs.danaher.com/global/en/abcam -
Abcam
@abcam
This Ovarian Cancer Awareness Month, join us in raising awareness about ovarian cancer, a disease that affects thousands of women each year. Ovarian cancer is often called the "silent killer" because its symptoms can be vague and easily overlooked. Early detection is crucial, as the five-year survival rate is significantly higher when the disease is caught in its early stages.
Here are some key facts to know:
- 1 in 78 women will be diagnosed with ovarian cancer in their lifetime.
- There are no reliable screening tests for ovarian cancer, making awareness of symptoms even more important.
- Common symptoms include bloating, pelvic or abdominal pain, difficulty eating, and urinary symptoms.
At Abcam, we are committed to supporting research and providing high-quality products that aid in the fight against ovarian cancer. This month, let's come together to spread the word, support those affected, and contribute to the ongoing efforts to find a cure.
💙 How you can help:
- Share this post to raise awareness
- Learn about the symptoms and risk factors
- Support organizations dedicated to ovarian cancer research and patient support
Together, we can make a difference. Let's turn awareness into action and help save lives.
For more information, visit ovarian.org.uk/get-involved/campaigns/ovarian-cancer-awar… -
Abcam
@abcam
This week on Behind the Breakthroughs, we’re exploring the work of George Köhler and César Milstein
Through their research on the diversity of antibodies in the 1970s and 80s, Köhler and Milstein developed a method for producing monoclonal antibodies.
This revolutionized biomedical research. Today, monoclonal antibodies are responsible for the diagnosis and treatment of cancers, AIDS, and dozens of other diseases, saving countless lives globally.
At Abcam, we believe that breakthroughs made by one of us empower us all.
#progresshappenstogether -
Abcam
@abcam
Move your Alzheimer’s disease research forward with our interactive pathway, helping you discover precision antibodies to Tau’s domains, isoforms, and modified sites.
Check out the pathway here: go.myabcam.com/LP=4157 -
Abcam
@abcam
🌟 Meet Adam, our Senior Facilities Manager 🌟
At Abcam, we're passionate about people and creating a great collaborative workplace. That's why we strive to build environments where teams can learn from one another and thrive when working together.
Adam, our Senior Facilities Manager, says: “What I value most about Abcam is the culture of teamwork and collaboration”.
If this sounds like something you’re passionate about too, we want to hear from you. Check out our careers page here: jobs.danaher.com/global/en/abcam -
Abcam
@abcam
If you’re a new lab, have recently moved, or have just received your first grant, you can enjoy a new lab discount that includes 20% off and free shipping for three months. It only takes two minutes to apply, and you can choose when you want your three-month period to start.
Learn more here: www.abcam.com/en-us/offers-and-initiatives/new-lab-program -
Abcam
@abcam
The Digital Cell Cycle Club is taking place at 3pm today! Register for free to join us for short talks and breakout sessions, plus a keynote presentation from @harvardmed 's Dr David Pellman.
events.abcam.com/E5DAGg?RefId=cellcycle0325-sm
#cellcycleresearch #webinar -
Abcam
@abcam
This week on Behind the Breakthroughs we’re celebrating the work of Rosalind Franklin.
Rosalind Franklin's work on the X-ray diffraction images of DNA led to the discovery of the DNA double helix in the 1950s.
Her devotion to scientific research brought her very close to singlehandedly unraveling the mystery of how life is transmitted from cell to cell.
Let us know who is inspiring you this week!
At Abcam, we believe that breakthroughs made by one of us empower us all.
#progresshappenstogether -
Abcam
@abcam
🚀 Scientists discover a potential mechanism of epigenetic memory during cell division 🚀
Researchers have discovered the crucial role of the Mrc1 protein in ensuring that cells maintain their identity during division.
The research, led by Dr Sebastian Jespersen Charlton and Professor Geneviève Thon at the University of Copenhagen, identifies the fork protection complex (FPC) as crucial in maintaining epigenetic memory during cell division. The FPC promotes the recycling of parental histones, ensuring that chemical tags essential for cell identity are evenly distributed to both new DNA strands.
This discovery has significant implications for understanding certain cancers and the aging process.
"During my PhD work at the Department of Biology, we knew this protein was important for maintaining the heterochromatic state in cells. We had a good idea of how it worked, but while we had experimental data, we didn't have the tools in our lab to confirm it on a molecular level," says Sebastian Charlton, now Postdoc at the Novo Nordisk Foundation Center for Protein Research (CPR), who is the shared first author of the study.
Read the full study here 👉 www.cell.com/cell/fulltext/S0092-8674(24)00777-3 -
Abcam
@abcam
This week on Behind the Breakthroughs we’re taking it all the way back to the 17th century.
Robert Hooke was one of the most influential scientists of his time. He had an impressive ability to manipulate microscopes, unveiling the world of cells and introducing the field of cell biology.
Hooke's discoveries, including coining the term 'cell', laid the foundation for our understanding of cellular structure and function, shaping the course of modern biology as we know it.
At Abcam, we believe that breakthroughs made by one of us empower us all.
#progresshappenstogether -
Abcam
@abcam
🌟 Meet Lucia, our Customer Support Manager 🌟
At Abcam, our Customer Support team is the lifeline of our business, providing customers with on-demand access to dedicated scientists who are experts in our products. Whether it's protocol guidance or troubleshooting, we're just a click or a call away.
We support scientists from discovery through to clinical trials, giving us the privilege of witnessing their breakthroughs first-hand – something we find incredibly rewarding. As Lucia puts it, “I get to work with incredible scientists and witness their growth every day.”
Everything we do at Abcam comes back to one goal: helping scientists progress their research. Seeing their achievements first-hand is what drives us.
If this sounds like something you’re passionate about too, we want to hear from you. Check out our careers page here: careers.abcam.com/us/en/search-results -
Abcam
@abcam
Our Anti-BrdU antibody is multi-talented, just like you are ✨
Here’s JK, a validation and technical quality scientist at Abcam, with the ins and outs of this popular proliferation marker. This is one of many primary antibodies now available for 20% less – reduced prices are already applied online, so simply visit our catalog to start saving.
www.abcam.com/en-us/products/primary-antibodies/brdu-anti… -
Abcam
@abcam
Have you heard of the Abcam trial program? 🤔
The Abcam trial program enables you to work with a product in a species or application that has not previously been tested in-house with the confidence that the costs are covered, whatever your results.
Try the product, submit a review letting us know the results, and whether they’re positive or negative, we’ll give you a specific discount code for the product’s full value that you can use on a future order.
Find out more here: www.abcam.com/en-us/offers-and-initiatives/trial-program -
Abcam
@abcam
Selecting the right fluorochrome may seem challenging if you don't have the right tools.
Enter our fluorochrome chart, a convenient guide that allows you to quickly choose what fluorochromes are the most suitable for your next multiplex experiment 📊
This comprehensive chart will take you through each of the steps involved in selecting a fluorochrome and features the 30 most popular labels. Get it here: www.abcam.com/en-us/technical-resources/pathways/fluoroch… -
Abcam
@abcam
When you buy from us, you get guaranteed product quality and expert scientific support. Our Abcam product promise guarantee covers all our products and gives you peace of mind that the products you purchase will perform as indicated on their datasheet.
Under our product promise, we give you:
✔ Access to transparent, trusted data
✔ On-demand scientific support from our team of experts, tailored to you
✔ An investigation into any concerns by our dedicated quality control experts
✔ Fast, easy delivery so you can keep moving your research forward
To learn more about our product promise and the other programs available to you, click here 👉 www.abcam.com/en-us/offers-and-initiatives/product-promise -
Abcam
@abcam
Mark your calendars for the next Cell Cycle Club, featuring @harvardmed's Dr David Pellman. Register for free to join us online on March 4, and submit an abstract to be considered for the short talk or breakout talk opportunities
events.abcam.com/E5DAGg?RefId=cellcycle0325-sm
#cellcycleresearch #callforabstracts -
Abcam
@abcam
Anyone who uses ELISAs knows that traditional kits are time-consuming, taking around four hours to produce results with no guarantee of accuracy and reproducibility.
We changed that when we launched our SimpleStep ELISA® kits in 2012, accelerating workflows by generating data in 90 minutes or less, saving researchers everywhere decades at the bench. Don’t just take it from us: hear from our customers on how SimpleStep ELISA® kits have saved the day 💪 👉 -
Abcam
@abcam
At Abcam, we take pride in building teams that collaborate effectively, designing environments that help people perform at their best. A key part of this is listening to our employees to create spaces that work for them, alongside areas that foster collaborative, in-person connections 🙌
Hannah Tweddle, Manufacturing Data Lead, experiences these benefits first-hand: “When I see how much people enjoy working together, I know this place is for me.”
If this sounds like the kind of work environment you’d thrive in, we’d love to hear from you. Click the link to learn more about joining Abcam and view our current vacancies: jobs.danaher.com/global/en/abcam-search-results -
Abcam
@abcam
Reach your next breakthrough with tailored solutions designed to overcome the unique challenges of obesity drug discovery. Learn more about our solutions for obesity research here 👉 www.abcam.com/en-us/products/product-recommendations/obes…
-
Abcam
@abcam
Among other discoveries, American microbiologist Esther Lederberg revolutionized the field of microbial genetics by discovering the lambda phage in the early 1950s – a bacterial virus that became a widely used tool for studying genetic recombination and gene regulation.
Her work paved the way for medical and biotechnology breakthroughs and advanced our understanding of genetic variation and evolution. Lederberg's innovative methods continue to shape the field of life sciences today.
At Abcam, we believe that breakthroughs made by one of us empower us all.
#progresshappenstogether -
Abcam
@abcam
With our new 20 µl trial sizes for over 3,000 recombinant antibodies, you can easily test your antibody or perform pre-screening before committing to a larger quantity. Have confidence in consistent results and move your research forward – learn more here: www.abcam.com/en-us/technical-resources/product-overview/…
-
Abcam
@abcam
Our portfolio includes antibodies to 90% of key targets in major glioblastoma pathways, including mTOR. See our pathway poster to learn how mTOR regulates cellular processes. Download here: www.abcam.com/en-gb/technical-resources/pathways/mtor-pat…
-
Abcam
@abcam
This week on #behindthebreakthroughs, we’re going back to our bread and butter: the antibody.
The antibody’s Y-shaped structure was discovered by Rodney Porter and Gerald Edelman in the late 50s and early 60s, providing fundamental insight into the body's immune response.
Their theory revolutionized our understanding of how the immune system generates a range of antibodies to combat different diseases, leading to advancements in immunology, vaccine development, and antibody-based therapies, saving many lives.
#progresshappenstogethern -
Abcam
@abcam
Attending #slas2025? Join our #immunoassay experts for lunch at 12pm, room 28B and learn how SimpleStep ELISA® technology and SureFire® assays can enhance research efficiency and precision 🧪🌟 lifesciences.danaher.com/us/en/events/slas2025/abcam-slas…
-
Abcam
@abcam
Set your week up for success with one of our top pathways.
The tumor microenvironment (TME) consists of various support cells subverted by the cancer cells to assist in the progression of the tumor. Here we review the complex interplay of the tumor, stromal cells, and immune cells within the TME.
Download your copy of our tumor microenvironment pathway: www.abcam.com/en-us/technical-resources/pathways/tumor-mi… -
Abcam
@abcam
Excited to be at #slas2025! Visit us at @DanaherCorp booth #1619 to catch a demo of our 384-well ELISA on a @BCILifeSciences Biomek i5. Plus, join us for lunch on Jan 28 in room 28B and hear from our #immunoassay experts 🧪 🌟 lifesciences.danaher.com/us/en/events/slas2025/abcam-slas…
-
Abcam
@abcam
Our SimpleStep ELISA® kits are designed to help you achieve more, faster. Powered by recombinant technology for reproducible results, these kits can take you from sample to result in just 90 minutes. Discover how our kits can drive your research forward, faster:
-
Abcam
@abcam
Barbara McClintock's observation that no two maize plants were alike led her to investigate, and later challenge, the prevailing genetic theory of the 1930s and 40s.
Throughout her career in cytogenetics, Barbara made discovery after discovery. Today, much of our understanding of genetics, medicine, and evolutionary biology is based on her findings.
At Abcam, we believe that breakthroughs made by one of us empower us all.
#progresshappenstogether -
Abcam
@abcam
At Abcam, we understand that sometimes, life can get in the way. That's why we adopt a culture of trust and respect for individual needs, demonstrated through flexibility and unique opportunities.
Emily Dell, Service Enablement Lead, says: “I love how easily I can fit work around my life and personal priorities.”
If this sounds like the work environment for you, get in touch! Visit our careers site today: jobs.danaher.com/global/en/abcam-search-results -
Abcam
@abcam
What gets you into the lab on a Monday morning?
For Joe, it's to answer a fundamental question: what makes us human? Or in his words: “Trying to understand what makes you you, and what makes me me.”
In our award nominated short film series ‘Love Letters to Science’, Joe tells us how he chose biology class at school when philosophy wasn’t giving him adequate answers. In this first class, he learned something that meant he would never turn back from science.
Find out what it was in episode 3 of the series here: www.abcam.com/en-us/stories/films/joe-beechem -
Abcam
@abcam
🌟 Connect, learn, and share ideas with fellow #cancer and #metabolism researchers at #cancerandmetabolism in Austin TX and online next month! Whether you join us in person or virtually, you'll gain valuable insights and inspiration to drive your research forward 💡
events.abcam.com/bPVoa?RefId=cancermetabolism2025-sm
#conference #oncology #progresshappenstogether -
Abcam
@abcam
🚨 Just published 🚨
Together with collaborators at @mcgillu @theneuro_mni @YCharOS1, as well as other antibody manufacturers, we’re excited to announce the publication of a new open science platform for the characterization of research antibodies.
The approach, published in @nature, aims to set out an industry standard for antibody characterization that will enable researchers to effectively compare performance of antibodies in various applications, and ultimately support enhanced reliability and reproducibility of scientific research.
Discover more about the news here: www.abcam.com/en-us
Read the paper here: go.nature.com/3DMw7Ql -
Abcam
@abcam
Kickstart your year with insights into #innateimmunity and #inflammasome biology! Register for the #inflammazoom, our free monthly webinar series.
Next session: January 20 at 8.00am GMT w/ @keshu_VRimmCh -@iiscbangalore & @mere_conjecture - @UTAS_
events.abcam.com/event/Inflammazoom2025/summary?RefId=inf… -
Abcam
@abcam
With our new 20 µl trial size antibodies you can experience the specificity and reproducibility of recombinant antibodies without the risk. Look for the 20 µl tag on our product search results and move to the next step with confidence: www.abcam.com/en-us/technical-resources/product-overview/…
-
Abcam
@abcam
We’re excited to announce that Nadia Altomare has joined Abcam as our new Vice President of Commercial Operations.
With over 20 years of experience in the biotech, diagnostics, and life sciences industries combined, Nadia brings a wealth of expertise, fresh perspectives, and innovative ideas to our team. We're excited about the impact she’ll have in driving Abcam’s commercial strategy and look forward to her contributions as we continue to empower scientific discoveries worldwide.
Please join us in giving Nadia a warm welcome to the Abcam community! 🎉 -
Abcam
@abcam
Research is challenging. We get it. There are highs and lows. Good days and bad days. But whatever you’re using our immunoassays for, we’re here to help you every step of the way. See how we can work together.
Scale with confidence. www.abcam.com/kits/simplestep-elisa-kits -
Abcam
@abcam
Using multiple protocols can slow down research. That’s why we use the same immunoassay protocol across all platforms and formats. By making the process simpler, it's easier for you to shape your research and move forward faster. Learn more here.
Scale with confidence. -
Abcam
@abcam
Final call for today's #inflammazoom!
Abcam
@abcam
Join us on December 16 for the final Inflammazoom webinar of 2024, featuring talks on from Kate Shroder @inflammasomelab @UQ_News and @SiMingMan1 @ourANU 🔬🎤
Register here to access the live session as well as on-demand talks from past sessions: events.abcam.com/AnYVL?rt=QlpM0tX1GkSpcP0HYA7SVg&RefId=in…
#innateimmunity #immunology #inflammasome #immuneresponse @ClareBryant13 -
Abcam
@abcam
Explore the mechanisms of neuroinflammation thought to contribute to Alzheimer’s disease pathology in our neuroinflammation in Alzheimer's disease pathway poster. Get your poster here: go.myabcam.com/neuroinflammation-poster
-
Abcam
@abcam
We understand that a flexible approach is key in research. That’s why we’ve created a diverse offering of carrier-free antibodies. Whether you need to create new conjugates or adapt your assay, we can help you find the antibodies you need.
www.abcam.com/primary-antibodies/pbs-only-formulations-fo… -
Abcam
@abcam
Join us on December 16 for the final Inflammazoom webinar of 2024, featuring talks on from Kate Shroder @inflammasomelab @UQ_News and @SiMingMan1 @ourANU 🔬🎤
Register here to access the live session as well as on-demand talks from past sessions: events.abcam.com/AnYVL?rt=QlpM0tX1GkSpcP0HYA7SVg&RefId=in…
#innateimmunity #immunology #inflammasome #immuneresponse @ClareBryant13 -
Abcam
@abcam
We've got your glioblastoma research covered with antibodies covering key targets including VEGF. Download your VEGF pathway poster now. www.abcam.com/en-gb/technical-resources/pathways/vegf-sig…
-
Abcam
@abcam
We know how quickly you need to adapt to new situations. That’s why we provide immediate access to a huge variety of recombinant antibody pairs and kits. From 384-well assays to individual capture and detector antibodies, our immunoassays are as flexible as you.
Scale with confidence: www.abcam.com/kits/simplestep-elisa-kits -
Abcam
@abcam
Don’t miss the chance to showcase your research at #cancerandmetabolism in Texas next February! Register for the conference and submit a poster abstract by December 9 for a chance to be featured. Prizes worth up to $100 await the top entries! 🏆🔬
More details about the conference are available here 👉 events.abcam.com/bPVoa?RefId=cancermetabolism2025-sm
#metabolism #cancer #callforabstracts -
Abcam
@abcam
Download our poster to explore the complex interactions between the immune and nervous systems and discover how this understanding could be key to preventing or slowing Alzheimer's and other neurodegenerative diseases 🧠
go.myabcam.com/alzheimers-interactive-pathway -
Abcam
@abcam
If you want antibodies you can depend on, we have the answer. We extensively test our antibodies to ensure you achieve consistent, accurate results every time. To see how you can benefit from ultimate precision, click here: www.abcam.com/primary-antibodies/recombinant-antibodies
-
Abcam
@abcam
Here’s a recent comment from a customer who used one of our 90-minute SimpleStep ELISA kits: "I hate to do ELISAs but this kit changed it all. Reached very good results with ease and in no time."
Exactly the same highly specific and sensitive recombinant monoclonal antibodies used in our kits are also available in other formats so you can move onto the unique assay your research needs. Get carrier-free pairs and even individual capture and detector antibodies.
Learn more here: go.myabcam.com/simplify-your-assay-design-with-our-matche… -
Abcam
@abcam
🚨 Live #immunology webinar today at 3.30pm GMT 🚨
Tune in to hear talks from Serge Mostowy @LSHTM @mostowylab and @PrajwalGurung @uiowa at @Inflammazoom, our free webinar series on #innateimmunity and #inflammasome biology
Register here to join live: events.abcam.com/AnYVL?rt=QlpM0tX1GkSpcP0HYA7SVg&RefId=in… -
Abcam
@abcam
One result can take your research in a totally different direction. But, as we use recombinant antibody pairs, you can be confident that our immunoassays will always be the same.
Scale with confidence: www.abcam.com/kits/simplestep-elisa-kits -
Abcam
@abcam
In June, a groundbreaking study published in Nature Medicine brought two important firsts for Parkinson’s disease, an area long in need of better diagnostics and treatments. Here’s what has researchers excited:
➡ A diagnostic test that detects abnormal alpha-synuclein in cerebrospinal fluid.
➡ An immune-based treatment, similar to a vaccine, that trains the immune system to target misfolded proteins.
The ability to measure these proteins has been a key focus in Parkinson’s research for years, making this a significant milestone. This article from TIME Magazine explores how the test and vaccine work, the journey to these discoveries, and what this could mean for future diagnostics and treatments for Parkinson’s disease. Read it here: time.com/6883054/parkinsons-test-vaccine-study-vaxxinity/ -
Abcam
@abcam
What gets you into the lab on a Monday morning?
For Virginia, its the the answers to big questions: “Why do we age? Why do we become forgetful?”
In our award nominated short film series ‘Love Letters to Science’, Virginia works to address one of humankind’s inevitable processes – getting older. Here, she explains how her work has made her feel optimistic about aging, and why we should too.
Watch the episode: www.abcam.com/en-us/stories/films/virginia-man-yee-lee -
Abcam
@abcam
Professor Tansey, a pioneer in chronic inflammation in neurological disorders, joins us to discuss how inflammation influences the risk of Alzheimer’s, and how her new approach could reshape how we treat the disease. Watch here: go.myabcam.com/webinar-role-of-chronic-inflammation-in-ri…
-
Abcam
@abcam
🌟 Just released! Explore the #cancerandmetabolism program for 2025, featuring big names in the field, including Alec Kimmelman @nyulangone, @EileenWhitePhD @rutgerscancer, and Matthew Vander Heiden @mvh_lab @kochinstitute. Learn more and register here 👉 events.abcam.com/L88Y25?RefId=cancermetabolism2025-progra…
#cancer #metabolism -
Abcam
@abcam
You have your hypothesis. Your experiments are planned. Now you need results, and our antibodies will give you the precision you need. We use recombinant technology and extensive validation techniques to ensure consistent, reliable results from the first step to the last.
Follow the link to learn more: www.abcam.com/primary-antibodies/recombinant-antibodies -
Abcam
@abcam
Hannah Cable, Vice President of New Product Development, was interviewed by Nature to discuss how we’re fueling the recombinant revolution with our extensive portfolio of over 32,000 highly specific recombinant antibodies 💪 Check out the full article here:
-
Abcam
@abcam
In many cancers, including glioblastoma, MAPK is deregulated or mutated. Download our poster to understand MAPK's role in glioblastoma and find the best products to support your research 🔬
Discover the MAPK Pathway: www.abcam.com/en-us/technical-resources/pathways/mapk-sig… -
Abcam
@abcam
When you’re looking for low abundance targets, why use anything but the highest quality immunoassays optimized for sensitivity? Even at small sample volumes, our leading immunoassay technology can identify your module of interest and deliver results. Learn how:
-
Abcam
@abcam
The #1 cited antibody – now for 20% less.
Labs rely on antibodies like these. That’s why we’ve reduced its price by 20% to keep your research moving forward. Find out more here: www.abcam.com/en-us/products/primary-antibodies/ki67-anti… -
Abcam
@abcam
Biophysical quality control detects any impurities and aggregates and provides us with a unique profile or ‘fingerprint’ of each product that isn’t open to interpretation. Our innovative technique was recognized by CiteAb 2024, winning the Highly Commended Digital Science Tool of the Year award. Read more here: go.myabcam.com/BiophysicalQuality
-
Abcam
@abcam
Our 384-well SimpleStep ELISA® means you can make your precious samples go 300% further: built on our revolutionary 96-well SimpleStep ELISA® kit, the 384-well requires only a quarter of your sample.
Together, our 96-well and 384-well kits enable easy, seamless scaling and high-quality results in just 90 minutes. Learn more about how our SimpleStep technology can move your Alzheimer’s research forward faster.
Alzheimer’s disease resources: danaher.com
Abcam
@abcam
Make your precious Alzheimer’s samples go further with our 384-well SimpleStep ELISA®.
Made with the same precision recombinant antibody pairs as our 96-well kits, this new, miniaturised format allows four times more samples to be processed in 90 minutes using a quarter of the sample volume (12.5 µL vs. 50 µl for 96-well plates).
Learn more about how our assays can accelerate your research: www.abcam.com/en-us/technical-resources/research-areas/ne… -
Abcam
@abcam
Introducing our new murinized anti-Ly6g antibody [1A8]- mouse IgG2c, designed for long-term neutrophil depletion in vivo.
This chimeric Ly6g antibody (low endotoxin, azide free) is produced recombinantly and validated using advanced validation techniques to ensure it works exactly as expected, consistently over time.
To find out more see: www.abcam.com/en-us/products/primary-antibodies/ly6g-anti… -
Abcam
@abcam
13,000 carrier-free antibodies. 4,000 matched antibody pairs. 45 labels. We believe in delivering flexibility that matches your imagination. So, let’s push boundaries together and see what’s possible. Click here to find out more: www.abcam.com/primary-antibodies/pbs-only-formulations-fo…
-
Abcam
@abcam
Nearly three weeks on and we’re still buzzing from #sfn2024! It was great to work with our wonderful collaborators at @MichaelJFoxOrg, @BrainXell_Inc, and @YCharOS1.
Did you manage to catch us at SfN?This media couldn't be displayed. See it on the original post. -
Abcam
@abcam
#cancerandmetabolism is back on Feb 9-10 and we’re excited to showcase our fantastic speaker line up, including @EileenWhitePhD , @rutgerscancer . Swipe to view the full speaker list and watch an interview with Dr White from our 2022 conference 👉 events.abcam.com/bPVoa?RefId=cancermetabolism2025-sm
-
Abcam
@abcam
Scaling up your screening process? Abcam's SimpleStep ELISA® kits streamline it.
Our 96-well and 384-well kits use the same matched antibody pairs, allowing you to easily scale from 96-well to 384-well kits and efficiently process data samples with a standard plate reader. Discover more here: go.myabcam.com/simplify-your-assay-design-with-our-matche… -
Abcam
@abcam
In glioblastoma research, we know how precious your samples are. Each sample needs to go a long way, so it makes sense to only use the best antibodies to get the accurate result you need.
Our recombinant antibodies are highly specific and extensively validated. This means they’ll work first time, every time, so you can keep moving your research forward.
Learn more about how we can help you to progress your glioblastoma research: lifesciences.danaher.com/us/en/research-areas/oncology/di… -
Abcam
@abcam
📣 There's still time to register for #mucosalimmunology2024! 📅 Join us in Boston or online on November 4-5. Visit the website to learn more about the program and register 👉 web-eur.cvent.com/event/723ef7a2-859e-432b-b3c7-98777fe52…
-
Abcam
@abcam
The race to market can seem daunting, but our high-performance immunoassays can help you navigate the stops and starts so that you can move to the next stage sooner. Keep moving forward with our immuoassays.
Scale with confidence: www.abcam.com/en-us/technical-resources/product-overview/… -
Abcam
@abcam
ICYMI: Earlier this month, researchers unveiled a groundbreaking achievement: the largest neural map, or ‘connectome,’ of an adult fruit fly’s brain ever created. Nearly 50 labs worldwide collaborated on the project, using advanced AI algorithms to catalog over 50 million connections between 130,000 cells. This incredible work brings us closer to understanding brain behavior and disease states. 🔬🧠
Dive into the details in @statnews: www.statnews.com/2024/10/02/connectome-fruit-fly-brain-ne…
Explore the connectome yourself: codex.flywire.ai
#flywire @FlyWireNews -
Abcam
@abcam
Rediscover our award nominated short film series, Love Letters to Science. Five scientists share the story of how they fell in love with science - and how it helped them find their collaborators, their people, and their community.
Watch here: go.myabcam.com/What-sparks-a-love-of-science
#progresshappenstogether #loveletterstoscience #abcam #peoplebehindthescience -
Abcam
@abcam
Have you seen that our trusted loading controls and tag antibodies are now available at a new, lower price?
Offering high performance, consistency, and extensive validation across a variety of applications, our loading controls provide you with the ultimate peace of mind, so that you can keep your research moving forward. www.abcam.com/en-us/offers-and-initiatives/lab-essentials -
Abcam
@abcam
Not only can our 384-well SimpleStep ELISA kits generate 300% more from your samples, but they can offer the ultimate flexibility.
This is because the core components that power our kits are available individually in multiple formats, including carrier-free antibody pairs, individual carrier-free capture and detector antibodies, conjugation kits, and protein standards. And as they only call for a quarter of your sample size, you can make your precious samples go further.
Your assay, your way. Learn more about how our kits and reagents are turning the dial on Alzheimer’s research: Alzheimer’s disease resources (danaher.com)
Abcam
@abcam
Power your Alzheimer’s research with the ultimate catalog of gold-standard, curated, validated and cited recombinant antibodies and assays. Backed by data so you can make informed decisions.
Learn more here: www.abcam.com/en-us/products/product-recommendations/alzh… -
Abcam
@abcam
What a time we had at #sfn2024 last week! Thank you to everyone who stopped by to chat with us, and a special shout-out to our amazing collaborators at @MichaelJFoxOrg, @BrainXell_Inc and @YCharOS1 for making it an unforgettable event.
This year’s conference brought in over 21,000 attendees and saw researchers at all stages of their careers present their latest work relating to the brain and nervous system.
We’re already looking forward to next year. Will we see you in San Diego? -
Abcam
@abcam
Trust your data no matter the throughput when you use recombinant antibodies. With extensive validation and gold-standard quality control, our recombinant antibodies offer the highest specificity, sensitivity, and consistency across any scale. www.abcam.com/primary-antibodies/recombinant-antibodies
-
Abcam
@abcam
Today’s the day! Join us from 3pm GMT+1 for talks from our #cellcyclecommunity at the #cellcycleconference! 👉 events.abcam.com/event/cellcycleconference/websitePage:a4… @DeRobertus
-
Abcam
@abcam
Using recombinant antibodies means you can have peace of mind knowing your antibody will behave the same years down the line as it does today.
Hear from Alejandra Solache, Abcam’s Senior Vice President of R&D, about the benefits of recombinant antibodies, including why they’re superior over polyclonal and traditional monoclonal antibodies: go.myabcam.com/how-better-antibodies-can-save-time-in-the… -
Abcam
@abcam
When researching glioblastoma and screening for a wide range of biomarkers, sometimes across hundreds of potential targets, you need an extensive selection of high-quality antibodies at your fingertips.
Our catalog offers the largest selection of gold-standard, curated, validated, and cited recombinant antibodies. This means there’s no need to search across multiple suppliers, saving you valuable time. Supercharge your glioblastoma research with everything you need in one place. Learn more here: lifesciences.danaher.com/us/en/research-areas/oncology/di… -
Abcam
@abcam
Join us online on October 15 for the final instalment of the #cellcycleconference for 2024! Browse talks and speakers below, and click here to register for free 👉 events.abcam.com/event/cellcycleconference/websitePage:a4… @DeRobertus
-
Abcam
@abcam
If you’re feeling a little stretched, lean on us. We can help you find the right immunoassay for your project, so you can achieve reliable results and move your research forward. Find out more: abcam.com/kits/simplestep-elisa-kits
-
Abcam
@abcam
This Hispanic Heritage Month, Abcam’s Alejandra Solache reflects on on her own lived experiences.
We believe that diverse perspectives unlock scientific breakthroughs. As a global science and technology innovator, we’re committed to building and sustaining a workplace that fosters diversity, equity, and inclusion.
We trust in providing many pathways to success, allowing good ideas to flourish freely, and empowering everyone to reach their fullest potential. -
Abcam
@abcam
⏰ Last chance to book early bird tickets for #cancerandmetabolism! Join Eyal Gottlieb @MDAndersonNews, Karen Vousden @TheCrick, Ralph DeBarardinis @UTSWMedCenter & Oliver Maddocks @FaethTx plus an epic speaker list in Austin on Feb 9-10 🌟👉
events.abcam.com/event/cancer-and-metabolism/summary?RefI… -
Abcam
@abcam
Using biophysical QC to validate our antibodies gives them a profile that isn’t open to interpretation, so you can move your research forward faster with renewed confidence in the quality of your reagents.
In collaboration with Nature, we dig deeper into our biophysical QC process and why it’s an essential step in beating the reproducibility crisis.
Read it here: How to put an end to the reproducibility crisis | Abcam (myabcam.com) -
Abcam
@abcam
It’s finally here! #sfn2024 begins this weekend in Chicago, IL. We’re looking forward to reconnecting with the neuroscience community and getting up to date on the latest insights in the field. Don’t miss poster presentations from Abcam experts and collaborators – find details and save time by booking an onsite meeting with us, here: events.abcam.com/event/efe6dbfb-89b0-4651-95b2-fe9e892524…
-
Abcam
@abcam
Our recombinant antibodies are extensively validated to bring specificity to your research, bringing you closer to your goals with every step.
Click here to learn how our recombinant antibodies can keep you on track:
www.abcam.com/primary-antibodies/recombinant-antibodies -
Abcam
@abcam
Last Wednesday, the Abcam Women's Network hosted ‘Autumn Reflections' in our UK and US offices. These inspiring panel discussions reflected back on the careers of some of Abcam’s senior associates and their portfolios so far, offering advice on mentoring connections and acquiring new skills.
-
Abcam
@abcam
Check out the conference program for #mucosalimmunology2024 now and join us in Boston or online on November 4-5! Poster submissions welcome - submit yours by October 7 💡 web-eur.cvent.com/event/723ef7a2-859e-432b-b3c7-98777fe52…
-
Abcam
@abcam
By raising the standard of antibody quality, we’re helping scientists to reach their discoveries faster with reagents that work first time, every time, over time.
One way we achieve this is by taking a unique fingerprint of each antibody, known as biophysical quality control. This eliminates lot-to-lot variability, delivering the same best-performing antibody every time, over time. Read more about our biophysical QC here: go.myabcam.com/BiophysicalQuality -
Abcam
@abcam
What’s at the heart of successful assay development? Choosing a high-performing antibody pair.
That’s why we select our antibody pairs from hundreds of multiple clone combinations and validate them in biological samples to ensure specificity.
Discover how we optimize the performance of our matched antibody pairs to help speed up, simplify and de-risk your assay design and development: go.myabcam.com/simplify-your-assay-design-with-our-matche… -
Abcam
@abcam
We’re proud to be part of a 40-year journey.
This week, our parent company, @DanaherCorp, celebrates its 40th anniversary – marking four decades of impact in life sciences and diagnostics.
As a newer chapter in the Danaher story, Abcam is excited to contribute to this legacy. Building on Danaher’s commitment to innovation, listening to its customers, and continuous improvement, we look forward to continuing to help customers solve complex challenges and improve human health for many more years to come.
#speedoflife #lifesciences #danaher #progresshappenstogether -
Abcam
@abcam
The Abcam games might be nearing an end but there are still plenty of prizes up for grabs, including Abcam loyalty points to be redeemed for money off our high-quality products. Win anything from 70 to 700 points, redeemable for $15 or $150 off your order.
Sign up, shuffle the deck, and draw a card. Other prizes include discounts and merch, like our exclusive Abcam playing cards.
Join the games: go.myabcam.com/join-the-game -
Abcam
@abcam
Don't miss your chance to present at the Digital Cell Cycle Conference on October 15! Submit your short talk abstracts by September 27, and let's share groundbreaking research together 🧬✨
events.abcam.com/event/cellcycleconference/websitePage:a4…
#cellcycle #researchopportunity #abstractdeadline @DeRobertus -
Abcam
@abcam
Fewer steps mean less errors. Less errors mean more reliable results. And more reliable results mean faster progress. Find out how our single-wash immunoassays can simplify your workflow in just 90 minutes: www.abcam.com/kits/simplestep-elisa-kits
-
Abcam
@abcam
⏳ Time’s running out! ⏳
Book tickets for #cancerandmetabolism by Oct 7 and save up to $150!
Join us in Austin or online on Feb 9-10 for two days of lively discussion and novel ideas on the complex interactions between #metabolicreprogramming and #cancerbiology 👉 -
Abcam
@abcam
On World Alzheimer’s Day, we’re honoring all those in the life sciences community working relentlessly to advance our understanding of Alzheimer’s and develop new approaches to tackling the disease.
Recently published papers in @science and @CellPress are great examples of the progress being made in the field of neurodegeneration, describing two new potential therapies that use TRIM21 to selectively remove aggregated tau proteins and prevent the formation of new aggregates.
Have you read them yet? If not, find out more here: www.ukri.org/news/new-therapy-that-destroys-tau-tangles-s…
@MRC_LMB @UKDRI @UKRI_News
#alzheimers #dementia #progresshappenstogether -
Abcam
@abcam
Are you attending Biomarkers Europe 2024 and Spatial Biology Europe 2024? If so, come and find us there!
We’ll be joined by Abcam’s Head of Characterization, Antonella Galli, PhD, to discuss how to advance your oncology research with highly validated antibodies from Abcam. Check out more details and book a meeting with our on-site team: events.abcam.com/event/cd51be97-0e04-4579-a357-469be0cacc…
#ogbiomarkers #biomarkerseu24 -
Abcam
@abcam
Join us in celebrating postdoc researchers and the brilliant contribution they make towards research and academic life.
It’s a time where we can showcase, recognize and thank them for their efforts!
Tag a postdoc colleague for us to give a shout out to, and tell us why they should be celebrated.
#npaw2024 #progresshappenstogether -
Abcam
@abcam
“If researchers knew the extent of the inherent variability of these antibodies, they would quickly switch to antibodies produced recombinantly.”
Antibody reliability is an issue close to Alejandra Solache’s heart. As Abcam’s Senior Vice President of R&D, Alejandra is a key player in our mission to beat the reproducibility crisis in science by promoting the use of high-quality recombinant antibodies.
Recombinant antibodies generated from gene sequences offer major advantages over traditional monoclonal and polyclonal antibodies. And when robustly validated, they save time and improve reproducibility.
Here’s how: go.myabcam.com/how-better-antibodies-can-save-time-in-the… -
Abcam
@abcam
Have you played our online game yet? Sign up using the link below, shuffle the deck, draw a card, and win prizes.
Why not get your lab and colleagues involved, too? A bit of friendly competition never hurt anybody, after all...
With prizes up for grabs to help navigate the twists and turns of research, join the games today.
go.myabcam.com/join-the-game -
Abcam
@abcam
That idea that came to you as you were drifting off to sleep?
We’re here to help make it happen. With over 13,000 carrier-free antibodies to choose from, you can easily conjugate any label or scale up.
Start your journey here: www.abcam.com/primary-antibodies/pbs-only-formulations-fo… -
Abcam
@abcam
Power your Alzheimer’s research with the ultimate catalog of gold-standard, curated, validated and cited recombinant antibodies and assays. Backed by data so you can make informed decisions.
Learn more here: www.abcam.com/en-us/products/product-recommendations/alzh… -
Abcam
@abcam
Whether you’re scaling up or changing format, our immunoassays provide flexibility without losing accuracy or efficiency. From assay optimization to platform versatility, we’ll help find the right assay for you.
Find out more: www.abcam.com/kits/simplestep-elisa-kits -
Abcam
@abcam
Introducing our online games!
Play to win prizes to help you navigate the twists and turns of research. Prizes include merch, loyalty points, and even up to 50% off one item from our catalog... we’re not messing around!
All you need to do to join the games is sign up here: go.myabcam.com/join-the-game
Good luck – the game’s on. -
Abcam
@abcam
Make your precious Alzheimer’s samples go further with our 384-well SimpleStep ELISA®.
Made with the same precision recombinant antibody pairs as our 96-well kits, this new, miniaturised format allows four times more samples to be processed in 90 minutes using a quarter of the sample volume (12.5 µL vs. 50 µl for 96-well plates).
Learn more about how our assays can accelerate your research: www.abcam.com/en-us/technical-resources/research-areas/ne… -
Abcam
@abcam
Researching neuroinflammation?
DAP12, also known as TYROBP, is a transmembrane signaling adaptor protein that, together with TREM2, plays a crucial role in modulating microglia-derived neuroinflammation. If you’re investigating TREM2/DAP12 signaling, keep your research moving forward with our recombinant DAP12 (pY91) antibody and ELISA kit, designed to enhance the precision and efficacy of drug discovery and development.
Find out more about our recombinant DAP12 (pY91) antibody here: www.abcam.com/en-us/products/primary-antibodies/dap12-pho…
Find out more about our human DAP12 (pY91) + DAP12 total ELISA kit here: www.abcam.com/en-us/products/elisa-kits/human-dap12-py91-…
#neuroinflammation #dap12 #trem2 #neurodegenerative -
Abcam
@abcam
🚨 #cancerandmetabolism returns for its 7th conference this February, with chairs Karen Vousden @thecrick, Ralph DeBerardinis @UTSMedCenter, Eyal Gottlieb @MDAndersonNews, & Oliver Maddocks @FaethTx! Learn more here 👉 events.abcam.com/bPVoa?RefId=cancermetabolism2025-sm
#cancer #metabolism #immunometabolism #tme #cancerbiology -
Abcam
@abcam
Everyone’s voice matters.
We're proud to foster a culture where everyone feels safe to express their thoughts and ideas, knowing we’ll be heard, valued, and respected.
Hear it from Clive, our Digital Workplace Manager: “When you share your opinions, you will be heard”.
If that sounds like somewhere you’d like to work, check out careers at Abcam: jobs.danaher.com/global/en/abcam -
Abcam
@abcam
🚨 Registration is now open for the next #cellcycleconference, taking place on Oct 15 🚨
Join 800+ researchers worldwide for this virtual forum for new ideas and share your research in a short talk or breakout session 🎤 events.abcam.com/event/cellcycleconference/websitePage:a4…
@DeRobertus
#cellcycle #callforabstracts -
Abcam
@abcam
From discovery to clinic, our antibodies deliver consistent, reliable results – no matter the scale or throughput. This means you can scale up and keep moving forward with the confidence that quality and accuracy are on your side.
Get reliable results at any scale. Click here to learn more about our recombinant antibodies: www.abcam.com/primary-antibodies/recombinant-antibodies -
Abcam
@abcam
The #chromatinbiologysummerschool2024 at @HelmholtzMunich has wrapped up! Congratulations to our 2024 student cohort and a massive thank you to everyone who made it such an unforgettable experience 🙌🔬✨
@robert_ife @metorrespadilla #handsontraining #careerdevelopment #networking #thoughtleadership -
Abcam
@abcam
“I’m thrilled to be able to say that last week I completed an amazing work experience at Abcam. The insights gained and the connections made have left a lasting impression on me.
I was welcomed by a team of passionate professionals, who had given up their valuable time to help guide me and others through some of their projects. I had the opportunity to actively participate in tasks I had only previously heard about in school, such as antibody and conjugate development.
A huge thank you to everyone at Abcam for their warm welcome and guidance. Your passion for your work and willingness to share your knowledge has helped open my mind to other career prospects. Special thanks to our host Lisa Bamber and my mentor Sophia Day for helping me make the most of this experience.
Through this I found a new sense of enthusiasm for the future, as this experience has not only expanded my skills but also deepened my passion for the field. I’m looking forward to staying connected with all the wonderful people I met there!” - Leila A. -
Abcam
@abcam
Set the bar – then rise above it.
Our antibodies are rigorously validated and characterized using industry-leading approaches, including knock-out validation and application testing.
Now, by introducing the biophysical characterization of our antibodies, we’ve raised the standards even higher. Today, our dedicated biophysical QC team has tested 75% of our portfolio of 32,000+ recombinant monoclonal antibodies.
Read our article with Nature to learn more: go.myabcam.com/how-to-put-an-end-to-the-reproducibility-c… -
Abcam
@abcam
Our matched recombinant antibody pairs give you confidence when scaling across new formats or developing your own assays, knowing they will yield consistent results across formats and platforms.
Scale with confidence: www.abcam.com/kits/simplestep-elisa-kits -
Abcam
@abcam
Coming soon...
In life science, the game is long. For every step forward there’s a potential step back just around the corner, but we keep going despite it all, one move at a time.
Launching soon, our online games are a chance to win merchandise, savings on Abcam products, and loyalty points to redeem on your Abcam account. Keep an eye on our channels and play to win!
Sign up here to be notified when the games go live: go.myabcam.com/join-the-game -
Abcam
@abcam
The early bird ticket deadline for #mucosalimmunology2024 is Sept 6!
Here's a sneak peek at confirmed talks from @Jie_Immunology, @DrShrutiNaik, @ordovas_phd, @SmitaGopinath, Megan Orzalli & Gretchen Diehl.
Book tickets and submit abstracts 👉 web-eur.cvent.com/event/723ef7a2-859e-432b-b3c7-98777fe52…
#immunology #mucosalimmunology
@Lo_Zanzi -
Abcam
@abcam
“When we introduce a validation technique, it can benefit thousands of researchers globally. It also helps set industry standards in antibody validation.”
- Dr Alejandra Solache, Abcam’s Senior Vice President of Research and Development.
We're constantly improving our antibody quality with recombinant technology, application testing, and knock-out validation. Now, we’re raising the bar even higher with our industry-leading technique. Find out what it is here: go.myabcam.com/BiophysicalQuality -
Abcam
@abcam
When like-minded people come together with a shared goal, amazing things happen.
We bring together passionate and hardworking individuals from all over the world. By giving them the freedom to be curious, we create an environment that ultimately keeps science moving forward. -
Abcam
@abcam
We provide you with the tools to keep your project running smoothly so you can achieve your goals faster.
How? It’s simple – with reliable, high-quality recombinant antibodies that work first time, every time.
www.abcam.com/en-nl/technical-resources/product-overview/… -
Abcam
@abcam
Recombinant antibodies can give you confidence in reproducible results where traditional antibodies fall short.
Hear from our Senior Vice President of R&D, Alejandra Solache, on the benefits of recombinant antibodies, here: go.myabcam.com/how-better-antibodies-can-save-time-in-the… -
Abcam
@abcam
We know that making samples go as far as possible is important in your research. Our immunoassays are optimized so you only need to use 50μl of sample in our standard 96-well plate and 12.5μl in our 384-well to detect your protein of interest. Learn more: abcam.com/kits/simplestep-elisa-kits
-
Abcam
@abcam
What makes Abcam such a special place to work?
🌟 We create collaborative environments where teams can learn from one another and thrive when working together.
🌟 We support one another and make our people a priority
Check out our careers site for more reasons why our people love working here: jobs.danaher.com/global/en/abcam -
Abcam
@abcam
Investigating the role of SGLT2 and GIP in metabolic disorders? We’ve recently launched new tools to help you keep your research moving in the right direction.
Anti-SGLT2 antibody: www.abcam.com/en-gb/products/primary-antibodies/sglt2-ant…
GIP ELISA Kit : www.abcam.com/en-gb/products/elisa-kits/human-gip-elisa-k… -
Abcam
@abcam
Having a plan is critical, but we understand it’s not always that straightforward. We have over 13,000 carrier-free antibodies to choose from so you can always find the right antibody, whatever the situation.
Find out more:
www.abcam.com/en-nl/technical-resources/product-overview/… -
Abcam
@abcam
We’re pioneering the use of a new method of antibody quality control, using biophysical ‘fingerprinting’ to confirm the purity and molecular identity of our antibodies.
Read about this new approach and its role in tackling the reproducibility crisis: go.myabcam.com/how-to-put-an-end-to-the-reproducibility-c… -
Abcam
@abcam
We’re committed to creating a workplace where personal and professional growth are encouraged and celebrated. And whether you’re just starting your career or seasoned in your area, we put your happiness and development first.
Discover careers at Abcam: careers.abcam.com/us/en/working-here -
Abcam
@abcam
Spinning plates shouldn’t mean quality is compromised. Deliver results quickly and keep your research flowing with high-quality immunoassays for quicker decision making.
Learn more: www.abcam.com/kits/simplestep-elisa-kits -
Abcam
@abcam
Working in blood cancer research?
At Abcam, we never stop innovating to fill gaps in the reagent market for novel, emerging targets. We recently launched a new recombinant antibody against GPRC5D – a unique product to support the development of treatments for multiple myeloma.
Suitable for IHC and WB applications for human samples, this newly launched reagent is highly specific, supported by detailed characterization data to give you that peace of mind and keep your research moving forward.
Find out more, here: www.abcam.com/en-gb/products/primary-antibodies/gpcr-gprc…
#multiplemyeloma #bloodcancer -
Abcam
@abcam
One of the biggest challenges of a transition is ensuring that results stay reproducible from lab to lab. Our high-quality recombinant antibodies ensure that no matter where your research takes you, you're always moving forward with confidence in accurate and reproducible results
-
Abcam
@abcam
When hurdles in your day-to-day are slowing you down, know that your research is under control thanks to high-quality immunoassays that keep you on track – and keep you moving forward. Learn more about staying on track with our immunoassays: www.abcam.com/kits/simplestep-elisa-kits
-
Abcam
@abcam
AI is advancing industries all over the world & life science is no exception. At Abcam, we embrace AI & use it as a tool to drive science forward.
Joining Abcam’s Digital team means you can make an impact on how AI accelerates life science. jobs.danaher.com/global/en/abcam -
Abcam
@abcam
We’re excited to share that we’ve been recognized for our LGBTQ+ inclusivity work by @stonewalluk – receiving a Silver Award in this year’s Workplace Equality Index 🏳️🌈
Read about the news here: corporate.abcam.com/abcam-recognized-by-stonewall-for-com…
#prideinstem #wei #lgbtq #stonewall #workplaceequalityindex -
Abcam
@abcam
📢 Just published 📢
In their latest paper, our collaborators Nils Mülling and @GrahamHeieis (@LUMC_Leiden) use Met-Flow to reveal how inhibition of CD38 can rejuvenate CMV-specific cytotoxic T-cell metabolism and functionality in kidney transplant recipients.
Read more:
www.jci.org/articles/view/179561
@JCI
Abcam
@abcam
Working in met-flow? Discover the latest solutions to support your research in this recent @Biocompare article featuring Abcam’s Elena Loche: www.biocompare.com/Editorial-Articles/612491-Recent-Devel…
-
Abcam
@abcam
Working with #ibex?
@JoVEJournal is looking for protocol submissions that extend the utility of the original IBEX method. Find out more here: app.jove.com/methods-collections/3182 -
Abcam
@abcam
Using their One Day Volunteer hours, members from Abcam’s Rainbow Community (ARC) at our Eugene, OR office recently had the opportunity to support Oregon’s “Love is Love Day” event, celebrating the 10th anniversary of Marriage Equality in Oregon with complimentary marriage ceremonies for all couples.
A special shout-out to our remarkable team members that were able to contribute to creating a unique and memorable experience for the couples involved, while supporting various non-profits dedicated to uplifting the LGBTQ+ community👏
#loveislove
eu.registerguard.com/story/news/local/2024/05/17/oregon-s… -
Abcam
@abcam
Join us at #spatialbiologyec24 to learn more about exciting developments in spatial technologies, including our talk on Antibody validation at Abcam, presented by Will Howat, VP of Validation and Technical Quality, R&D.
Click the link below learn more: www.linkedin.com/uas/login?session_redirect=https%3A%2F%2… -
Abcam
@abcam
Explore the #cellcycle Conference program, featuring exciting talks from researchers @UniofOxford, @ICR_London & @MRC_LMB!
This half-day event is free to attend- register now to join us at @TheCrick or online on June 4 👉👉 events.abcam.com/event/cellcycleconference/websitePage:b6…
@DeRobertus @ThorpeLab -
Abcam
@abcam
When you put in that much work, you need antibodies that won’t let you down. We extensively test every antibody so you can be confident in your results and move forward faster.
Find out how our recombinant antibodies can benefit your research: www.abcam.com/primary-antibodies/recombinant-antibodies -
Abcam
@abcam
We strive to create a workplace where people feel safe, supported, and stronger when working together. Barbara, our Senior Production Planner, sums it up: “We welcome and support each other in a way that I've never seen before.” 💬
jobs.danaher.com/global/en/abcam -
Abcam
@abcam
Sometimes research can feel like it’s going in circles. With high-performance antibodies, we can help you break out of that loop and reach that breakthrough faster.
Find out how our recombinant antibodies can benefit your research: www.abcam.com/primary-antibodies/recombinant-antibodies -
Abcam
@abcam
Don’t miss Love Letters to Science - @abcam's short films where five scientists share the story of how they fell in love with science - and how it helped them find their collaborators, their people, and their community.
go.myabcam.com/What-sparks-a-love-of-science
#progresshappenstogether -
Abcam
@abcam
Why abcam supports extended paternity leave
We know that family time is precious. Which is why we continually review and evolve our policies. Hear from new fathers, Ben & Nick, about how our 6-week paid paternity leave positively impacted their families.
jobs.danaher.com/global/en/abcam -
Abcam
@abcam
How has your journey in science been shaped by the people around you?
Love Letters to Science explores 5 scientists' passionate relationship to their research & how it helped them find their collaborations, people & community.
Watch all five parts: go.myabcam.com/What-sparks-a-love-of-science -
Abcam
@abcam
Are you frustrated by inconsistent results? We are too.
That’s why we’ve partnered with Nature to explain how we’re using a new industry quality standard, Biophysical QC, to guarantee the best-performing antibody every time.
Read our article here: go.nature.com/3WJcjok -
Abcam
@abcam
📢 Our next #cellcycleconference meeting is coming up!
In-person attendees are encouraged to share their research as a short talk or poster – submit an abstract by May 17 to be considered!
events.abcam.com/event/cellcycleconference/websitePage:b6…
@EsashiLab @Dunn_School @UniofOxford @DeRobertus -
Abcam
@abcam
Your support network is there to help you through thick and thin. And so are we. From friendly scientific advice to recombinant antibodies that work every time, we’re here for you.
www.abcam.com/primary-antibodies/recombinant-antibodies -
Abcam
@abcam
Don’t miss Graham Heieis' film - part five of @abcam's Love Letters to Science!
OUT NOW! go.myabcam.com/What-sparks-a-love-of-science-Graham-Heieis
#progresshappenstogether #loveletterstoscience #abcam #peoplebehindthescience -
Abcam
@abcam
What does an effective mentor-mentee relationship look like to you?
Join us at PEGS Boston 24 to find out from our VP of Protein Development, Deborah Moore-La & visit the Marquee Room to find out what it means to be a mentor.
See the full schedule here: www.pegsummit.com/networking-events -
Abcam
@abcam
We rigorously validate our antibodies and proteins using advanced QC methods, ensuring the highest quality and reproducibility for your assays. Check out our poster #b003 at PEGS Boston this year to learn more about our quality processes.
Learn more here: lifesciences.danaher.com/us/en/events/pegs.html -
Abcam
@abcam
We’re at PEGS Boston 2024!
Find @abcam at the @DanaherCorp booth #500 & meet our experts: Deborah Moore-Lau, VP of Protein Development, and Will Howat, VP of Quality and Validation.
Click the link for more info and to schedule a meeting with our team: lifesciences.danaher.com/us/en/events/pegs.html -
Abcam
@abcam
That first moment of inspiration feels great. But it’s even better when you show that it’s right. We’ve got over 32,000 high-performance antibodies to help you reach that moment. Together, we move forward faster.
www.abcam.com/primary-antibodies/recombinant-antibodies -
Abcam
@abcam
📢 New publication alert! Our collaborators at @TiroshLab use integrative spatial analysis techniques to reveal new insights into the cellular organization and role of hypoxia within glioblastomas, the most aggressive and most common brain cancer. Read the paper in @CellPressNews to find out more: www.cell.com/cell/fulltext/S0092-8674(24)00320-9
To find out more about the technical and scientific approach behind this paper, including choosing the right reagents and integrating them into the workflow – read our accompanying application note, here: docs.abcam.com/pdf/cancer/glioblastoma-multiplex-applicat… -
Abcam
@abcam
“We take pride in knowing that we make a meaningful difference to our customers.” Ben Gordon, Logistics Manager.
From the lab to logistics, all roles at Abcam play a part in supporting our customers.
Learn more: jobs.danaher.com/global/en/abcam -
Abcam
@abcam
Graham Heieis explains how he came to be solving one of the world’s largest health burdens.
Hear from Graham, in part five of Love Letters to Science. OUT NOW!
Watch the short film here: go.myabcam.com/What-sparks-a-love-of-science-Graham-Heieis
#progresshappenstogether #loveletterstoscience #abcam -
Abcam
@abcam
To hit the research bullseye, you need precision. That’s why we optimize our recombinant antibodies to give you unrivaled specificity and consistency every time.
-
Abcam
@abcam
“One of the best feelings in science is seeing new data… Something that hasn’t been discovered or shown by anyone else”. - Graham Heieis, EPISODE OUT NOW!
go.myabcam.com/What-sparks-a-love-of-science-Graham-Heieis
#progresshappenstogether #abcam #loveletterstoscience -
Abcam
@abcam
April is #parkinsonsawareness Month, and we're spotlighting the incredible work of Nicole Polinksi and Elisia Clark, both scientists-turned-connectors at @MichaelJFoxOrg. With a collaborative approach, they bridge the gap between researchers, tools, and funding to accelerate Parkinson's disease research.
Read their story here: go.myabcam.com/nicole-polinski-elisia-clark-story -
Abcam
@abcam
Our next #cellcycleconference meeting, featuring a keynote talk by Prof. Fumiko Esashi!
Join us online or in person on June 4
In-person attendees can share their research as a short talk or poster: events.abcam.com/event/cellcycleconference/websitePage:b6…
@EsashiLab @Dunn_School @UniofOxford @DeRobertus -
Abcam
@abcam
Today is Int. Day of Immunology! Check out groundbreaking research from @GrahamHeieis & team on the immune response to helminths – a major parasitic infection worldwide.
Graham shares his passion for his work in his #loveletterstoscience film - out May 1!
www.nature.com/articles/s41467-023-41353-z -
Abcam
@abcam
Explore #immunometabolism control by #nlrp3 #inflammasome activation with @PelegrinPablo @imib_Arrixaca, @olafgross_lab and @ClareBryant13 at #inflammazoom on April 29.
Register now!
events.abcam.com/event/inflammazoom/websitePage:b60365ca-… -
Abcam
@abcam
Joining Abcam isn't just a job, it's a journey of growth and opportunity. Meet Simon Pascoe, our Finance Business Partner, whose story proves that with determination, success knows no bounds. Ready about his journey:
careers.abcam.com/us/en/blogarticle/seizing-opportunities
#abcam #careergrowth #opportunity -
Abcam
@abcam
You work all hours, so you deserve antibodies to match. We use industry-leading validation methods, including biophysical QC, to ensure our antibodies work first time, every time.
-
Abcam
@abcam
“For me, it’s also really just about the mystery of it and solving that puzzle”.
Graham Heieis inherited a good memory from his grandmother and has put it to the test throughout his career in immunology.
Full episode out MAY 1!
#progresshappenstogether -
Abcam
@abcam
"There’s so many avenues to go within biotechnology.”
Josiah Wade-Green is a recent #bioversity grad, now excelling as a logistics technician at Abcam and making a global impact.
Read how #bioversity is helping create new pathways into STEM: www.biospace.com/article/bioversity-program-preps-grads-f… -
Abcam
@abcam
Don’t miss Virginia Man-Yee Lee’s film - part four of @abcam's Love Letters to Science!
OUT NOW: go.myabcam.com/What-sparks-a-love-of-science-Virginia-Man…
#progresshappenstogether #loveletterstoscience #abcam #peoplebehindthescience -
Abcam
@abcam
Virginia Man-Yee Lee shares why we should feel optimistic about getting older.
Hear from Virginia, in part four of Love Letters to Science. OUT NOW!
Watch here: go.myabcam.com/What-sparks-a-love-of-science-Virginia-Man…
#progresshappenstogether #loveletterstoscience #abcam #thepeoplebehindthescience -
Abcam
@abcam
You need to be able to rely on your reagents from the first experiment to the last. That’s why we deliver precision antibodies that give you consistent results time after time.
-
Abcam
@abcam
“I actually started this journey in science not knowing that I would be able to be where I am.” - Virginia Man-Yee Lee, EPISODE OUT NOW!
Hear how Virginia addresses one of humankind’s inevitable processes – getting older.
go.myabcam.com/What-sparks-a-love-of-science-Virginia-Man…
@PennMedicine @Penn -
Abcam
@abcam
“If they want to see my brain, they can see my brain”.
Virginia Man-Yee Lee works to address one of humankind’s inevitable processes – getting older. Explaining how her work has made her feel optimistic about aging & why we should too.
Full episode out Apr 17!
@PennMedicine -
Abcam
@abcam
You put a lot into your research, so we want to deliver antibodies that match your efforts.
We validate and optimize our recombinant antibodies to help every experiment keep you moving. -
Abcam
@abcam
🎙️ On #worldparkinsonsday, dive into the latest episode of the @MichaelJFoxOrg podcast to hear how new tools are being developed to further understanding of new and emerging targets in this area of research. www.michaeljfox.org/podcast/episode-12-accelerating-disco…
-
Abcam
@abcam
Dive into the world of immunohistochemistry and multiplexing techniques with industry experts, including speakers from @abcam and @LeicaBio at our upcoming webinar in partnership with Leica Biosystems.
Click here to register: us06web.zoom.us/webinar/register/9717098615708/WN_JUvvf95… -
Abcam
@abcam
We were delighted to meet up with the @CiteAb team yesterday at #aacr24 to receive four awards recognizing our initiatives and products in 2023. Thank you to CiteAb and to this incredible community for your support!
More details here: corporate.abcam.com/abcam-most-cited-antibody-supplier-fo…
#citeabawards -
Abcam
@abcam
Don’t miss Joe Beechem’s film - part three of @abcam's Love Letters to Science!
OUT NOW!
go.myabcam.com/What-sparks-a-love-of-science-Joe-Beechem
#progresshappenstogether #loveletterstoscience #abcam #peoplebehindthescience -
Abcam
@abcam
Joe Beechem chose a biology class at school when philosophy wasn’t giving him adequate answers. In this first class, he learned something that meant he would never turn back from science.
Hear from Joe, in part three of Love Letters to Science. OUT NOW!
go.myabcam.com/What-sparks-a-love-of-science-Joe-Beechem -
Abcam
@abcam
Join us for Love, Factually at #aacr24. Endulge all of your senses in our pop-up art exhibition and immersive planetarium experience, accompanied by extraordinary and exciting canapés and cocktails.
Register now, here: web-eur.cvent.com/event/a2695f95-ac16-4799-975e-80f50388a… -
Abcam
@abcam
“Me staring into that one square inch of a person’s body looks exactly the same as the night sky through a telescope” - @joebeechem, EPISODE OUT NOW!
Hear how Joe uses science to answer a fundamental question: what makes us human?
go.myabcam.com/What-sparks-a-love-of-science-Joe-Beechem -
Abcam
@abcam
Are you at @AACR this year? Check out the link below to discover more about our on-site activities, including our talk, immersive event and partner poster presentations.
eur.cvent.me/KwdQr?RefId=AACR24
#aacr24 @AkoyaBio @nanostringtech -
Abcam
@abcam
We share your passion for research, so we’re committed to making sure every antibody works first time. From knock-out validation to biophysical QC, our exceptional quality management system means you get results you can rely on.
-
Abcam
@abcam
“Me staring into that one square inch of a person’s body looks exactly the same as the night sky through a telescope”.
Joe Beechem uses science to answer a fundamental question: what makes us human?
Full episode out Apr 3!
#progresshappenstogether -
Abcam
@abcam
Your attention to detail sets you up for success. Our antibodies undergo industry-leading validation so they're as precise as you are.
What else do you rely on when it comes to your research? Comment below.
Learn more: www.abcam.com/primary-antibodies/recombinant-antibodies -
Abcam
@abcam
Don’t miss Dr Alejandra Solache’s film - part two of @abcam's Love Letters to Science!
OUT NOW
go.myabcam.com/What-sparks-a-love-of-science-Alejandra-So…
#progresshappenstogether #loveletterstoscience #abcam #peoplebehindthescience -
Abcam
@abcam
We’re honored to be named ‘Supplier Succeeding in IHC’ in the 2024 #citeabawards, and to be highly commended in a further three categories.
A big thank you to @CiteAb and to all the researchers that place their trust in our products.
Read more: corporate.abcam.com/abcam-most-cited-antibody-supplier-fo… -
Abcam
@abcam
Join us at 2pm for talks on the regulation of innate inflammatory responses by cell volume and how mechanical stress boosts NLRP3 inflammasome activation at @Inflammazoom, our free webinar series on #innateimmunity
Use the link to join: events.abcam.com/event/inflammazoom/register?RefId=inflam… -
Abcam
@abcam
Science starts with a desire to answer the unanswered; a fascination with what makes us, us. And for many scientists, this feeling stems from a specific question, usually at a young age.
Hear from Alejandra Solache, in part 2 of Love Letters to Science.
go.myabcam.com/What-sparks-a-love-of-science-Alejandra-So… -
Abcam
@abcam
“I didn’t know that was immunology at that time, but just thought I want to learn more about that” @asolache1 EPISODE OUT NOW!
Hear how Alejandra’s need to understand how the body fights infection had her on a quest for knowledge from childhood.
go.myabcam.com/What-sparks-a-love-of-science-Alejandra-So… -
Abcam
@abcam
To make progress in your research, you need consistency – you need antibodies that produce highly reproducible results, first time, every time. Our antibodies can provide just that.
Learn more: www.abcam.com/primary-antibodies/recombinant-antibodies -
Abcam
@abcam
We’re excited to introduce Markus Lusser as President of Abcam.
Previously Chief Customer Officer at @Danaher, we’re excited about the expertise and customer-centric approach that Markus brings. Please join us in welcoming Markus to the Abcam community!
corporate.abcam.com/abcam-appoints-markus-lusser-as-new-p… -
Abcam
@abcam
Final call! Register now to join us in Cambridge UK on March 18-19 for #metabolism2024: Exploring the Links Between Obesity and its Adverse Health Outcomes.
events.abcam.com/event/metabolism2024/summary?rt=QlpM0tX1… -
Abcam
@abcam
Navigate the practicalities of CITE-seq from analysis worflow to antibody validation with Elena Loche, Senior Product Manager at Abcam & Jonathan Scolnick, General Manager @Singleron_Bio APAC at our upcoming webinar on March 20
us06web.zoom.us/webinar/register/5417089195673/WN_oGGmq9e… -
Abcam
@abcam
“I was always interested in how the body does all the magical things it does”.
Alejandra Solache’s innate need to understand the mysteries of the human body had her on a quest for knowledge when she was a child.
Full episode out Mar 20!
#progresshappenstogether
@asolache1 -
Abcam
@abcam
Don’t miss Robert Blelloch’s film - part one of @abcam's Love Letters to Science!
OUT NOW - go.myabcam.com/What-sparks-a-love-of-science
#progresshappenstogether #loveletterstoscience #abcam #peoplebehindthescience -
Abcam
@abcam
Knowing you can rely on your antibodies means you can focus on what matters most: moving your research forward. And when you choose antibodies with industry leading validation, you know they won’t let you down.
-
Abcam
@abcam
How do you find that spark that drives you forward and gives you your ‘why’?
Hear from Robert Blelloch, in our first Love Letters to Science episode. OUT NOW!
Watch the full episode: go.myabcam.com/What-sparks-a-love-of-science
#progresshappenstogether #loveletterstoscience #abcam -
Abcam
@abcam
Alejandra Solache and Will Howat are onsite at the #alpbach Affinity Proteomics Workshop this week. We’re excited to be sharing insights into our validation strategy during the #antibodyvalidation session on March 12.
If you’re onsite, let’s catch up!
events.abcam.com/event/Alpbach-Affinity-Proteomics-Worksh… -
Abcam
@abcam
In honor of International Women’s Day, Waltham Charity Committee & Women’s Network came together to hold an EmpowHER discussion.
The event provided a dynamic & inclusive forum where we discussed thought-provoking questions related to the empowerment & recognition of women. -
Abcam
@abcam
In honor of International Women’s Day, Waltham Charity Committee & Women’s Network came together to hold an EmpowHER discussion.
The event provided a dynamic & inclusive forum where we discussed thought-provoking questions related to the empowerment & recognition of women. -
Abcam
@abcam
🚨 Hot off the press 🚨 This new paper in @Cancer_Cell from our collaborator @AndreaJRadtke and team uses advanced multiplex imaging to evaluate the #tme in #follicularlymphoma. Fantastic to see our antibodies help produce such a spectacular image! Congrats to all involved.
-
Abcam
@abcam
“Our body really is just a bunch of things working together in remarkable ways” @RobertBlelloch, EPISODE OUT NOW!
Watch Robert talk about his personal connection with his work in the first film in @abcam's new five-part series, Love Letters to Science.
go.myabcam.com/What-sparks-a-love-of-science -
Abcam
@abcam
We know you work hard to make sure you get reproducible results.
Our highly consistent antibodies can give you that peace of mind and will keep your research moving forward.
www.abcam.com/primary-antibodies/recombinant-antibodies -
Abcam
@abcam
What aspect of antibody research are you most interested in?
We’re looking forward to the #alpbach Affinity Proteomics Workshop and being a part of the antibody validation session on March 12 with the highly anticipated talk from our SVP of R&D, Alejandra Solache.
events.abcam.com/wVDGo?locale=en&Refid=alpbach2024-sm -
Abcam
@abcam
We’re excited to be at AD/PD 2024!
This groundbreaking Alzheimer's and Parkinson’s conference works towards advancing innovative strategies in therapy, prevention, clinical trials and diagnostic markers.
You can find us at booth #59, come and say hi!
web-eur.cvent.com/event/3d9fb814-e832-421c-b62e-1b9342ba0… -
Abcam
@abcam
When it comes to people vs. worms, we’re more similar than we think...
@robertblelloch's fascination with science began with the realization that everything living starts in the same way.
Full episode out Mar 6 - follow @abcam to be the first to watch
#progresshappenstogether -
Abcam
@abcam
Sometimes it can feel hard to keep going, but with the right support and tools, such as our expert scientific advice and highly reproducible antibodies, you can get to the next stage faster.
-
Abcam
@abcam
We're attending Biomarkers 2024! We can’t wait to join prominent leaders and scientists in sharing new case studies, data, and industry outlook.
Hope to see you there!
#biomarkersseries24 #biomarkers #clinicaldevelopment #precisionmedicine #digitalpathology #abcam -
Abcam
@abcam
Join us online today for the first @InflammaZoom of 2024, featuring @anandparas @imperialcollege and Petr Broz @broz_lab @unil
events.abcam.com/event/inflammazoom/feb-26-2024?rt=QlpM0t…
#inflammasome #innateimmunity #immunology #webinar -
Abcam
@abcam
Progress feels good.
That’s why we extensively validate our antibodies, with over 3,800 knock-out validated – so you can have confidence in your results and keep your research moving forward.
www.abcam.com/primary-antibodies/recombinant-antibodies -
Abcam
@abcam
Don’t forget to vote for your favourite reagent supplier in @CiteAb's ‘Researchers’ Choice’ award – voting closes Feb 21.
www.citeab.com/awards/2024/researchers-choice -
Abcam
@abcam
Join us March 11-13 at the Alpbach Affinity Proteomics Workshop to hear how we’re using an advanced approach to antibody validation to help drive robust research results.
We look forward to seeing you there!
events.abcam.com/event/Alpbach-Affinity-Proteomics-Worksh…
#progresshappenstogether #abcam #antibody -
Abcam
@abcam
Greta Lindberg (Abcam’s Wellbeing Manager) took a visit to our Cambridge office last week and shared her ‘stair-fie’ with us to share her excitement at our new decor!
We echo your thoughts Greta. There’s definitely no doubt about what drives us at Abcam! -
Abcam
@abcam
💡 Looking for a source of inspiration for your #innateimmunity and #inflammasome biology research? 💡
Check out @InflammaZoom, a free webinar series organized in collaboration with @ClareBryant13!
Register once to access all 2024 sessions 👇
events.abcam.com/event/inflammazoom/summary?rt=QlpM0tX1Gk… -
Abcam
@abcam
Exciting news for cell cycle enthusiasts!
Join us online for the #cellcycleconference, chaired by @DeRobertus, @Thorpelab & Snezkha Oliferenko on March 13. Joined by Jan Skotheim, Professor of Biology Stanford University.
To submit an abstract by Feb 16: events.abcam.com/event/cellcycleconference/summary?rt=Qlp… -
Abcam
@abcam
Your research requires all your focus.
We’re here to ensure you get antibodies that are just as precise – our high-performance antibodies can guarantee the specificity you need to keep making progress.
What else helps you to hit that mark? Let us know in the comments. -
Abcam
@abcam
Have we helped progress your research in some way in the last year? If so, we’d love you to consider nominating us for @CiteAb’s ‘Researchers’ Choice’ award. Voting closes on Feb 21.
www.citeab.com/awards/2024/researchers-choice -
Abcam
@abcam
What would make you feel better supported in the workplace as a woman in STEM?
This International Day of Women and Girls in Science, we want to open up the conversation to explore the ways we can all support and empower each other to help bridge the gender gap in STEM. -
Abcam
@abcam
You've put in the hours... a lot of them. And antibodies that work first time, every time, save time. That’s why all our antibodies undergo industry-leading validation – to keep you and your research moving forward.
What else do you put in to get the job done? Let us know 👇 -
Abcam
@abcam
Ready, set, job!
As part of our partnership with @Waltham4Youth, we held an all-day workshop to help students at Waltham High School develop professional skills, meet future employers & grow confidence to apply for internships.
Will you be applying for an internship this year? -
Abcam
@abcam
Tell us how you reduce risk in your research 👇
Consistency is always key. As scientists, we consistently show up each day – so why choose antibodies that perform any differently?
Our antibodies deliver unrivaled batch-to-batch consistency for highly reproducible results. -
Abcam
@abcam
Have your say!
@CiteAb’s ‘Researchers’ Choice’ award is open for nominations and we’d love for you to consider nominating us if you feel we’ve helped you move your research forward this past year. Voting closes on Feb 21.
Vote here: www.citeab.com/awards/2024/researchers-choice -
Abcam
@abcam
We’re still riding high from our 3rd annual Global (ERG) Leader Summit.
Here’s to three days of passionate and thoughtful discussions that have set us up for an increasingly positive and enriching experience for colleagues at Abcam in 2024. - Miguela Gonzalez, Head of D&I -
Abcam
@abcam
Today is #worldcancerday and we’re celebrating the researchers working tirelessly to advance cancer understanding and treatment! 🌍🔬
This @Nature article is a great example of how a multidisciplinary approach is helping drive progress: go.nature.com/3OpbNXN -
Abcam
@abcam
We know how much you put into your research each day. Our highly reproducible, precision antibodies can keep your research on track, and keep you moving forward.
What else goes into your research to keep it moving? Comment below 👇 -
Abcam
@abcam
Join us at booth #955 at #slas2024 this week as we explore how recombinant technology can help you advance your research. Learn how to problem solve and boost efficiency using high-throughput immunoassays in tutorials and poster talks throughout the event: web-eur.cvent.com/event/5e889b90-f673-451d-87e7-e1b4f0f7a…
-
Abcam
@abcam
When it comes to research, we know how much you put into every day. That’s why we’re here to provide you with the highest quality, precision antibodies that you can rely on, to keep on making progress.
What else do you rely on to get the job done? List your top three below 👇 -
Abcam
@abcam
Abcam’s commitment to help accelerate breakthroughs in life science started with antibodies.
We can proudly say we now offer so much more, from proteins to cell lines. And for over a decade, we’ve been pioneering immunoassay technology, too.
www.abcam.com/content/beyond-antibodies -
Abcam
@abcam
Standard pricing and the call for posters for the Exploring the Links Between Obesity and its Adverse Health Outcomes Conference ends February 1. In Cambridge, UK on March 18-19 for 2 days of discussions and networking with the #metabolicscience community. events.abcam.com/event/metabolism2024/summary?rt=QlpM0tX1…
-
Abcam
@abcam
Who would you love to hear from in the science community?
Let us know below 👇
Watch the full season here: go.myabcam.com/LP=3756?elqTrackId=050effaf73694c239c856b3…
#progresshappenstogether #abcam #colliderscope -
Abcam
@abcam
Have you mastered your multiplex immunofluorescence technique? Join our webinar in partnership with Leica Microsystems, including what to consider when planning multiplex immunofluorescence, your protocol checklist, and troubleshooting tips. Sign up go.myabcam.com/leica-joint-webinar-ROA
-
Abcam
@abcam
Summer School on Chromatin Biology is back in August at @HelmholtzMunich. Start your journey into state-of-the-art chromatin biology with #epigenetics experts @robert_ife @metorrespadilla and Aloys Schepers – apply by April 5 for the 2024 student cohort. events.abcam.com/event/HelmholtzSummerSchool/summary?rt=Q…
-
Abcam
@abcam
Unsure which label you need for your assay? Our fluorochrome chart explores the most common labels to help you identify your ideal fluorochrome.
Learn more: www.abcam.com/secondary-antibodies/fluorochrome-chart-a-c…
#progresshappenstogether #abcam -
Abcam
@abcam
What’s your favourite episode of Colliderscope season two? 🧵1/2
Watch all episodes here: go.myabcam.com/LP=3756?elqTrackId=050effaf73694c239c856b3…
Abcam
@abcam
🧵2/2
Watch all episodes here: go.myabcam.com/LP=3756?elqTrackId=050effaf73694c239c856b3… -
Abcam
@abcam
Curious about the future of biotech?
Don't miss Deborah Moore-Lai, abcam's Senior Director of Protein Development, at Peptalk's Fireside Chat this month.
Click the link to learn more and join the conversation: web-eur.cvent.com/event/b7f336fe-a969-4413-b6bc-6ed12a388… -
Abcam
@abcam
Reviewing our products is quick, easy, and you’ll earn rewards that save you money off future purchases.
Find out how you can help the scientific community make choices that help science progress: www.abcam.com/help/what-is-an-abreview
#progresshappenstogether #abcam -
Abcam
@abcam
With a one-wash protocol, our SimpleStep ELISA® kits will take you from sample to result in just 90 minutes. Made with our recombinant matched antibody pairs for the highest specificity, batch-to-batch consistency, and unrivaled reproducibility.
www.abcam.com/content/beyond-antibodies -
Abcam
@abcam
How do you embark on a less conventional career path in science?
Hear from Dr Alicia Levey in the new episode of abcam’s Colliderscope podcast, OUT NOW!
Watch the full episode: go.myabcam.com/colliderscope-alicia-levey
#progresshappenstogether #colliderscope #stem #thepeoplebehindthescience -
Abcam
@abcam
Did you see the full episode? If you haven't then watch it now! 👇
go.myabcam.com/colliderscope-alicia-levey
#dralicialevey
#progresshappenstogether #colliderscope #abcam #stem #thepeoplebehindthescience -
Abcam
@abcam
📣 It’s here! 📣
Check out the program for our upcoming #metabolism conference chaired by
@StephenORahilly and David Savage @IMS_MRL
Tickets are limited so book now to join us in #cambridge next March: events.abcam.com/event/metabolism2024/websitePage:078b0d7…
#progresshappenstogether #abcam -
Abcam
@abcam
“As a leader I wanted to make sure my thermostat wasn’t set to no all the time” – Dr Alicia Levey FULL EPISODE OUT NOW!
Listen now & watch the full episode: go.myabcam.com/colliderscope-alicia-levey
#progresshappenstogether
@AliciaLevey -
Abcam
@abcam
Speed up your research with reagents that ensure long-term supply and consistency at every step of your journey.
Find out more: www.abcam.com/primary-antibodies/recombinant-antibodies
#recombinant #reproduciblescience #kovalidation #progresshappenstogether #abcam -
Abcam
@abcam
Share your experience of our products and help others like you find the right antibody, faster.
We publish all reviews, positive or negative – and over time, your feedback helps improve antibody quality.
Find out more about our review and reward program: www.abcam.com/help/what-is-an-abreview -
Abcam
@abcam
“I don’t want to do something incremental. I want to do something that is a step change.”
Hear Dr Levey discuss her unique career, the joy of personal connections, and lessons in sharing data.
OUT DEC 13TH!
#progresshappenstogether #abcam #thepeoplebehindthescience -
Abcam
@abcam
Get to know the essentials of antibody conjugation, including how to choose between direct and indirect assays, commonly used labels, and methods you can use to conjugate your primary antibody with our easy conjugation guide.
Click here to download now: go.myabcam.com/antibody-conjugation-guide -
Abcam
@abcam
Abcam is now part of @DanaherCorp, a leading global life sciences and diagnostics innovator.
Together we combine our capabilities to accelerate the power of science and technology to improve human health. -
Abcam
@abcam
For more than a decade, we’ve been pioneering immunoassay technology that drives science forward, faster.
Click here to learn how our 90-minute SimpleStep ELISA® can help you achieve more. www.abcam.com/kits/simplestep-elisa-kits
#elisa #progresshapennstogether #abcam -
Abcam
@abcam
Share your feedback on our products and help the whole community make better choices for their research.
As a thank you, you’ll get rewarded with savings on future purchases. Find out how you can contribute, here: www.abcam.com/help/what-is-an-abreview
#progresshappenstogether #abcam -
Abcam
@abcam
Watch @tojuolufeko do the final step of the ELISA assay, using the @abcam kit to asses the effects of cytotoxic agent gallic acid on MCF-7 human breast cancer cells at varying concentrations to determine the optimum.
Find our more here: www.abcam.com/kits/simplestep-elisa-kits -
Abcam
@abcam
📈 Reduce variations in your experiments with #antibodies designed for reproducibility.
Learn more: www.abcam.com/primary-antibodies/recombinant-antibodies
#recombinant #reproduciblescience #kovalidation #progresshappenstogether #abcam -
Abcam
@abcam
Join our webinar on December 6 at 3.00pm GMT to discuss the technology behind the GeoMx DSP®, including the ins and outs of the GeoMx IO Proteome Atlas.
Click the link to register now: nanostring.zoom.us/webinar/register/9816986714967/WN_FHye…
#sitc #cancerresearch #webinar -
Abcam
@abcam
Have you mastered your multiplex immunofluorescence staining and imaging?
We’ve got you covered with our on-demand webinar in partnership with Leica Microsystems:
Sign up here: go.myabcam.com/leica-joint-webinar-ROA
#abcam #progresshappenstogether -
Abcam
@abcam
Another great year of immunology insights from around the world at our @Inflammazoom webinar series!
Join us for one last hurrah this December at the Innate Sensing and Signaling in #immunology Conference - in-person and virtual tickets available: events.abcam.com/event/innatesensing2023 -
Abcam
@abcam
Issy shares with us what she values most about working with abcam:
“I’m extremely grateful for my wonderful team & colleagues for providing me with the support and flexibility to navigate what this diagnosis means to me personally, and how to bring my best self to work.” -
Abcam
@abcam
Abcam’s commitment to accelerating scientific discovery started with antibodies.
We can proudly say we now offer so much more, from proteins to cell lines. And for over a decade, we’ve been pioneering immunoassay technology, too.
Read more: www.abcam.com/content/beyond-antibodies -
Abcam
@abcam
To celebrate & support women in STEM, some colleagues in our global R&D and Digital teams share their best tips to other women looking to find success in STEM, and beyond.
Read more of Neveen’s advice & from more of our colleagues: jobs.danaher.com/global/en/abcam -
Abcam
@abcam
What does it mean to build a community with intention?
Hear from Dr Rose Perry in the new season of abcam's Colliderscope podcast, OUT NOW!
Watch the full episode here: go.myabcam.com/rose-perry
#progresshappenstogether #colliderscope #stem #thepeoplebehindthescience -
Abcam
@abcam
@InflammaZoom is live today at 4.00pm GMT – register now to hear talks from @psmitchej_ and @frickellab !
events.abcam.com/event/inflammazoom/summary?rt=QlpM0tX1Gk…
Can’t make the live session? Register anyway to access the on-demand recording.
#innateimmunity #immunology #inflammasome -
Abcam
@abcam
With over 3,800 knock-out validated antibodies to choose from, you can be confident that abcam antibodies will deliver confirmed specificity.
Find out more: www.abcam.com/primary-antibodies/recombinant-antibodies
#recombinant #reproduciblescience #kovalidation #progresshappenstogether -
Abcam
@abcam
Did you see the full episode? If you haven't then watch it here: go.myabcam.com/rose-perry
#drroseperry
#progresshappenstogether #colliderscope #abcam #stem #thepeoplebehindthescience -
Abcam
@abcam
Dr Houssein Abdul Sater first approached abcam in 2016. It sparked a research collaboration to improve the assessment of PD-L1 in cancer tissue.
Read the full story here - www.abcam.com/primary-antibodies/advancing-immuno-oncolog… - 5-minute read.
#abcam #progresshappenstogether -
Abcam reposted
Society for Neuroscience (SfN)
@SfNtweets
Another day of science and fun!
What’s your number one take away from #sfn23? -
Abcam
@abcam
“We still very much want to move the needle on social connection” – Dr Rose Perry
Hear Dr Perry discuss the different languages of science, breaking down silos, and how our community can influence our health.
Watch the full episode now: go.myabcam.com/rose-perry -
Abcam
@abcam
Registration for Monday's #inflammazoom session is still open! Sign up now to join us.
Clare Bryant (clarebryant@bsky.social)
@ClareBryant13
Get ready Inflammazoomers for our next instalment: @FrickelLab and Patrick Mitchell next Monday at 4 www.abcam.com/webinars/inflammazoom-webinar-series
-
Abcam
@abcam
Our one-wash SimpleStep ELISA® kits will get you there faster, with no compromise on performance.
We have over 1,400 kits in our portfolio, including our new 10-pack sizes and 384-well kits.
Discover our range of SimpleStep ELISA® kits www.abcam.com/kits/simplestep-elisa-kits
#elisakit -
Abcam
@abcam
Your western blot questions answered
Get everything you need to know to perform your experiments in our convenient guide; expert insights on recommended controls, sample prep, electrophoresis, protein transfer & visualization.
Click here to download now: go.myabcam.com/western-blot-guide-form-submitted -
Abcam
@abcam
"The number one predictor of lifespan is the strength of relationships in the community."
Hear from Dr Rose Perry on breaking down silos, the different languages of science, and how our community can influence our health.
OUT NOV 15! -
Abcam
@abcam
Join us at Neuroscience 2023.
Discover our neuro nook at booth #2122, where we’ll be featuring six insightful talks throughout the week. Let's accelerate your neuroscience research journey together.
events.abcam.com/event/neuroscience2023/summary
#sfn2023 #abcam #progresshappenstogether -
Abcam
@abcam
How can sharing ideas help you progress in science?
Hear from Dr Ravindran Kumaran in the new season of abcam's Colliderscope podcast. OUT NOW!
Watch the full episode here: go.myabcam.com/colliderscope-ravindran-kumaran
#progresshappenstogether #colliderscope #stem #thepeoplebehindthescience -
Abcam
@abcam
Did you see the full episode? If you haven't then watch it now!
go.myabcam.com/colliderscope-ravindran-kumaran
#drravindrankumaran
#progresshappenstogether #colliderscope #abcam #stem #thepeoplebehindthescience -
Abcam
@abcam
‘At some point you realise you can’t do it all on your own.' - Dr Ravindran Kumaran FULL EPISODE OUT NOW!
go.myabcam.com/colliderscope-ravindran-kumaran
#progresshappenstogether #abcam #colliderscope #stem #thepeoplebehindthescience -
Abcam
@abcam
Working with the Michael J. Fox Foundation, we have been generating antibodies & making them widely available to industry, academic and non-profit groups to accelerate therapeutic development for Parkinson’s patients.
Learn more: www.abcam.com/neuroscience/parkinsons-disease?elqTrackId=…
@MichaelJFoxOrg -
Abcam
@abcam
How can our community help get us through the challenges we face as scientists?
Hear from @abcam's Dr Ravindran Kumaran on his career turning point, the value of support systems and why fostering a strong community is key to success.
OUT NOV 1!
#progresshappenstogether -
Abcam
@abcam
We’re always looking for ways to improve antibody quality. Now, we’re raising the bar even further with an industry-leading initiative: biophysical characterization of our antibodies.
Learn how we’re helping to drive reproducible results for researchers: www.abcam.com/content/biophysical-characterization-how-ab… -
Abcam
@abcam
The early bird deadline for #metabolism2024 is coming up! Book tickets and submit a short talk abstract before Nov 1 to connect with fellow metabolic science enthusiasts next March.
events.abcam.com/l41QZ?rt=QlpM0tX1GkSpcP0HYA7SVg&RefId=me…
@IMS_MRL @cammetabonet @StephenORahilly #metabolicscience -
Abcam
@abcam
How can you foster a positive attitude to setbacks?
Hear from Dr Kara Margolis in the new season of abcam's Colliderscope podcast. OUT NOW!
Watch the full episode: go.myabcam.com/colliderscope-kara-margolis
#progresshappenstogether #colliderscope #stem #thepeoplebehindthescience #drkaramargolis -
Abcam
@abcam
Our one-wash SimpleStep ELISA® kits will get you there faster, with no compromise on performance.
Ready in 90 minutes or less, focus on getting more done in the lab.
www.abcam.com/kits/simplestep-elisa-kits -
Abcam
@abcam
🚀 Get ready, #immunology enthusiasts! 🧪 The program for Innate Sensing and Signaling in Immunology is now out. Book by Oct 30 for the best price and join us this Dec in Boston. events.abcam.com/innatesensing2023
@InflammaZoom @ClareBryant13 @Davie_boucher @Rebecca_Coll @JelenaLab -
Abcam
@abcam
Did you see the full episode? If you haven't then watch it now 👇
go.myabcam.com/colliderscope-kara-margolis
#drkaramargolis
#progresshappenstogether #colliderscope #abcam #stem #thepeoplebehindthescience -
Abcam
@abcam
CUBIC, an emerging imaging technique, is the method of 3D tissue clearing and imaging invented by Professor Hiroki Ueda from the RIKEN research institute in Japan.
Learn more about the technique here:
www.nature.com/articles/nprot.2015.085
www.nature.com/articles/s41467-020-15906-5 -
Abcam
@abcam
'The thing that is most important to me in the lab is kindness.' - Dr Kara Margolis FULL EPISODE OUT NOW!
Dr Margolis tells us why bringing diverse scientific minds together is so key!
Listen & watch the full episode here: go.myabcam.com/colliderscope-kara-margolis
#progresshappenstogether -
Abcam
@abcam
📢 Just published 📢
Collaborators at @AkoyaBio & @UQMedicine have comprehensively mapped the spatial proteome of #headandneck tumors using ultrahigh-plex #singlecell #spatialphenotyping.
Great to be involved in such exciting work!
www.liebertpub.com/doi/epdf/10.1089/genbio.2023.0029 @GENBiotechJrnl @aruthak -
Abcam
@abcam
Meet the team that developed our new 384-well SimpleStep ELISA kits based on your feedback.
A powerful upgrade, made possible by teamwork 💪
Find out how our immunoassays can help you take your science further, faster: www.abcam.com/kits/high-throughput-screening-elisa-based-…
#abcam #progresshappenstogether
Abcam
@abcam
Seems like the link isn’t working! Sorry about that, here it is again: www.abcam.com/kits/high-throughput-screening-elisa-based-…
-
Abcam
@abcam
We’re excited to be attending ELRIG Drug Discovery 2023 this October!
Visit booth C29 to learn more about how our solutions can help you reach your research goals and speed up your drug discovery journey.
web-eur.cvent.com/event/9c4a4b1c-db49-4e4c-a40e-eb4033dad…
#elrig2023 #drugdiscovery -
Abcam
@abcam
Why is it so important to bring together diverse minds in science?
Hear from @karagm2009 on the power of a shared goal, strong relationships and how kindness in the lab can go a long way.
OUT OCTOBER 18!
#progresshappenstogether -
Abcam reposted
Cambridge Metabolism
@CamMetaboNet
Its official! Registration is now open for this highly anticipated conference in March 2024 in Cambridge. An impressive list of 17 speakers from across the globe with opportunities for posters and short talks. Don't delay - apply today
👇👇👇
Abcam
@abcam
Attention #metabolic scientists!
We’ve teamed up with @StephenORahilly & Prof. David Savage @IMS_MRL @cammetabonet for a conference on #metabolicdisorders linked to #overnutrition. Book now to join us next March.
More info here 👇
events.abcam.com/event/metabolism2024/summary?rt=QlpM0tX1… -
Abcam reposted
Inst Metabolic Science-Metabolic Research Labs
@IMS_MRL
Have a listen to our very own @GilesYeo discussing the influence of serendipity in science. He talks about being in the right place at the right time, his motivations for staying in science, and navigating the different cultures inside and outside the lab.
Abcam
@abcam
'If you don't have that joy, overall joy, the moment that frustrating thing hits you’re just not going to push through' @gilesyeo FULL EPISODE OUT NOW!
Listen now go.myabcam.com/colliderscope-giles-yeo -
Abcam reposted
Milner Therapeutics Institute
@TheMilnerInst
Join us for our October seminars, with a focus on disease models 👀
Wed 18th October on the @CamBioCampus.
Our speakers this month will be Emma Rawlins (@GurdonInstitute) and Matteo Martufi of @GSK*.
Register now at www.milner.cam.ac.uk/milner-seminar-series/
*Please note speaker change” -
Abcam
@abcam
What are the differences between direct and indirect methods of immunofluorescence?
Find out how they compare on time, sensitivity, and background, and learn how to reduce the complexity of your assay using conjugated antibodies.
Learn more here: www.abcam.com/secondary-antibodies/direct-vs-indirect-imm… -
Abcam
@abcam
Have you seen what's on the program for the Digital #cellcycle Conference this October?
Discover talk topics & featured speakers. This community has really taken off since we started hosting sessions virtually. Register for free & join us on October 17.
events.abcam.com/CellCycle1023 -
Abcam
@abcam
What does it take to be successful in science?
Hear from @gilesyeo in the new season of abcam's Colliderscope podcast. OUT NOW!
Watch the full episode here: go.myabcam.com/colliderscope-giles-yeo
#progresshappenstogether #colliderscope #stem #thepeoplebehindthescience #drgilesyeo -
Abcam
@abcam
Have you seen the full episode yet?! Comment 'YES' below if you have and if you haven't then head to the post below to watch it now 👇
@gilesyeo
#progresshappenstogether #colliderscope #abcam #stem #thepeoplebehindthescience
Abcam
@abcam
'If you don't have that joy, overall joy, the moment that frustrating thing hits you’re just not going to push through' @gilesyeo FULL EPISODE OUT NOW!
Listen now go.myabcam.com/colliderscope-giles-yeo -
Abcam
@abcam
Alice Faisali, abcam’s Head of HR, shares with us her personal and professional career highlights where flexibility has been key to her career development and growth.
Read the full article here: work180.com/en-au/blog/alice-in-abcam-a-workplace-where-f…
#progresshappenstogether #abcamemployee #womeninstem -
Abcam
@abcam
'If you don't have that joy, overall joy, the moment that frustrating thing hits you’re just not going to push through' @gilesyeo FULL EPISODE OUT NOW!
Listen now go.myabcam.com/colliderscope-giles-yeo -
Abcam
@abcam
“I'm pleased to share my recent experience at Abcam, where I had the remarkable opportunity to spend a week among pioneering figures in the Biotech industry.
I aspire to work for an employer as inspiring as Abcam in the future.” - Henry Field -
Abcam
@abcam
Our range of antibody conjugation solutions is designed to give you choice.
With over 7,000 conjugated recombinant antibodies & 13,000 conjugation-ready carrier-free antibodies, you have the flexibility to design the assay you need.
www.abcam.com/primary-antibodies/antibody-conjugation-sim… -
Abcam
@abcam
Attention #metabolic scientists!
We’ve teamed up with @StephenORahilly & Prof. David Savage @IMS_MRL @cammetabonet for a conference on #metabolicdisorders linked to #overnutrition. Book now to join us next March.
More info here 👇
events.abcam.com/event/metabolism2024/summary?rt=QlpM0tX1… -
Abcam
@abcam
What was the biggest learning curve when you started in science?
Hear from Dr Giles Yeo MBE on his joys, sacrifices and loves that changed his career path and brought him to new discoveries.
OUT OCTOBER 4!
@gilesyeo
#progresshappenstogether -
Abcam
@abcam
📈 Reduce variations in your experiments with #antibodies designed for reproducibility. Learn more: www.abcam.com/primary-antibodies/recombinant-antibodies
#recombinant #reproduciblescience #kovalidation #progresshappenstogether -
Abcam
@abcam
'Discover the people behind the science' in our new series Colliderscope. A bi-weekly podcast where Dr Caitlin Shure talks to world-leading scientists & hears how the scientific community helps them find joy in their work and life.
Coming to all major podcast platforms soon! -
Abcam
@abcam
New research published in @science sheds light on the connection between the build up of abnormal proteins in the brain and the loss of neurons that leads to Alzheimer's symptoms.
Have you read the paper yet? www.science.org/doi/10.1126/science.abp9556 -
Abcam
@abcam
Our SimpleStep ELISA® kits have saved researchers over 61 years at the bench since 2012, so they can focus on what matters most – moving research forward.
Learn more: www.abcam.com/content/beyond-antibodies -
Abcam
@abcam
For anyone based near Cambridge, UK, don't miss this opportunity to hear from Dr Andrew Guirguis👇
Milner Therapeutics Institute
@TheMilnerInst
"The epitranscriptome – a potential role in anti-tumour immunity" 👀
Friday 29th September, JCBC, @CamBioCampus.
📣 @TheMilnerInst and Affiliate Partner @storm_tx brings you Dr Andrew Guirguis @TheDawsonLab for this specialty talk.
More info: www.milner.cam.ac.uk/event/the-epitranscriptome-a-potenti… -
Abcam
@abcam
Great work by @GrahamHeieis @EvertsBart & others. The study characterizes macrophage populations using an innovative technique that pushes beyond the limitations of #flowcytometry, providing valuable tools for #immunometabolism researchers.
@LUMC_Leiden
www.nature.com/articles/s41467-023-41353-z -
Abcam
@abcam
Join us October 17 for our virtual conference for the #cellcycle community! Featuring @Cambridge_Uni ‘s Ian Henderson.
Register for free to join us & don’t miss out on the short talk opportunities; abstract submissions are now open! 🧪
Register here: events.abcam.com/event/CellCycle1023/summary -
Abcam
@abcam
📢 Exciting news for spatial biologists 📢
Today @NanoStringtech launches its #geomx IO Proteome Atlas, enabling researchers to spatially profile >500 IO-relevant targets simultaneously in FFPE using abcam’s IHC-validated antibodies.
Find out more: corporate.abcam.com/nanostring-launches-the-most-comprehe… -
Abcam
@abcam
Register now and submit your abstract by Sept 15! 📢
@ClareBryant13 and the @InflammaZoom scientific committee have put together an incredible speaker lineup for our first-ever in-person conference this December!
Submit your abstracts here: events.abcam.com/event/innatesensing2023 -
Abcam
@abcam
Speed up your research with reagents that ensure long-term supply and consistency at every step of your journey.
Find out more: www.abcam.com/primary-antibodies/recombinant-antibodies
#recombinant #reproduciblescience #kovalidation #progresshappenstogether -
Abcam
@abcam
Discover the epic line-up of speakers for our upcoming conference on #liquidbiopsy. Developed in partnership with @svploeg (@MassGeneralNews) and Klaus Pantel (@UKEHamburg). Registration and poster submission now open 👉👉 events.abcam.com/liquidbio2023
-
Abcam
@abcam
Explore the full program for #adultneurogenesis 2023 - taking place Sept 25-27 at @tudresden_de
Short talks have now been selected but there's still time to submit a poster! Learn more about the conference, speakers, poster sessions and register here 👉 events.abcam.com/adultneurogenesis23 -
Abcam
@abcam
📈 Reduce variations in your experiments with #antibodies designed for reproducibility. Learn more: www.abcam.com/primary-antibodies/recombinant-antibodies
#recombinant #reproduciblescience #kovalidation #progresshappenstogether -
Abcam
@abcam
At the World Clinical Biomarkers & CDx Summit 2023, discover what we’re doing at abcam to address the reproducibility crisis.
Join us on September 18 at 11.50am, and let’s tackle the reproducibility crisis together. 🚀
web-eur.cvent.com/event/de27ae47-9abf-45de-8134-e90aecb3c… -
Abcam reposted
WORK180
@WORK180_
Are you worn down by a workplace that favors grind over grace, competition over compassion, or fixed mindsets over flexibility? Then according to Alice Faisali, @abcam will surely seem something of a ✨wonderland✨ Read Alice’s story below👇work180.com/en-au/blog/alice-in-abcam-a-workplace-where-f…
-
Abcam
@abcam
The early 20th century saw extraordinary pace of scientific advancement. We’re celebrating these brilliant minds for the role they played and for making scientific understanding what it is today.
A thread (1/3)
Abcam
@abcam
A great reminder that scientific discovery means nothing in isolation – it takes this whole community to make progress and continue pushing boundaries!
(2/3)
Abcam
@abcam
Which of these scientists inspires you the most? 🧪👇
#progresshappenstogether #abcam #stem #stemm #genomics #biotech #lifescience
(3/3) -
Abcam
@abcam
We’re mesmerized watching Immunology_lab429 adding stopping solution to this ELISA assay 👀
The stopping solution stops the reaction, stabilising the colour change and changing the chromogen from blue to yellow for precise quantification in the ELISA 🔎 -
Abcam
@abcam
Unsure which label you need for your next assay?
Our fluorochrome chart explores the most common labels to help you identify your ideal fluorochrome.
Download chart here: www.abcam.com/secondary-antibodies/fluorochrome-chart-a-c…
#progresshappenstogether #flurochromechart #antibodies -
Abcam
@abcam
Get practical tips for preparing different sample types for ELISA assays in this @biocompare article featuring @abcam 's Head of ELISA Assay Development, Chelcie Eller.
Read the full article here: www.biocompare.com/Editorial-Articles/597129-Optimizing-E…
#progresshappenstogether #elisa -
Abcam
@abcam
Nicole Polinski & Elisia Clark are bridging the gap between scientists and the tools they need to push Parkinson’s research forward.
Read full article: go.myabcam.com/nicole-polinski-elisia-clark-story
#progresshappenstogether #parkinsonsdisease #mjff -
Abcam
@abcam
Poetry and science should come together more often in our opinion! Click on the original post to see verse two in the comments ⬇️ @DenaProcaccini @_hubmap 👏
Find out about Organ Mapping Antibody Panels here: www.nature.com/articles/s41592-023-01846-7
NIH Common Fund
@NIH_CommonFund
Ode to an OMAP
I thought that I would never see
A set of antibodies just for me
A panel that can tell me where
Molecules call their lair
And where within tissues they do roam
And where in the cells they call home
But then the researchers at #_hubmap
Did create the OMAP -
Abcam
@abcam
Speed up your research with reagents that ensure long-term supply and consistency at every step of your journey.
Find out more: www.abcam.com/primary-antibodies/recombinant-antibodies
#recombinant #reproduciblescience #kovalidation #progresshappenstogether -
Abcam
@abcam
📈 Reduce variations in your experiments with #antibodies designed for reproducibility. Learn more: www.abcam.com/primary-antibodies/recombinant-antibodies
#recombinant #reproduciblescience #kovalidation #progresshappenstogether -
Abcam
@abcam
How are organ mapping antibody panels playing an important role in the construction of a Human Reference Atlas?
Our collaborator Andrea Radtke takes us ‘Behind the Paper’ in this @NaturePortfolio blog:
protocolsmethods.springernature.com/posts/high-affinity-t…
@NIH #hubmap -
Abcam
@abcam
Join us in Boston this December for our first-ever in-person @InflammaZoom, featuring insightful talks from leaders in #innateimmunity.
Register here: www.abcam.com/events/innate-sensing-and-signaling-in-immu…
@ClareBryant13 @dave_boucher @ybri_uoy @rebecca_coll @qubelfast @JelenaLab -
Abcam
@abcam
Unreliable antibodies can create a lot of problems for researchers. Our Senior Vice President of R&D @asolache1 tells @NaturePortfolio how choosing recombinantly manufactured antibodies can provide peace of mind.
Read the full article here: go.nature.com/3p7xOku -
Abcam
@abcam
If your work involves multiplexed antibody-based imaging – this one’s for you!
Proud to have worked together with @_HuBMAP and others to produce this community resource to help standardize multiplexed tissue imaging.
New paper out now in @naturemethods⬇️
www.nature.com/articles/s41592-023-01846-7 -
Abcam
@abcam
It’s really exciting to see this body of work from @_HUBMAP published in a new collection across the @Nature family of journals.
Take a look to discover the exceptional progress they’ve made in mapping human tissues at the cellular level 👇
Human BioMolecular Atlas Program (HuBMAP)
@_hubmap
We're proud to have a set of articles out in @Nature today - thank you to all consortium members for your significant contributions!
www.nature.com/collections/aihihijabe -
Abcam
@abcam
We love this video from @DukeNUS explaining the role bats can play in helping us understand inflammasome-driven diseases 🦇
Join us at @inflammazoom on July 28 to hear @linfa_wang and Matae Ahn discuss the topic in more detail! #bats #immunesystem #virus
www.youtube.com/watch?v=EeaG7uqhzf8&t=10s
Abcam
@abcam
Register here to join us for the upcoming InflammaZoom webinar on July 28th: www.abcam.com/webinars/inflammazoom-webinar-series
-
Abcam
@abcam
📈 Reduce variations in your experiments with #antibodies designed for reproducibility. Learn more: www.abcam.com/primary-antibodies/recombinant-antibodies
#recombinant #reproduciblescience #kovalidation #progresshappenstogether -
Abcam
@abcam
It’s great to see a glimpse of our customers in their day to day - thank you Zeynep Hilal Durkaya for sharing a little bit of your world with us.
Share your lab photos & tell us about about you, for an opportunity to feature on our page 🧪
#progresshappenstogether #womeninstem -
Abcam
@abcam
Missed the last @inflammazoom session on July 3? Catch up on-demand here!
go.myabcam.com/webinar-inflammazoom-july-3-2023
@avi_cambi @cinflammasome @Toniolo_chiara
#inflammasomebiology #innateimmunity #pyrin -
Abcam
@abcam
We're looking forward to the next #inflammazoom! Join us by registering here: www.abcam.com/webinars/inflammazoom-webinar-series
JelenaBezbradicaLab
@JelenaLab
Save the date for the next #inflammazoom July 28th at 2 pm BST: Linfa Wang and Matae Ahn from Singapore #dukenus discuss their great recent work on bat immunology, how bats suppress their inflammasomes? Evolution story at its best! Register at
www.abcam.com/webinars/inflammazoom-webinar-series -
Abcam
@abcam
We hosted a fascinating panel discussion where the panellists – David Olusoga, Mojisola Adebayo and Alan Hirzel - discussed Henrietta’s life, how her cell line was discovered and how those cells have been used in science since 1951.
Abcam
@abcam
Did Johns Hopkins Hospital believe that by giving black people free treatment they could use anything learnt or collected for further research and financial gain?
Abcam
@abcam
There’s so much more to learn about what happened in 1951 with Henrietta Lacks. Below is a link to further reading:
www.statnews.com/2017/04/14/henrietta-lacks-hela-cells-sc…
#henriettalacks #progresshappenstogether -
Abcam
@abcam
Our new packaging has helped eliminate eight tons of plastic waste a year and improved recyclability.
Find out more about how we partnered with @Swiftpak to make this happen ⤵️
www.business-reporter.co.uk/management/swiftpak-and-abcam…
#progresshappenstogether -
Abcam
@abcam
Speed up your research with reagents that ensure long-term supply and consistency at every step of your journey.
Find out more: www.abcam.com/primary-antibodies/recombinant-antibodies
#recombinant #reproduciblescience #kovalidation #progresshappenstogether -
Abcam
@abcam
Ignite discovery in #adultneurogenesis 🔥🧠 Present a short talk at Adult Neurogenesis 2023 this September, chaired by Gerd Kempermann @DZNE_de
Submit your abstract by July 10 ⬇️
www.abcam.com/events/adult-neurogenesis
#progresshappenstogether -
Abcam
@abcam
There’s still time to submit a poster for our upcoming #liquidbiopsy conference ⌛️ 🧪 – get yours in by June 30 to be reviewed by meeting chairs Klaus Pantel UKEHamburg and Shannon Stott @svploeg
#progresshappenstogether -
Abcam
@abcam
“First ELISA ever and Scott Frank nailed it!” - @EyeDaisyShu
We love it when things go to plan! 🙌
📸 Tag us when you’re next in the lab and let us know what you’re working on.
#progresshappenstogether #lifescience #behindthescientist -
Abcam reposted
Nature Custom Media
@NatureCustom
Choosing recombinants can improve experimental reproducibility #adfeature with @abcam
-
Abcam
@abcam
“I’m very proud to work in a place that takes pride very seriously (not only during pride month). These are more than just stairs… to me, they are validation, support, equality and love! Happy pride month all! 🏳️🌈 - Danilo Lemon”
-
Abcam
@abcam
Let’s take the next step in #cancer treatment together 👣 Present a poster at Liquid Biopsy: Beyond Cell-Free Tumor DNA this November -submission closes on June 30
Submit your poster here: www.abcam.com/events/liquid-biopsy-beyond-cell-free-dna
#progresshappenstogether #liquidbiopsy -
Abcam
@abcam
“I stand tall in the knowledge that slavery was
Not the start of our existence, it was a violent
Interruption of our story and not a reflection of our worth”.
from @HerisaTravels poem, Freedom.
Watch the full video here: www.youtube.com/watch?v=TyVADY6qn-Y&t=816s
@PAlexdeV -
Abcam
@abcam
Scientists trust Abcam validated antibodies: choose from over 29,000 recombinant antibodies to more than 5,000 different genes today at abcam.com
#recombinantantibodies #progresshappenstogether #recombinant #lifescience #antibodytest -
Abcam
@abcam
“It reminds me of the sunset” - Alex Bannister, Abcam Brand Manager
What does our new packaging remind you of?
Share your photos with us, we’d love to see them! 📸
#progresshappenstogether -
Abcam
@abcam
📢 Calling all oncology researchers 📢 Elevate the field of liquid biopsy to new heights by sharing your latest findings at our upcoming conference.Submit your posters by June 30 📅
Submit your poster here:www.abcam.com/events/liquid-biopsy-beyond-cell-free-dna
#liquidbiopsy #progresshappenstogether -
Abcam
@abcam
Recombinantly manufactured antibodies offer significant advantages over traditional monoclonal and polyclonal antibodies. And, when robustly validated, they can save time and improve reproducibility.
@NaturePortfolio
Read the full article here: go.nature.com/3p7xOku -
Abcam
@abcam
"Although STEMM fields have traditionally been male-dominated, there are many women breaking down barriers and excelling in these industries."
This @WORK180 article hears from eight incredible women thriving in STEMM careers 👉 work180.com/en-gb/blog/the-myths-and-realities-of-being-a…
#womeninstem -
Abcam
@abcam
We ❤️ your passion @AaronGoodman33!
Abcam
@abcam
You can download your own version of this human CD antigen guide here 👉 www.abcam.com/primary-antibodies/human-cd-antigen-guide
-
Abcam
@abcam
Speed up your research with reagents that ensure long-term supply and consistency at every step of your journey.
Find out more: www.abcam.com/primary-antibodies/recombinant-antibodies
#recombinant #reproduciblescience #kovalidation #progresshappenstogether -
Abcam
@abcam
"No plastic, still reusable and jazzy colours.... What's not to like?!" - @ben_hewitt97 - Abcam Customer.
People are loving our new packaging! Tell us what you think ⬇️
#sustainablepackaging #progresshappenstogether #abcam -
Abcam
@abcam
'Greg knows, categorically, that LGBTQ+ people belong across the scientific industry and he’s determined to ensure that spaces where all scientists can flourish continue to grow, both in the corporate world and within academia.'
Read the full article here: www.attitude.co.uk/culture/sexuality/lgbtq-in-science-gre… -
Abcam
@abcam
Does the good from Henrietta Lacks’ legacy outweigh the injustice that created it?
Join our conversation led by historian David Olugosa.
In person tickets are now sold out!
Get your free online tickets via Eventbrite, below ⬇️
www.eventbrite.co.uk/e/the-legacy-of-henrietta-lacks-expl…
#progresshappenstogether -
Abcam
@abcam
🏳️🌈 This #pridemonth, join us in celebrating diversity and championing equality in #stem. 🏳️🌈
To kick us off, this @Realstaffing article ft. @MJGonzie covers the importance of listening, role models & creating a positive working environment.
Read here: www.realstaffing.com/en-gb/blog/2022/06/the-smart-move-lg… -
Abcam
@abcam
📈 Reduce variations in your experiments with #antibodies designed for reproducibility. Learn more: www.abcam.com/primary-antibodies/recombinant-antibodies
#recombinant #reproduciblescience #kovalidation #progresshappenstogether -
Abcam
@abcam
Here's a great read for anyone working on the #tumor #microenvironment.
#spatialbiology #progresshappenstogether
Lunaphore (a Bio-Techne brand)
@lunaphore
Our latest #spatialbiology blog showcases recent data presented at the #aacr23, discussing the creation of a panel of 22 markers for use on COMET™, including the SPYRE™ Immuno-Oncology Core Panel and validated antibodies from @abcam .
Learn more: lunaphore.com/our-blog/exploring-spatial-insights-between… -
Abcam
@abcam
We are excited to bring home GOLD at the #exa23 awards. Read more about what #diversityandinclusion means to us here: careers.abcam.com/us/en/Diversity-and-Inclusion
#employeeexeprience #progresshappenstogether @awardsinter -
Abcam
@abcam
Researching #ibd? Hear about the latest developments in mucosal immunology (inflammation of the gut) in this on-demand session 👇
go.myabcam.com/spotlight_ni_session4_1
Ft. @RauchLab, @UpasanaDA, Valentina Discepolo (@UninaIT) -
Abcam
@abcam
Today is #worldibdday
Want an overview of the latest treatment approaches being explored by the inflammatory bowel disease research community? Check out this review in @IJMS_MDPI: www.ncbi.nlm.nih.gov/pmc/articles/PMC9266456/
#worldibdday #crohns #colitis #ibd -
Abcam
@abcam
With over 3,600 knock-out validated antibodies to choose from, you can be confident that abcam antibodies will deliver confirmed specificity.
Find out more: www.abcam.com/primary-antibodies/recombinant-antibodies
#recombinant #reproduciblescience #kovalidation #progresshappenstogether -
Abcam
@abcam
Dr Beatrice Lana, @CR_UK ’s alliance executive, shares her experience in building collaborations that work✍️
Anything here ring true with you? Please share in the comments. 👇
www.abcam.com/cancer/attitude-is-everything
#progresshappenstogether #partnering #alliancemanagement #strategicalliances -
Abcam
@abcam
At #pegsboston today? Connect with Deborah to learn about our latest advances in reagent generation.
www.abcam.com/events/pegs-boston-essential-protein-engine…
@PEGSboston #pegs23 #progresshappenstogether #proteinproduction #proteincharacterization -
Abcam
@abcam
Congratulations Kirstie Speck for being recognized by the “#datascience & #analytics” community🌟 👏🏽
www.onconferences.com/2023-data-analytics-winners
@onconferences #bigdata #womeninstem #progresshappenstogether -
Abcam
@abcam
#aai2023 starts today, and we can’t wait to share with the community our latest work, products and resources for advancing #immunology research! Join us at booth 8012.
www.abcam.com/events/american-association-of-immunologist…
@ImmunologyAAI @J_Immunol @ImmunoHorizons #progresshappenstogether #immunoassays -
Abcam
@abcam
How to determine if sample preparation affects your results.
@CharlotteTeuni1 and @Inge_Verberk provide a good methodology here:
alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz…
@alzassociation @NeuroGen_papers @PaperbirdsN @AlzheimerAms @MScentrum020 @FluidMarkersPIA
#biomarkers #reproduciblescience -
Abcam
@abcam
Great to see how the #spatialbiology community contributes to further the understanding of therapy resistance in #bladdercancer
#nmibc #progresshappenstogether
Akoya Biosciences
@AkoyaBio
Learn how we worked w/ @abcam, @EnableMedicine & @MountSinaiNYC to develop a #spatialphenotyping application using #phenocodediscoverypanels on #phenocyclerfusion for comprehensive analysis of #nmibc tissues w/ 57 protein #biomarkers. www.akoyabio.com/wp-content/uploads/2023/04/Akoya-5648-AA… #bladdercancer @AACR
-
Abcam
@abcam
The results are in on data sharing!
It was great to see so many of you participating. Most of you voted that data sharing should be selective - we'd love to know why!
Let us know in the comments 👇
#progresshappenstogether #openscience #academictwitter #phdchat
Abcam
@abcam
Where do you stand on sharing unpublished data? Take our poll and join the discussion about #openscience 👇 👇
Let us know why in the comments.
#progresshappenstogether -
Abcam
@abcam
Calling all #cellcycle researchers. Don’t miss out our conference next week and connect with the cell cycle community to learn and exchange about the latest findings.
Register now: www.abcam.com/events/london-cell-cycle-club
@DeRobertus @Thorpelab @TheCrick #progresshappenstogether #phdchat -
Abcam
@abcam
Interested in #parkinsons or seeking inspiration for navigating life’s challenges? This podcast is for you! Six friends talk openly to give an honest – and even uplifting – view of life after diagnosis. Listen here: spoti.fi/3AwuGAu
#parkinsonsawarenessmonth @Podotpods -
Abcam
@abcam
Last chance to register:
#spatialbiology #progresshappenstogether #singapore @astar_research @ASTARsg
The Innovation | Medicine
@Innov_Medicine
This May, @abcam are in Singapore for two days of science and collaboration with ‘Spatial Biology: Translating basic research into clinical insights’ hosted with @mysgh, @dukenus, co-chaired by @JoeYeong
and Carlo Bifulco - click here to find out more and register! www.abcam.com/events/spatial-biology-translating-basic-re…
More details from: @JoeYeong's Linkdin: www.linkedin.com/feed/update/urn:li:activity:703253503033… -
Abcam reposted
Eric Topol
@EricTopol
When the evolutionary trees of generative #ai and #sarscov2 start to look alike ;-)
-
Abcam
@abcam
🔬 .@JeffRathmell tweeted 31 reasons why he loves his career in science.
What’s yours? Let us know in the comments 👇👇
@VUMC_VCI @vumchealth #progresshappenstogether #worklifebalance #teamworkmakesthedreamwork #mentoring #stem
www.nature.com/articles/d41586-023-01027-8 -
Abcam
@abcam
Join stimulating discussions from the #spatialbiology community! Thank you @JoeYeong (@mysgh @ASTARsg) and @carlobifulco (@ProvHealth) for pulling together such an exciting program: www.abcam.com/events/spatial-biology-translating-basic-re…
-
Abcam
@abcam
Join Prof Karim Labib from @UoDLifeSciences for the latest insights on the #cellcycle on May 9th. Share your data, discuss new ideas and foster new collaborations. Register now: www.abcam.com/events/london-cell-cycle-club
@DeRobertus @Thorpelab @TheCrick
#progresshappenstogether #phdlife #phdchat -
Abcam
@abcam
“This is the first time that there has been an identification of a biochemical assay that can predict the likelihood that somebody has Parkinson’s disease”
Great to see such huge progress in #parkinsonsresearch from our friends at @MichaelJFoxOrg ⬇️ www.statnews.com/2023/04/12/michael-j-fox-parkinsons-biom… -
Abcam
@abcam
Where do you stand on sharing unpublished data? Take our poll and join the discussion about #openscience 👇 👇
Let us know why in the comments.
#progresshappenstogether
Abcam
@abcam
Learn how the scientific community has pushed for more transparency with Prof. @memartone here: go.myabcam.com/maryann-martone-story
#progresshappenstogether #openscience -
Abcam
@abcam
Congratulations @LeicaBio on the recent #fdaclearance of your BOND MMR panel. It’s great to see our antibodies being used to support better patient diagnosis and treatment.
Read more:
➡️ www.leicabiosystems.com/en-gb/news-events/leica-biosystem…
➡️ www.leicabiosystems.com/en-gb/ihc-ish/ihc-primary-antibod…
#ihc #lynchsyndrome #ivd -
Abcam
@abcam
Great to bring home the ‘Antibody Supplier of the Year’ award! A big thank you to @CiteAb for presenting James, our VP of Growth Marketing, with our #citeabawards certificates at #aacr23.
#icymi, check out the details 👉 www.abcam.com/en-us
#recombinant #reproducibility -
Abcam
@abcam
Proud to be presenting at #aacr23 with our partners and colleagues at @Lunaphore about how to better characterize the tumor microenvironment – don’t miss our joint poster 👉 4616/6.
@AACR #cancerresearch #progresshappenstogether
www.abcam.com/events/american-association-for-cancer-rese…
Lunaphore (a Bio-Techne brand)
@lunaphore
Would you like to learn more about the research conducted with our partner @abcam? The study highlights how reagents can be used on COMET™ to study tissue biology without requiring lengthy customization processes. Fix the date of this poster presentation in your #aacr23 agenda!
-
Abcam
@abcam
#aacr23 - Excited to work alongside @AkoyaBio @MountSinaiNYC @EnableMedicine and contribute to their latest findings on therapy resistance in #bladdercancer. Learn more at poster 👉 5648/23
www.abcam.com/events/american-association-for-cancer-rese…
@AACR #cancerresearch #progresshappenstogether #aacr23
Akoya Biosciences
@AkoyaBio
📢 Visit #aacr23 Poster #5648 from 1:30-5 PM today in Sec 43 to learn how we developed a #spatialphenotyping app on PCF to analyze human #nmibc tissues w/ 57 protein biomarkers to study potential immune responses. www.akoyabio.com/wp-content/uploads/2023/04/Akoya-5648-AA…
@EnableMedicine @Abcam @MountSinaiNYC -
Abcam
@abcam
Ever been guilty of exaggerating what you can do in a collaboration? You’re not alone. But according to @MIT’s @LindaGGriffith1, it's what you do next that defines you as a collaborator. Listen ➡️ spoti.fi/3oghNrn
#progresshappenstogether @ScienceMagazine @MITCGR -
Abcam
@abcam
#aacr23 starts tomorrow! We're looking forward to connecting with scientists, collaborators, and partners to learn about their latest work and the life-changing breakthroughs of tomorrow.
www.abcam.com/events/american-association-for-cancer-rese…
@Akoya @Lunaphore @Visiopharm @EnableMedicine -
Abcam
@abcam
How can we move the needle in Parkinson’s research?
Nicole Polinksi and Elisia Clark at @MichaelJFoxOrg believe that to make progress, we as a community need to work together. Read their story 👉 go.myabcam.com/nicole-polinski-elisia-clark-story
#progresshappenstogether #parkinsonsawarenessmonth -
Abcam
@abcam
“Science won’t move forward unless views on data sharing do too”
Watch @memartone tell her story ➡️ go.myabcam.com/maryann-martone-story
#progresshappenstogether @UCSanDiego @PopUpMag -
Abcam
@abcam
We’re excited to announce a new agreement with @lunaphore to support the research community with tools for high-plex spatial proteomic analysis. Read the news here: www.abcam.com/en-us
$ABCM #spatialproteomics #multiplex -
Abcam
@abcam
What’s the latest in Parkinson’s research? Abcam’s Ally Hughes reflects on progress.
We’re proud to be working with @MichaelJFoxOrg to help researchers make discoveries that positively impact lives. More here 👉 go.myabcam.com/nicole-polinski-elisia-clark-story
#worldparkinsonsday #parkinsons -
Abcam
@abcam
If you are eager to showcase your work to the #spatialbiology community, don’t miss the #callforabstracts below 👇👇👇
www.abcam.com/events/spatial-biology-translating-basic-re…
@JoeYeong @carlobifulco @HSaterMD, @SizunJ, @AmirHorowitz, @BcellBruno, @CottrellLab, @aruthak, @JWilmott38, @Quan_Nguyen_UQ @adj_23 -
Abcam
@abcam
How do you truly open yourself up to new opportunities?
@doctorpoe reminds us that solutions sometimes come from unlikely places: go.myabcam.com/gina-poe-story
@UCLA_BRI @UCLASemel @UCLA @ESRS_Sleep @SfNtweets
#scicomms #careerdevelopment #progresshappenstogether #phdchat #phdlife -
Abcam
@abcam
How much should you disclose about your research results?
Find out more with @memartone: go.myabcam.com/maryann-martone-story
@UCSDnews @UCSanDiego @FORCE11rescomm @BioMedCentral @SciCrunch #openscience #progresshappenstogether @_open_science_ @PLOSBiology @PLOSONE @jbiolchem -
Abcam
@abcam
Attention #spatialbiology researchers! Don't miss out on the opportunity to share your science with @JoeYeong, @HSaterMD, @SizunJ, @AmirHorowitz, @BcellBruno, @adj_23 @CottrellLab, @aruthak, @JWilmott38, @Quan_Nguyen_UQ – submit your abstract now: www.abcam.com/events/spatial-biology-translating-basic-re…
-
Abcam
@abcam
Uniting 25 labs is an ambitious goal, but it's crucial to collaborate with other experts to drive impactful changes. Read Dr. @GiovannaRoncad1 ‘s story:
go.myabcam.com/giovanna-roncador-teamwork
@CNIOStopCancer @euromabnet #progresshappenstogether #cancerresearch #mabs #phdlife #collaboration -
Abcam
@abcam
.✍️ @GiovannaRoncad1 emphasized to @GuardianLabs what speeds up scientific progress in #cancerresearch and #mabs technology.
➡️ go.myabcam.com/giovanna-roncador-teamwork
@CNIOStopCancer
@euromabnet
#progresshappenstogether #phdlife #inspiration #leadership #collaboration -
Abcam
@abcam
Feeling the pressure to publish, get funding or secure a position? Neuroscientist @doctorpoe explains what fast-tracked her career to a tenure position.
go.myabcam.com/gina-poe-story
#progresshappenstogether #phdchat @UCLA_BRI @UCLASemel @UCLA @ESRS_Sleep @SfNtweets -
Abcam
@abcam
🇸🇪 Attending #adpd2023 in Gothenburg this week? Don’t miss poster 627 that explores innovative ways to identify #alzheimers disease subjects. 🧠
www.abcam.com/events/adpd
@adpdnet #progresshappenstogether #parkinsons #neuroscience #brainresearch -
Abcam
@abcam
We’re proud to receive this @CiteAb award. Thanks to the scientific community for trusting us for your research.
Read more: www.abcam.com/en-us
#progresshappenstogether #citeabawards #lifescience #research #reagents #awards #recombinant #kovalidation #reproducibility -
Abcam
@abcam
Are you looking for #careerdevelopment advice?? Take a page from @doctorpoe 's book!
As a junior professor, she learned the importance of building strong connections at any stage of a career.
youtu.be/OKtW0DXzOYc
@UCLA_BRI @UCLASemel @UCLA @ESRS_Sleep @SfNtweets -
Abcam
@abcam
If you are looking to turn your research into societal impact, you might learn a thing or two in this new #podcast with @GSK’s Director of academic liaison.
✍️ spoti.fi/3xNCigI
#colliderscope #progresshappenstogether #phdlife #postdoclife #phdchat #phdvoice #phdgenie -
Abcam
@abcam
No science should happen in a silo. Find out how Dr. @GiovannaRoncad1 brought together a network of labs to create better data sharing in antibody technology
➡️ go.myabcam.com/giovanna-roncador-teamwork
@CNIOStopCancer @euromabnet #progresshappenstogether #cancerresearch #mabs #phdlife -
Abcam
@abcam
Our 2022 financial year results are here:
corporate.abcam.com/wp-content/uploads/2023/03/Abcam-plc-…
$ABCM #progresshappenstogether #irchat #investorrelations #earningscall -
Abcam
@abcam
Learn the 🟢DOs and 🔴DONTs of academia-industry collaborations, directly from @GSK’s Director of Academic Liaison, Prof @MalcolmSkingle
#progresshappenstogether #colliderscope @ScienceMagazine @aaas
open.spotify.com/episode/5ZFgPjXeLttgLAzH6En1wU -
Abcam
@abcam
What are the biggest risks when forming cross-border, cross-cultural, or cross-disciplinary partnerships? Get expert insight from @GSK's Prof @MalcolmSkingle:
✍️ spoti.fi/3xNCigI
#progresshappenstogether #postdoclife #phdchat #newlab #phdgenie #academicchatter -
Abcam
@abcam
When walking away is for the best.
@GSK’s Prof Skingle gives his tips for building great collaborations.
Listen here: spoti.fi/3xNCigI
#colliderscope #progresshappenstogether #postdoc #postdoclife #phdchat #phdvoice #newlab #phdgenie #academicchatter #academictwitter -
Abcam
@abcam
As we celebrate the achievements and determination of all #womeninscience today, it’s great to see Sally Swift, Lab Manager, @ICR_London, share her career journey and work on the breakthrough discovery of #brca2 with @MetroUK.
Read it here 👉 metro.co.uk/2023/03/04/how-i-made-it-im-a-breast-cancer-l…
#iwd2023 -
Abcam
@abcam
How do the most successful industry-academia collaborations come about?
Find out with Director of academic liaison at @GSK, Prof @MalcolmSkingle in episode 3 of #colliderscope.
➡️ spoti.fi/3xNCigI
#progresshappenstogether #podcast #collaboration @ScienceMagazine @aaas -
Abcam
@abcam
Big congrats to our collaborators at @10xGenomics who also made it to the world’s Most Innovative Companies list! Great to see #spatialbiology represented.
www.fastcompany.com/90846833/most-innovative-companies-bi…
@FastCompany #fcmostinnovative #progresshappenstogether -
Abcam
@abcam
Join us online for an inspiring, thought-provoking, and insightful #cellcycle conversation with @KarleneCimprich @DeRobertus @Thorpelab, Snezhana Oliferenko, @lab_reyes, @HeinemannLab, @V_Gottifredi and many more
👉 register here: www.abcam.com/events/london-cell-cycle-club
#phdlife #phdchat -
Abcam
@abcam
Thrilled to be in Fast Company’s Top 10 world’s most innovative companies of 2023! Tribute to the amazing work our teams do to progress science. Thank you @FastCompany
www.fastcompany.com/90846833/most-innovative-companies-bi…
#fcmostinnovative #progresshappenstogether
@HeidiCreighton @asolache1 -
Abcam
@abcam
Attending #slas2023 this week? Don’t miss Paul, tomorrow, as he will be sharing insights about accelerating drug development from idea finding to IND filing (and beyond).
www.abcam.com/events/society-for-laboratory-automation-an…
#slas23 #labautomaton #progresshappenstogether @SLAS_Org -
Abcam
@abcam
Find out why these two researchers believe teamwork is our best chance to better understand #parkinsonsdisease.
👉 go.myabcam.com/nicole-polinski-elisia-clark-story
@MichaelJFoxOrg @GuardianLabs @guardian @GuardianUS #progresshappenstogether #parkinsons #womeninstem #neuroscience #brainscience -
Abcam
@abcam
Ever find that solutions are often discovered while doing something completely different? @doctorpoe found the missing piece of her research puzzle through a spontaneous friendship. Hear her story ➡️ go.myabcam.com/gina-poe-story
@UCLA_BRI @UCLASemel @ESRS_Sleep @SfNtweets @PopUpMag -
Abcam
@abcam
Taking drugs to the clinic? Meet us next week at #slas2023 to discuss how you can get there faster.
www.abcam.com/events/society-for-laboratory-automation-an…
#slas23 #labautomaton @SLAS_Org -
Abcam
@abcam
What if the tool you need doesn’t exist? Nicole Polinski and Elisia Clark researchers at @MichaelJFoxOrg connect scientists with research tools they need to better understand #parkinsonsdisease.
Hear their fascinating story 👉 go.myabcam.com/nicole-polinski-elisia-clark-story
@GuardianLabs @GuardianUS -
Abcam
@abcam
.@doctorpoe neuroscientist at @UCLA shared what mentoring means to her. Watch the video now: go.myabcam.com/gina-poe-story
#progresshappenstogether #teamwork #stem #diversitymatters #womeninstem #phdchat @UCLA_BRI @UCLASemel @ESRS_Sleep @SfNtweets @PopUpMag -
Abcam
@abcam
. @MichaelJFoxOrg’s Nicole Polinski and Elisia Clark share with us how they bring the scientific community together to progress #parkinsonsdisease research.
👉 go.myabcam.com/nicole-polinski-elisia-clark-story
@GuardianLabs @guardian @GuardianUS #progresshappenstogether #parkinsons #collaborations -
Abcam
@abcam
When chance meetings lead to unusual projects. Find out what happened when neurobiologist @OdedRechavi met biblical scholar, Noam Mizrahi, in the second episode of #colliderscope.
Listen here ➡️ spoti.fi/3I4mOeg
@of_sagol @TelAvivUni @ScienceMagazine @aaas -
Abcam
@abcam
Excited to see our collaborator at @mcgillu publish 2 new papers in @Nature that use single-cell mapping and #ai to reveal insights into disease progression in #brain and #lungcancer:
www.nature.com/articles/s41586-022-05672-3
www.nature.com/articles/s41586-022-05680-3
@DanielaQuail #glioblastoma #nsclc #imc -
Abcam
@abcam
Removing barriers to progress in #parkinsonsdisease research starts with creating the right tools. Read about two @MichaelJFoxOrg’s researchers who are making this happen. go.myabcam.com/nicole-polinski-elisia-clark-story
@GuardianLabs @guardian @GuardianUS #progresshappenstogether #parkinsons -
Abcam
@abcam
How could a conversation over a coffee lead to major breakthrough? Find out with @doctorpoe:
➡️ go.myabcam.com/gina-poe-story ⬅️
#progresshappenstogether #teamwork #stem #diversitymatters #womeninstem #phdchat @UCLA_BRI @UCLASemel @UCLA @ESRS_Sleep @SfNtweets @PopUpMag -
Abcam
@abcam
How do you make time to explore and connect with other researchers across different disciplines? Hear more: go.myabcam.com/gina-poe-story
@doctorpoe #progresshappenstogether #womeninstem #phdchat #researchlife #phdlife @UCLA_BRI @UCLASemel @UCLA @ESRS_Sleep @SfNtweets @PopUpMag -
Abcam
@abcam
What if we don’t have all the answers? Find out how @doctorpoe has learned to rely on her connections when she hits a dead end.
➡️ go.myabcam.com/gina-poe-story ⬅️
#progresshappenstogether #teamwork #womeninstem #phdchat @UCLA_BRI @UCLASemel @UCLA @ESRS_Sleep @SfNtweets @PopUpMag -
Abcam
@abcam
Have you voted yet for @CiteAb’s ‘Researchers’ Choice’ award? If we’ve made an impact on your research in the last year, show us your appreciation by voting for us before Feb 24.
www.citeab.com/awards/2023/researchers-choice
#citeabawards #citeabawards2023 -
Abcam
@abcam
What do you look for in a collaborator?
Hear more from @OdedRechavi
➡️ spoti.fi/3I4mOeg ⬅️
@of_sagol @TelAvivUni @ScienceMagazine @aaas
#progresshappenstogether #podcast #epigenetics #genetics #neuroscience #learning #memory #inspiration #leadership #collaboration -
Abcam
@abcam
To anyone doing translational research 👇👇👇
Milner Therapeutics Institute
@TheMilnerInst
Registration for #milnersymp23 is now live! Once again we'll welcome people live at @WestRoadCH and also online.
We've announced a fantastic lineup of plenary speakers... and more will be revealed in the coming weeks.
For more details and to register👇
www.milner.cam.ac.uk/milner-symposium-2023/ -
Abcam
@abcam
Calling out all #amr and #infectiousdiseases researchers to discuss best approaches to tackle Anti-Microbial Resistance. Present alongside @Lab_AmitSinghal @DKeo__ @NiranjanTW @tstinear @abhilashakarkey and many more.
Submit your abstract now www.abcam.com/events/multidisciplinary-approach-in-curtai… -
Abcam
@abcam
When the science community works together, great things happen. This is especially true for the nematode community, says @OdedRechavi.
Listen to the 2nd episode of #colliderscope ➡️ spoti.fi/3I4mOeg
@of_sagol @TelAvivUni @ScienceMagazine @aaas
#progresshappenstogether -
Abcam
@abcam
‘Other people get recognized. Great actors and authors. Yeah, why not scientists?’ - Sally Swift talks to @GlamourMagUK about how it feels to be celebrated for her work.
Read the article: www.glamourmagazine.co.uk/article/brca2-gene-sally-swift-…
@ICR_London #womeninscienceday #womeninstem #setinstone -
Abcam
@abcam
Thank you @doctorpoe for reminding us the importance of connections and friends that you can rely on at any stage of a career.
Hear more: go.myabcam.com/gina-poe-story
#womeninscienceday #progresshappenstogether #phdchat @UCLA_BRI @UCLASemel @UCLA @ESRS_Sleep @SfNtweets @WORK180_ -
Abcam
@abcam
How can we better work together to contain Anti-Microbial Resistance? Join experts from academia, the industry and the clinic for an exciting 2-day event co-organized with @idlabs_astar and chaired by @Lab_AmitSinghal. Register now: www.abcam.com/events/multidisciplinary-approach-in-curtai…
#amr #onehealth -
Abcam
@abcam
‘The discovery of BRCA2 was an incredibly important moment, and its impact continues to be felt decades later’ – read how abcam is commemorating this landmark discovery with @ICR_London in @MetroUK
#worldcancerday #progresshappenstogether #setinstone #brca2 @CRUKCamCentre -
Abcam
@abcam
What gets you out of bed each morning? Read what motivates @bjmarlin:
☞ go.myabcam.com/bianca-jones-marlin-story
@GuardianLabs @zuckermanbrain @guardian @GuardianUS #progresshappenstogether #neuroplasticity #trauma #neuroplasticity #motivation -
Abcam
@abcam
Have we had a positive impact on your research over the past year? If so, nominate us for @CiteAb’s ‘Researchers’ Choice’ award. Voting closes on Feb 24.
www.citeab.com/awards/2023/researchers-choice
#citeabawards #citeabawards2023 -
Abcam
@abcam
Is social media good for science? Find out more with @OdedRechavi in the 2nd episode of #colliderscope:
➡️ spoti.fi/3I4mOeg
@of_sagol @TelAvivUni @ScienceMagazine @aaas
#progresshappenstogether #podcast #epigenetics #genetics #neuroscience #learning #memory #inspiration -
Abcam
@abcam
Ever wondered why unusual collaborations often create inspiring work? Find out with @OdedRechavi, Professor at @of_sagol (and @Twitter legend) in the 2nd episode of #colliderscope. spoti.fi/3I4mOeg
@TelAvivUni @ScienceMagazine @aaas #progresshappenstogether #epigenetics -
Abcam
@abcam
Learn from @bjmarlin, a neuroscientist at @zuckermanbrain @ColumbiaPSYC, about how personal drivers give her work purpose.
go.myabcam.com/bianca-jones-marlin-story
@GuardianLabs @guardian @GuardianUS #progresshappenstogether #neuroplasticity #trauma #motivation -
Abcam
@abcam
It all started with a publication in 1995 – now it is a crucial genetic diagnostic for the most common cancer globally. Read about how 41 researchers transformed the field of cancer research: go.myabcam.com/setinstone
@ICR_London #progresshappenstogether #worldcancerday -
Abcam
@abcam
A great reminder of what’s possible when teams work together 🙌 Read more in @standardnews.
#worldcancerday #progresshappenstogether #setinstone #brca2
@CRUKCamCentre @ICR_London
Standard News
@standardnews
A team of 41 London scientists have been honored for their work in the landmark discovery of the BRCA2 breast cancer gene www.standard.co.uk/news/health/london-cancer-scientists-h…
-
Abcam
@abcam
Is there a link between ancestral stress and pregnancy-related deaths? @bjmarlin is collaborating with a chemical engineer to find the answer. Read more ➡️ go.myabcam.com/bianca-jones-marlin-story
@GuardianLabs @guardian @GuardianUS
#progresshappenstogether #trauma -
Abcam
@abcam
To anyone interested in #spatialbiology and characterization of cancer tissues, don't miss this poster from our collaborators at @AkoyaBio
#cancerresearch #progresshappenstogether
Akoya Biosciences
@AkoyaBio
Working w/ @abcam and @CedarsSinai, we developed a #spatialphenotyping application that permits the comprehensive characterization of human #glioblastoma Multiforme (GBM) tissues.
Download our poster to learn about our #gbm research: www.quanterix.com/events-conferences/
#tissuetuesday -
Abcam
@abcam
We agree with Sir Bruce Ponder. That’s why we’ve launched a new type of commemorative plaque to honour the team behind the #brca2 gene discovery.
Read more: go.myabcam.com/setinstone
@ICR_London #setinstone #progresshappenstogether #worldcancerday @CRUKCamCentre -
Abcam
@abcam
How is trauma passed on to future generations?
Find out more in @bjmarlin’s extraordinary story go.myabcam.com/bianca-jones-marlin-story
@GuardianLabs @ColumbiaPSYC @guardian @GuardianUS @zuckermanbrain
#progresshappenstogether #neuroscience #trauma #neuroplasticity -
Abcam
@abcam
LIVE NOW - Anyone interested in cancer research at @ICR_London, don't miss this @bbc5live show with @tonylivesey
BBC Radio 5 Live
@bbc5live
✨ @tonylivesey is live from @ICR_London today after the release of a special episode of #youmebigc.
🗣️ He'll be hearing from patients and staff inside the Institute, and celebrating those who work in researching new drugs, treatments and trials.
🎧 Listen @BBCSounds from 4PM. -
Abcam
@abcam
41 people, 1 breakthrough discovery. We’re celebrating the researchers that discovered #brca2 with commemorative plaques at the @ICR_London’s sites.
Read about it here: go.myabcam.com/setinstone
#setinstone #progresshappenstogether #worldcancerday #cancerresearch @davidkelsell -
Abcam
@abcam
#icymi we launched a new type of plaque today to honor the 41 scientists that identified the BRCA2 breast cancer gene. Because it’s rarely one person that makes a breakthrough happen.
Read more: go.myabcam.com/setinstone
@ICR_London #setinstone #progresshappenstogether -
Abcam
@abcam
Are breakthroughs the result of one or two geniuses only? Rarely. Today we’ve launched a new type of commemorative plaque to celebrate the power of teams for progressing science.
Read more: go.myabcam.com/setinstone
@ICR_London #setinstone #progresshappenstogether -
Abcam
@abcam
“Is it fun?” Hear some of the ways @DrShrutiNaik approaches collaborations: open.spotify.com/episode/5OzZbmckI4K1cZcIwRSQiS
@ScienceMagazine @aaas @nyugrossman @nyulangone
#progresshappenstogether #podcast #colliderscope #teamwork #leadership -
Abcam
@abcam
An insightful conversation between @ScienceMagazine’s Sean Sanders and @DrShrutiNaik about why the scientific community is better together. Listen here: ➡️ open.spotify.com/episode/5OzZbmckI4K1cZcIwRSQiS
#progresshappenstogether #podcast #colliderscope #inspiration @nyugrossman @nyulangone @aaas -
Abcam
@abcam
Building a professional network, but don't know where to start? Self-proclaimed extrovert @DrShrutiNaik shares her tips here:
🎧 Listen now open.spotify.com/episode/5OzZbmckI4K1cZcIwRSQiS
#progresshappenstogether #colliderscope #podcast @ScienceMagazine @aaas @nyugrossman @nyulangone -
Abcam
@abcam
Introducing a new podcast series in partnership with @ScienceMagazine!
Ex-stand-up comedian and Assistant Prof at @nyulangone, @DrShrutiNaik shares how personalities and the all-important ‘spark’ influence her science.
Listen ➡️ open.spotify.com/episode/5OzZbmckI4K1cZcIwRSQiS
#progresshappenstogether -
Abcam
@abcam
No discovery happens alone. Explore how the research community achieves amazing things when it comes together.
go.myabcam.com/together
#progresshappenstogether -
Abcam
@abcam
Hear from +20 world-renowned experts about the latest advances in #neuroscience and #immunology in our 8-part #virtual #conference! Explore topics and register here 👉 www.abcam.com/events/spotlight-on-neuroscience-immunology…
@nunoraimundo @UCoimbra_Rsrch @UniofNewcastle @MitoResearch @Lizasome @UnivdeCoimbra -
Abcam
@abcam
Great to see @ISSCR helping to improve reproducibility in stem cell work. 🙌
We’re very much looking forward to this free #webinar from #isscrdigital, which will outline recommendations for standardizing the validation of cell lines. Don’t miss it 👇
ISSCR
@ISSCR
Join our lineup of speakers next month for a free #isscrdigital #webinar highlighting recommended standards for human pluripotent & tissue stem cell research.
👀 Register for a first look at the standards document & ask questions before the release.
👉 www.isscr.org/upcoming-programs/standards-for-human-stem-… -
Abcam
@abcam
Not sure whether to go recombinant? Our very own Jayne Hammersley spoke with @biocompare about why the research community is opting more and more for recombinant antibodies. Read the article here:
www.biocompare.com/Editorial-Articles/584011-When-to-Use-…
#recombinantantibodies -
Abcam
@abcam
How can scientists work more closely with clinicians to reach better outcomes for infectious disease research?
@ravgup33_ravi gives his take 👇 Watch the full interview here: go.myabcam.com/ravi_gupta_interview -
Abcam
@abcam
#icymi - Beautiful artwork from @_hubmap on the front cover of @naturemethods back in March. Read the Hickey et al., perspective on multiplexed tissue imaging here: www.nature.com/nmeth/volumes/19/issues/3
@red_ven @NIH_CommonFund @StanfordPath @johnhickey22 @DrE_Neumann @NIAIDnews @StanfordMed -
Abcam
@abcam
How can we use our knowledge of existing viruses to tackle future pandemics?
We sat down with @ravgup33_ravi to hear about the parallels between HIV and SARS-CoV-2. Watch the interview here: go.myabcam.com/ravi_gupta_interview
#internationaldayofepidemicpreparedness @GuptaR_lab -
Abcam
@abcam
#icymi - Great to see @Roche taking our PRAME antibody beyond research use to become a key component in improved diagnostic tests for #melanoma, back in October. Incredibly rewarding to see our partners finding new ways to help patients and clinicians.
diagnostics.roche.com/global/en/news-listing/2022/roche-l… -
Abcam
@abcam
If you’re new on the biomedical research scene and aren’t sure how to go about choosing an antibody, this article in @GENbio featuring advice from Abcam’s own Simon Cooper could be helpful. Read the article here: www.genengnews.com/topics/translational-medicine/spoilt-f…
-
Abcam
@abcam
‘Can we really confer unique metabolic properties to T cells to boost their function in hostile environments?’
Hear @UPenn’s Dr. Roddy O'Connor discuss trending topics from at #immunometabolismconference2022 👇
#metabolism #cartcells #immunotherapy -
Abcam
@abcam
We are excited to continue evolving as a public company and start today sole trading on Nasdaq. Many thanks to AIM, our prior home since 2005.
otp.tools.investis.com/clients/uk/abcamplc2/rns/regulator… -
Abcam
@abcam
How can the latest understanding in immunometabolism be translated into novel therapies?
Dr Patrik Foerch, SVP Pre-Clinical Drug Discovery at UK #biotech #sitryx, shares his thoughts following #immunometabolismconference2022 👇
#metabolism #translationalresearch -
Abcam
@abcam
We are thrilled to further develop our collaboration with WuXiDiagnostics, to advance #companiondiagnostics for innovative #cancer therapies in China. Read the news here:
corporate.abcam.com/wuxi2022/
@WuXi_AppTec #cdx #precisionmedicine #immunotherapies #oncology #immunooncology -
Abcam
@abcam
‘’The field is moving beyond the interrogation of one particular target to understand the pathogenesis of a disease.’’
@JuleenRZierath shares her takeaways from #immunometabolismconference2022 👇
#immunometabolism @karolinskainst -
Abcam
@abcam
Thanks for your support @SfNtweets @SfN_Events ! We had an amazing time !!
@PopUpMag #sfn2022
Society for Neuroscience Events
@SfN_Events
What did you love at this year’s annual meeting?
We really enjoyed “Better Together” the live storytelling event brought by Abcam and Pop-up magazine. Follow @abcam for more stories that celebrate the impact of teams.
#sfn22 -
Abcam
@abcam
How do you map and visualize the 37 trillion cells of the human body at single-cell resolution?
Let’s find out during this unmissable event from our friends at @_hubmap @cnscenter @humancellatlas #katycns
humanatlas.io/events/2022-24h/ -
Abcam
@abcam
We loved Akoya’s poster at #sfn2022 on Monday which demonstrated that they can multiplex 40 biomarkers at once with spatial imaging. We're excited to work with @AkoyaBio to continue advancing #spatialbiology
-
Abcam
@abcam
A big thanks to @doctorpoe, @memartone, Molly @Radiolab, and @cordjefferson for sharing their inspiring, thought-provoking stories. And thank you to everyone that came along and made “Better Together” such a memorable experience.
#sfn2022 #sfn22 @SfNtweets @PopUpMag -
Abcam
@abcam
#sfn2022 is a great opportunity to catch up with allies in the #neuroscience community. If you’re here, we recommend going to see our friends @MichaelJFoxOrg at their poster board E9!
#parkinsons @SfNtweets -
Abcam
@abcam
One of our highlights at #sitc2022 was co-presenting on spatial phenotyping with our friends and collaborators at @AkoyaBio. Thank you to everyone who stopped by!
#multiplex #sitc22 @Pinkcigarette2 @sitcancer -
Abcam
@abcam
The results of our General Meeting, where we asked shareholders to vote on our delisting from AIM are now available. Find them here:
corporate.abcam.com/result-of-general-meeting-shareholder… -
Abcam
@abcam
We’re proud to be working together with @nanostringtech to support the #biomarker and clinical research communities with new tools to advance #spatialmultiomics research. Read the news here:
corporate.abcam.com/nanostring-and-abcam-expand-collabora…
$ABCM #oncology #cosmx -
Abcam reposted
Bruker Spatial Biology
@brukerspatial
Excited to announce collab with @abcam to advance #spatialmultiomics research! Inclusion of Abcam-validated antibodies in CosMx curated protein panels provides the 1st high-plex spatial multi-omic solution at #singlecell and subcellular resolution. investors.nanostring.com/news/news-details/2022/NanoStrin…
-
Abcam
@abcam
Great to kick off the #immunometabolism 2022 conference with Prof. @JuleenRZierath and her insights on the exercise-induced inflammatory response in people with Type 2 diabetes. Thank you for joining us in Boston!
@karolinskainst @vetenskapsakad -
Abcam
@abcam
A not-to-be-missed evening filled with inspiring stories for anyone going to #sfn2022 that weekend.
@SfNtweets
Pop-Up Magazine
@PopUpMag
San Diego friends: Pop-Up Magazine Productions is partnering with @abcam to produce a special evening of science and storytelling on 11/13. Learn more and get free tix: www.eventbrite.com/e/better-together-an-evening-of-scienc…
-
Abcam
@abcam
If you’re new on the biomedical research scene and aren’t sure how to go about choosing an antibody, this article in @GENbio featuring advice from Abcam’s own Simon Cooper could be helpful. Read the article here: www.genengnews.com/topics/translational-medicine/spoilt-f…
-
Abcam
@abcam
We love this Ab-solutely terrifying pumpkin lab replica from @DA_Academic 👏 👏 👏 Thanks for sharing!
Dustin Ammendolia
@DA_Academic
Shout out to @abcam for providing antibody containers that made fantastic lab benches for our pumpkin replica of our research institute! @SickKidsNews
-
Abcam
@abcam
Incredibly rewarding to see our partners finding new ways to help patients and clinicians. Great to see @Roche taking our PRAME antibody beyond research use to become a key component in improved diagnostic tests for #melanoma.
diagnostics.roche.com/global/en/news-listing/2022/roche-l… -
Abcam
@abcam
Webinar alert. Interested in actin and cell fusion? Don’t miss Prof. Sophie Martin’s talk at the digital “#cellcycle Conference” on Wednesday, Oct 5. Register now ⬇️⬇️
www.abcam.com/events/london-cell-cycle-club
@SophieMartinLab @unil @DeRobertus @Thorpelab -
Abcam
@abcam
What does the future hold for the AML research community? To mark the end of this year’s #bloodcancerawarenessmonth, we asked @PaoloGallipoli from @QMBCI to share his thoughts. Find out more and get insights on the epigenetic landscape of #aml, here: go.myabcam.com/epigenetic-landscape-of-aml
-
Abcam
@abcam
Today on #worldalzheimersday, we’re acknowledging the continuous and collaborative effort from the research community and celebrating recent progress. Find out more and hear how biomarkers are offering a promising avenue from @sudha_md, here: go.myabcam.com/world_alzheimers_day_2022 @UTHealthSA
-
Abcam
@abcam
Diverse teams produce more novel and influential ideas - a tremendous piece of work from @UzziLeadership and team who analyzed +6M papers in 45 different areas of medicine – read more: www.pnas.org/doi/full/10.1073/pnas.2200841119
#diversitymatters @Tanyaty8 @bfjo @KelloggSchool @NICOatNU @PNASNews -
Abcam
@abcam
A warm welcome from the Abcam community, @luba_greenwood. We are excited to have you join us in our journey to advance scientific breakthroughs.
otp.tools.investis.com/clients/uk/abcamplc2/rns/regulator… -
Abcam
@abcam
Anyone doing tissue-based research? Meet and talk with experts in digital pathology and advanced staining techniques at @LeicaBio’s Translational Research Summits 2022 – taking place this Sept in San Francisco (US), Boston (US) and Cambridge (UK). ⬇️⬇️
www.leicabiosystems.com/en-gb/life-sciences-and-research-… -
Abcam
@abcam
#cytokines: ultra-accurate cell signaling molecules involved in numerous human conditions from #cancer to #autoimmunity. But how do you accurately detect and measure their presence at ultralow concentrations? Find out more in this @Biocompare article:
www.biocompare.com/Editorial-Articles/588155-Detecting-an… -
Abcam
@abcam
Dele is passionate about helping you accomplish more. That’s why she’s dedicated to delivering tools that let you get more data and achieve outstanding results first time, every time. Discover more. www.abcam.com/content/quality-reagents-mean-faster-progress
-
Abcam
@abcam
Excited to hear your talk @JuleenRZierath. See you in Boston!
Juleen R. Zierath
@JuleenRZierath
Looking forward to participating in this upcoming meeting: Immunometabolism Fundamentals to Prospective New Therapies | Abcam
Check out program here 👇👇
Early registration deadline September 1! www.abcam.com/events/immunometabolism-fundamentals-to-pro… -
Abcam
@abcam
Early bird registration closes today! Don’t miss out on the discounted rate for the Immunometabolism: Fundamentals to Prospective New Therapies conference in #boston. Register below to join us there:
www.abcam.com/events/immunometabolism-fundamentals-to-pro… -
Abcam
@abcam
"Stop overthinking, let go of other people’s opinions, and enjoy the journey.” Karine Enesa, Abcam’s Director of Cell Engineering, shares the factors that have had the biggest impact on her career: work180.com/en-gb/blog/the-science-of-career-success
@WORK180_#endorsedemployerforwomen #work180uk -
Abcam
@abcam
By identifying a suite of high-quality reagents, our cancer experts helped a biotech advance to pre-clinical testing. Read our case study to find out more. www.abcam.com/content/quality-reagents-boost-biotech-success
-
Abcam
@abcam
Today is the last day of the @HelmholtzMunich Summer School. Thank you to all involved! If #cutntag and #cutnrun are your thing, don’t miss the recordings of Prof. Henikoff and @KamiAhmad3's sessions:
go.myabcam.com/summerschool_henikoff
go.myabcam.com/summerschool_ahmad
@robert_ife @METorresPadilla -
Abcam
@abcam
To empower the collection of more data, we developed a custom FirePlex® assay for a leading pharmaceutical company. Read our case study to see how we helped get the most from each sample. www.abcam.com/content/hts-multiplex-immunoassays-more-dat…
-
Abcam
@abcam
Like you, we’re passionate about quality. From increased efficiency in high-throughput screening to fast biomarker identification, see what our commitment to quality means for you. www.abcam.com/content/quality-reagents-mean-faster-progress
-
Abcam
@abcam
To help you accomplish more, we’re passionate about delivering tools that work time after time. From high-throughput multiplex assays to consistent antibodies, we’re dedicated to developing the highest quality solutions. Find out more here. www.abcam.com/content/quality-reagents-mean-faster-progress
-
Abcam
@abcam
Almost all known proteins now have a predicted 3D structure. Read about @DeepMind's latest achievement and the implications for vaccine and drug development in @ScienceMagazine: www.science.org/content/article/new-era-digital-biology-a…
#alphafold -
Abcam
@abcam
By identifying a suite of high-quality reagents, our cancer experts helped a biotech advance to pre-clinical testing. Read our case study to find out more. www.abcam.com/content/quality-reagents-boost-biotech-success
-
Abcam
@abcam
Our first summer school on #chromatin biology kicks off today: an exciting 12-day training packed with lectures from #epigenetics leaders, practical courses, knowledge-sharing, and networking. Many thanks, @METorresPadilla, @robert_ife, Aloys Schepers for hosting and organizing!
-
Abcam
@abcam
Congratulations to the teams at @KirOxford @InflamAge_UoB @BrighamResearch on this exciting publication. Great use of #scrna-seq and #celldive #multiplex tissue imaging to reveal two types of #fibroblasts shared across 4 chronic #inflammatory diseases. ➡️ www.cell.com/med/fulltext/S2666-6340(22)00184-2
-
Abcam
@abcam
⏰ Deadline approaching:
Join @laoneill111 and @evanna_mills and present at our upcoming #immunometabolism conference in #boston, Nov 7-8. Submit your abstract for a talk before Sept 1 – here 👇
www.abcam.com/events/immunometabolism-fundamentals-to-pro…
@DanaFarber @harvardmed @tcdbi -
Abcam
@abcam
We know that high-quality reagents speed up progress. That’s why we’re passionate about providing solutions that give accurate and reproducible results from the start. See how our dedication to quality boosts your research. www.abcam.com/content/quality-reagents-mean-faster-progress
-
Abcam
@abcam
Great to catch up with @PoulogiannisLab at the #cancer & #metabolism conference. #icymi, here is a digest prepared with one of the scientific organizers @OMaddocks tipbox.abcam.com/cancer-and-metabolism-2022/
@ICR_London @TheCrick @GottliebLab @LabVousden -
Abcam
@abcam
🏆 We’re proud to have been selected as a finalist for Best Innovation in Internal Recruitment at the #tiara2022 Talent Acquisition Awards, in recognition of our commitment to #internalmobility🏆
Thank you @TALiNT_Partners for the nomination, and congrats to all shortlisted! -
Abcam
@abcam
For anyone looking for summer reading inspiration, @MIT has curated a list of recommendations that spans the sciences, culture, technology, art, design, and the intersections in-between. Enjoy!
news.mit.edu/2022/books-mit-authors-0708
#sciencereads #stem #books -
Abcam
@abcam
Join us online on Tuesday July 26th for the @EpigeneticsClub Summer Symposium, when we’ll hear from Ana Boskovic and Anne Ferguson-Smith @BabrahamUK. Register now: www.abcam.com/events/cambridge-epigenetics-club-summer-sy…
-
Abcam
@abcam
We test our IHC antibodies on up to 100 tissue samples because we’re dedicated to delivering highly validated tools. See how we can partner with you to move your research to the next stage. www.abcam.com/content/quality-reagents-mean-faster-progress
-
Abcam
@abcam
We couldn’t be happier to end this 2022 edition of #cancer & #metabolism with a keynote from @EileenWhitePhD . Thank you so much. Here are her thoughts about the conference.
@rutgerscancer @TheCrick @GottliebLab @LabVousden @OMaddocks -
Abcam
@abcam
Kicking off today - our conference ‘#cancer and #metabolism 2022’ at @TheCrick. Thank you @GottliebLab @LabVousden @OMaddocks for helping to pull together such a great program!
-
Abcam
@abcam
We know pushing scientific boundaries can be challenging. Work with our experts to share knowledge and achieve outstanding results first time, every time. Learn more here. www.abcam.com/content/quality-reagents-mean-faster-progress
-
Abcam
@abcam
A very insightful conversation today at Abcam about the future of UK healthcare, with @wesstreeting @DanielZeichner @julie_hankin @NicolaAyton @RJG3062 @TracyDowling10 @RFitzgerald_lab @NHSFinanceTim @NickJSkinner1 @DrJSummersB Thank you for visiting us at our HQ! @CamBioCampus
-
Abcam
@abcam
Great article showing how everyone in life sciences can benefit from more diversity 🏳️🌈. #diversitymatters #pridemonth
@PrideinSTEM @DrCarpineti @proud_science @jaesloan @VertexPharma @ClaraMBaker
www.realstaffing.com/en-gb/blog/2022/06/the-smart-move-lg… -
Abcam
@abcam
Preparing for your first global #conference? Check out the #networking tips we shared in our #asco2022 digest: www.abcam.com/en-us
-
Abcam
@abcam
Reliable reagents mean faster progress. That’s why we’re passionate about quality. So we can accomplish more, together. www.abcam.com/primary-antibodies/we-can-accomplish-more-t…
-
Abcam
@abcam
🏳️🌈 Thank you @BAGLYinc @NewHavenPride @TransPonderNPO @volunteerqueer @TheKiteTrust for the work that you are doing all year round. You are making the world a more inclusive place. #westandwithpride for #pridemonth and every month 🏳️🌈
-
Abcam
@abcam
Can finding the right #biomarkers help us advance toward more equitable cancer care? Read about it in our #asco2022 digest. www.abcam.com/en-us
-
Abcam
@abcam
What a day at our HQ today! We received the @ourwavelength 2022 cohort. Excited to have been selected to share insights about business trends, industry challenges, high growth and help build #thefutureofbusiness. #leadership #leadershipdevelopment
-
Abcam
@abcam
Dear Prof Barré-Sinoussi, we very much agree with you about what makes great collaborations: www.youtube.com/watch?v=LEyj14Uz35s
@NobelPrize @institutpasteur @theNAMedicine @AcadSciences -
Abcam
@abcam
Throwback to #asco2022 with our very own Dr Subham Basu. Read his digest of this year’s edition with the latest #oncology breakthroughs, promising studies, and the biggest challenges for oncology clinicians and researchers. www.abcam.com/en-us
-
Abcam
@abcam
Science is fast-paced, demanding more data in less time. We test our IHC antibodies in up to 100 tissues, so you know it will work first time. Learn more about how we help accelerate your results.
www.abcam.com/content/were-a-little-bit-obsessed-with-the… -
Abcam
@abcam
Welcome to #abcam, Tommy! It is great to have you on board. We are looking forward to sharing our passion for life sciences with the finance community and the positive impact of our work on the sector and beyond!
corporate.abcam.com/vpir22/
#investorrelations #irchat #stockmarket -
Abcam
@abcam
How do you keep complex assays simple? We’ve partnered with @SelectScience to explore how to generate robust, reliable and scalable data from your assays. Broadcast: June, 28 - register here:
www.selectscience.net/webinars/antibody-to-assay-the-key-… -
Abcam
@abcam
Dele knows the importance of reliable products. It’s why she’s passionate about validation. We all are. Find out how we deliver the performance you need, first time, every time.
www.abcam.com/content/were-a-little-bit-obsessed-with-the… -
Abcam
@abcam
🏳️🌈 We wanted to share why #pridemonth is such a special moment for us at Abcam. For Christina, Elliot and Nissa, it is about building a more inclusive environment. Read more: go.myabcam.com/pride #standwithpride #takepride 🏳️🌈 @myGwork @WORK180_ @stonewalluk
-
Abcam
@abcam
🚨 Last chance to sign up: July 1! 🚨
World-renowned experts are regrouping to discuss the interplay between #cancer & #metabolism, in a conference chaired by @LabVousden @TheCrick, @GottliebLab @TechnionLive & @OMaddocks @UofGlasgow
www.abcam.com/events/cancer-and-metabolism-conference -
Abcam
@abcam
Before an IHC antibody earns a place in our catalog, we test it on up to 100 tissue samples, so you get a great result from the first attempt. Find out more about our obsession with validation.
www.abcam.com/content/were-a-little-bit-obsessed-with-the… -
Abcam
@abcam
We are excited to be able to connect with world-class researchers in Asia and work together to push the boundaries of science.
Thank you @AsiaBioSpectrum for this interview covering the recent opening of our hub in Singapore.
www.biospectrumasia.com/opinion/54/20473/it-is-abcams-goa… -
Abcam
@abcam
Seeing your name in big letters when award winners are announced is always a ✨special moment✨.
Thank you @TheFIRMrecruits for recognizing how we efficiently build world-class teams!
@Prospects #firmawards2022 @thefirmawards @eArcu
#growingwithabcam #weareabcam -
Abcam
@abcam
🏳️🌈 Standing with Pride means different things to different people. For Frances, John, Hannah and Nikki, #pridemonth is about self acceptance and mutual respect. Read more: go.myabcam.com/LP=3312 #standwithpride #diversitymatters #takepride 🏳️🌈
-
Abcam
@abcam
Stronger together? Yes, but how can you determine early on if this new collaborator will make or break the project? Carsten Lund Pedersen suggests a framework for success.
@NatureCareers @NaturePortfolio @CBScph
www.nature.com/articles/d41586-022-01323-9 -
Abcam
@abcam
First time in history: remission in every patient of small #rectalcancer trial, presented at @ASCO this week. Many congratulations to @AndreaCercek @ldiaz1971, & team for the unprecedented results
www.mskcc.org/news/rectal-cancer-disappears-after-experim…
@MSKCancerCenter @CYOC_MSK @MSK_DeptOfMed @LumishMelissa -
Abcam
@abcam
It was so exciting to be in-person at the @BIMSB_MDC this week with @GoCasteloBranco, @apombo1 and an epic speaker line-up! We enjoyed the lectures, networking & insights into #neuroepigenetics. Visit our hub to know what's next:
www.abcam.com/index.html?pageconfig=tradeshow -
Abcam
@abcam
🏳️🌈 We’ve asked our people why they stand with Pride. For Karen, Miguela, Danilo and Asher, it is about bringing your authentic self to work. Read what #pridemonth means to us here: go.myabcam.com/LP=3312 🏳️🌈
#standwithpride #diversitymatters #takepride -
Abcam
@abcam
Join @BiffiGiulia @CRUK_CI @CRUKCamPancCan @CRUKCamCentre , @lauradelongwood @JHUPath @hopkinskimmel , @CancerHacker @WhiteheadInst & @scotub @Harvard later today at our virtual conference on the earlier detection of #pancreaticcancer! Register here: us02web.zoom.us/webinar/register/7016546915014/WN_9gwpFMO…
-
Abcam reposted
Geraldine Zimmer-Bensch
@BenschZimmer
#epigeneticsinthenervoussystem meeting @abcam in Berlin! Super exciting science @Boyan84 @LabStricker @RTG_MeInBio and Daniele Canzio
-
Abcam
@abcam
Like Dele, we believe that what is worth doing is worth doing well. See how our obsession with validation helps drive innovation. www.abcam.com/content/were-a-little-bit-obsessed-with-the…
#kovalidation #reproducibility -
Abcam
@abcam
Great to catch up with @BristiBasu8 at #asco22 about the therapeutic potential of targeting #kras in gastrointestinal cancers. @CRUKCamCentre
This media couldn't be displayed. See it on the original post. -
Abcam reposted
Stuart Dickson
@StuartinTrosley
-
Abcam
@abcam
Could your lab routine be more green? Read our interview with @dorien_rsn and @AgataWitkowska from the #fmpgreeninitiative in Berlin to see how they inspired change in their lab. #worldenvironmentday #sustainablescience
tipbox.abcam.com/how-to-make-your-lab-greener-an-intervie…
@KristineOevel @Tania_lopezhdez -
Abcam
@abcam
Less than 5% of compounds make it out of high-throughput screening into preclinical testing. We’re on a mission to change that. Learn more about how we can help reduce your risk. www.abcam.com/content/we-reduce-risk-with-solutions-to-fi…
-
Abcam
@abcam
“Pride is about my child not feeling afraid to share who they are with their peers – this is why I stand with pride.” –
Nissa, Manufacturing Science, Cambridge, UK
🏳️🌈 Happy #pridemonth ! 🏳️🌈 -
Abcam
@abcam
Excited to be joined by Wendy Fantl @StanfordMed, James Brenton @CRUKCamCentre, @KatherineFuh @WUSTLmed & Ahmed Ahmed @MRC_WIMM later today as we unravel the challenges of overcoming ovarian cancer resistance. Register for free to join us!
us02web.zoom.us/webinar/register/2016479423849/WN_Bcyw3Jf… -
Abcam
@abcam
The beating heart of clinical oncology is due to regroup for 5 days in Chicago. Our teams are packing for #asco2022 & we're looking forward to hearing about the next life-changing advances in cancer treatment (including yours 👉 booth 4070)
www.abcam.com/events/american-society-of-clinical-oncolog…
#asco22 @ASCO -
Abcam
@abcam
Taking a project from ideation to completion is a complex journey. We are passionate about using our deep scientific expertise to help you succeed, fast. Find out more. www.abcam.com/content/we-work-with-you-to-help-you-succeed
-
Abcam
@abcam
Congratulations to our collaborators @Pionyrimmunotx for meeting the primary endpoints for #py314’s Phase 1a study. We are looking forward to seeing your presentation at #asco2022!
www.pionyrtx.com/view.cfm/82/press-release
@AliciaLevey @ASCO @AmitaPatnaikMD
#pembro #immunotherapy #trem2 -
Abcam
@abcam
Dele is passionate about quality in science - it’s why she’s a little bit obsessed with validation. We all are.
Read more: www.abcam.com/content/were-a-little-bit-obsessed-with-the…
#kovalidation #recombinant #reproducibility -
Abcam reposted
Foghorn Therapeutics
@foghorntx
On 5/26, don’t miss Foghorn Principal Scientist Richard Centore speaking on @abcam virtual panel around our core scientific approach centered on the chromatin regulatory system & how it can be applied to the development of potential treatments in #aml. us02web.zoom.us/webinar/register/5116527846898/WN_05k4my8…
-
Abcam
@abcam
Ahead of #wbcd, we’re excited to be joined by Brian Huntly @Cambridge_Haem @Cambridge_Uni and speakers from @uniklinik_hd @foghorntx @OhioState @uofcincy for a virtual conference on the #epigenetics of #acutemyeloidleukemia. Register for free to join! us02web.zoom.us/webinar/register/9216534714762/WN_05k4my8…
-
Abcam
@abcam
Is there anything more fascinating than nature breaking its own rules? In this video, researchers from @AcadSinica describe a new and unexpected kind of #celldivision that occurs without DNA replication: www.youtube.com/watch?v=fi3pGplAxy0
#cellbiology #zebrafish -
Abcam
@abcam
We are back @TheCrick for the Cell Cycle Conference featuring Keynote Julie Welburn from @EdinburghUni ! Register now to receive your live-stream link via email www.abcam.com/events/london-cell-cycle-club @Thorpelab @DeRobertus
-
Abcam
@abcam
1M+ cells across 33 organs – the @HumanCellAtlas announced a major milestone this month in its unprecedented cell mapping initiative. @StephenQuake tells @statnews how these maps impact researchers’ work. Read more: www.statnews.com/2022/05/12/human-cell-atlas-pioneer-stev…
-
Abcam
@abcam
Don’t let your reagents cause efficiency roadblocks in your high-throughput screening. Join Will Van Trump (@SpringDiscovery) and Delia Bucher (assay.works) as they discuss how they integrated FirePlex technology to support their discovery. www.abcam.com/kits/therapy-discovery-for-age-related-immu…
-
Abcam
@abcam
It was an honor today to receive 3 #exa22 awards🥇 🥈 🥉! So great to see teams coming together to create fulfilling work environments and companies raising the standards of #employeeexperience #talentdevelopment #diversityandinclusion @awardsinter #growingwithabcam #weareabcam
-
Abcam
@abcam
All #epigenetics aficionados are invited to join us on Monday at our hybrid forum featuring @rcollepardo from @Cambridge_Uni and @MAChristoLab from @BabrahamUK!
Register to join in-person or online.
www.abcam.com/events/cambridge-epigenetics-club
@EpigeneticsClub @hendersi @RuggGunnLab @rcollepardo -
Abcam
@abcam
There is still time to register! Join us on May 23 at @TheCrick in London (or online) to hear @dynamicMT from @WTcell presenting her work on dynamic remodeling of the microtubule cytoskeleton throughout #mitosis.
www.abcam.com/events/london-cell-cycle-club
@DeRobertus @Thorpelab #cellcycle -
Abcam
@abcam
#icymi: Our very own Jayne Hammersley spoke with @EmmaEasthope about why the research community is opting more and more for recombinant antibodies. Read the article here:
www.biocompare.com/Editorial-Articles/584011-When-to-Use-…
@Biocompare #recombinantantibodies -
Abcam
@abcam
When you partner with us, our dedicated team of scientific experts will help you overcome unexpected obstacles. Watch our webinar to see how we worked with Tiaki Therapeutics to support its translational biomarker program.
www.abcam.com/webinars/implementation-of-the-fireplex-mul… -
Abcam
@abcam
Share your research and connect with other scientists working on metabolic transformation in #cancer. Sign up for our Cancer & Metabolism Conference chaired by @LabVousden, @GottliebLab, and @OMaddocks before the standard deadline on May 20! www.abcam.com/events/cancer-and-metabolism-conference
-
Abcam
@abcam
Join us today as experts from around the globe present their work at the next InflammaZoom session, featuring Ana Belen Perez Oliva and
@fm1896 @DIB_UNIL
#inflammasome
www.abcam.com/webinars/inflammazoom-webinar-series -
Abcam
@abcam
Coming this May and June... our three-part #virtual #conference series on #oncology and #epigenetics! Explore topics and register for the sessions here: www.abcam.com/webinars/translational-and-therapeutic-adva…
#acutemyeloidleukemia #pancreaticcancer #ovariancancer -
Abcam
@abcam
Anyone at #aai2022? Don’t miss @Rebecca_Coll ’s #inflammasome talk about NLRP3 (May 8 at 3:45pm) and @Lo_Zanzi about the role of #interferon in #covid19 (May 10 at 8:00am) – Exciting weekend for all the immunology enthusiasts in #portland! @ImmunologyAAI
-
Abcam
@abcam
When time is critical, don't take any risks. Join Abcam’s Director of Multiplex, Dr Paul Wylie, as he reveals the unique benefits of FirePlex immunoassays, including their highly scalable automated format. www.abcam.com/kits/enabling-biomarker-discovery-and-scree…
#immunoassay #biomarker -
Abcam
@abcam
Attending AAI’s IMMUNOLOGY 2022? Stop by booth #629 to chat with Abcam experts and find the best resources for your #immunology research! #aai2022 www.abcam.com/events/american-association-of-immunologist…
-
Abcam
@abcam
Our Snr Director of Protein Development, Deborah Moore-Lai is having a blast at #pegs22 and enjoying talks from Amy Rosenburg @EpiVax and Roger Perlmutter @EikonTX @PEGSboston
This media couldn't be displayed. See it on the original post. -
Abcam
@abcam
Whether you’re just starting out on your career or looking for your next big challenge, find out how you can grow with Abcam on our new careers site: careers.abcam.com/us/en/growing-with-abcam #growingwithabcam #weareabcam
-
Abcam
@abcam
We are at #pegs22 right now, enjoying the welcome reception! Be sure to stop by and say hello at booth 1312! @PEGSboston
-
Abcam
@abcam
Attending #pegs22 next week? Don’t miss Deborah Moore-Lai’s presentation on bioactive proteins.
See you in Boston, we are at booth 1312! @PEGSBoston
www.abcam.com/events/pegs-boston-essential-protein-engine… -
Abcam
@abcam
#ourimpact2021 is Abcam’s second #sustainabilityreport to help protect what matters most to those who matter most to us. Follow our journey and discover initiatives we are committed to: corporate.abcam.com/sustainability/
#sdg #sustainability #environment #esg $ABCM #stockmarket #irchat -
Abcam
@abcam
.@MichaelJFoxOrg is moving mountains for researchers and for Parkinson’s patients – making critical reagents available globally for scientists. Learn how we are supporting their goal 👇 www.abcam.com/neuroscience/parkinsons-disease
#parkinsonsawarenessmonth -
Abcam
@abcam
We’re celebrating the opening of our new APAC hub in Singapore today, joined by friends, colleagues and collaborators from industry and academia. Exciting times! More here ➡️ corporate.abcam.com/apac/
-
Abcam
@abcam
We’re excited to open the doors of our new APAC hub in Singapore. Our new office will create closer connections and opportunities for collaboration with life science researchers across the region! ➡️ corporate.abcam.com/apac/
-
Abcam
@abcam
Is your project moving too slowly? We’ll work with you to find the optimal solution to achieve your goals, whether you need expert support or validated reagents. Click the link to learn more. www.abcam.com/content/we-work-with-you-to-help-you-succeed
-
Abcam
@abcam
Not sure whether to go recombinant? Our very own Jayne Hammersley spoke with @EmmaEasthope about why the research community is opting more and more for recombinant antibodies. Read the article here:
www.biocompare.com/Editorial-Articles/584011-When-to-Use-…
@Biocompare #recombinantantibodies -
Abcam
@abcam
Thinking of a big career change? We’ve been in @GlassdoorUK’s top 5 Best Places to Work two years in a row. Hear about life at Abcam from our people on our new careers site: careers.abcam.com/us/en/working-here #weareabcam
This media couldn't be displayed. See it on the original post. -
Abcam
@abcam
Looking to produce highly multiplexed images & reveal #spatialcontext? This perspective from our collaboration with @_hubmap offers essential guidance. Read it in @naturemethods: www.nature.com/articles/s41592-021-01316-y @johnhickey22 @DrE_Neumann @AndreaJRadtke @SinemKSaka1 @NIH_CommonFund
-
Abcam
@abcam
Today is our #finalcall for posters and to book standard rate tickets for the #epigenetics in the Nervous System Conference! Don't miss out - discover the program and book now on the website: www.abcam.com/events/epigenetics-in-the-nervous-system-co…
@apombo1 @MDC_Berlin @GoCasteloBranco @karolinskainst -
Abcam
@abcam
When you need to rely on your #highthroughputscreening reagents, rely on us.
Customizable products, scalable solutions, expert support. Why take the risk? www.abcam.com/content/we-reduce-risk-with-solutions-to-fi…
#biopharma #drugdiscovery #reducerisk -
Abcam
@abcam
Helping you find the right solution begins with understanding your challenges. We’ll work with you to provide the support and reagents you need from discovery to clinic. www.abcam.com/content/we-work-with-you-to-help-you-succeed
-
Abcam
@abcam
Great to have collaborated with @AkoyaBio on this comprehensive account of the spatial biology in different human #cancer tissues. See a teaser of the poster 3877 / 22 presented at #aacr22 today: www.abcam.com/events/american-association-for-cancer-rese… #singlecell #spatialphenotyping
-
Abcam
@abcam
Today at #aacr22, we’re looking forward to seeing @nanostringtech demonstrate the power of simultaneous #singlecell and subcellular protein detection for characterizing immune cell composition and infiltration of the tumor niche. Check out poster 3878 / 23 www.abcam.com/events/american-association-for-cancer-rese…
-
Abcam
@abcam
Exciting technology for all the #spatialbiology researchers at #aacr22! Tomorrow, @10xGenomics are demonstrating how RNA and protein expression can be simultaneously analyzed on the same FFPE section! Hear a teaser of the poster 3814 / 14 from @TheBioCed:
www.abcam.com/events/american-association-for-cancer-rese… -
Abcam
@abcam
If you want a career where you can make a difference – whether you’re a scientist, digital guru, business pro or finance mastermind – visit our new careers site to find more: careers.abcam.com/us/en
-
Abcam
@abcam
Happy faces at #aacr22 today! Thank you @CiteAb for presenting us with our certificates from this year’s #citeabawards. ICYMI 👉 www.abcam.com/en-us #recombinant #kovalidation #reproducibility
-
Abcam
@abcam
Get a taster below of our partner @nanostringtech’s poster being presenting today at #aacr22 - go to poster 2029 / 7 between 1:30-5pm to learn more www.abcam.com/events/american-association-for-cancer-rese…
-
Abcam
@abcam
We’ve been working with @MichaelJFoxOrg to remove barriers to progress in Parkinson’s research by generating antibodies to key targets. Watch the video to hear from Prof Dario Alessi @mrcpp @UoDLifeSciences on the impact the right research tools can make.
#worldparkinsonsdayThis media couldn't be displayed. See it on the original post.
Abcam
@abcam
Find out more: www.abcam.com/neuroscience/parkinsons-disease
-
Abcam
@abcam
We are excited to be here at #aacr22 connecting with scientists working in #oncology! Visit us at booth #1008 to learn how our customizable, reproducible solutions can help you reduce your risk or check out the following resources: www.abcam.com/events/american-association-for-cancer-rese… #cancer
-
Abcam
@abcam
Good news - we’ve extended the #callforabstracts deadline to April 11! Register now and submit yours to be considered for the #epigenetics in the Nervous System #conference
@apombo1 @GoCasteloBranco @MDC_Berlin @BIMSB_MDC @LabPombo @karolinskainst
www.abcam.com/events/epigenetics-in-the-nervous-system-co… -
Abcam
@abcam
A great example of a global effort towards a common goal – @ImmunoAtlas is a portal for sharing and referencing #multiplexihc images and results for #immunooncology. We’re proud to be a part of this important project!
immunoatlas.org/ABCM/220216-1/ABCM22001/
@JoeYeong @astar_research -
Abcam
@abcam
To help reduce risk in your #highthroughputscreening both today and in the future, we use extensive validation and recombinant techniques to deliver unrivaled #reproducibility. #drugdiscovery #biopharma #recombinant #kovalidation
www.abcam.com/content/we-reduce-risk-with-solutions-to-fi… -
Abcam
@abcam
#icymi, last month @YCharOS1 received $4M from @GenomeQuebec to support its efforts to advance antibody characterization and enable researchers to better evaluate reagents. Bravo from all of us to all of you! @mcgillu @TheNeuro_MNI @GenomeCanada www.mcgill.ca/neuro/channels/news/open-science-antibody-c…
-
Abcam
@abcam
Today we released our “Annual Report and Accounts” for the 18 months ended 31 December 2021 – find out more here: corporate.abcam.com/investors/reports-presentations/year-…
#stockmarket #investors #investorrelations #irchat $ABCM -
Abcam
@abcam
Join discussions with experts from around the globe at our upcoming #webinar series on translational and therapeutic advances in #oncology and #epigenetics!
www.abcam.com/webinars/translational-and-therapeutic-adva…
#immuno-oncology #ovariancancer #pancreaticcancer #cancer #aml -
Abcam
@abcam
We are excited to take our courses to the next level with this first hands-on training on #chromatin biology.
@METorresPadilla, @robert_ife and Aloys Schepers have prepared a stellar program and we can't wait to see you in Munich. Deadline: 14 Apr www.abcam.com/events/summer-school-on-chromatin-biology-a… -
Abcam
@abcam
🏳️⚧️What a beautiful day to celebrate the trans and non-binary people at Abcam + in the life sciences sector, and to launch our transitioning at work policy. Happy #transdayofvisibility🏳️⚧️
#tdov #diversityinstem #diversitymatters #diversityandinclusion -
Abcam
@abcam
An event not to be missed!
Pionyr Immunotherapeutics
@Pionyrimmunotx
We are excited to have @AliciaLevey and Nadine Jahchan participating on the panel discussion alongside @abcam and @Merck sharing the challenges along the drug discovery and development journey.. Join us in New Orleans on Friday, 8 April! ter.li/i1kywc
-
Abcam
@abcam
Why do some patients develop metastases while others don’t? We have been hooked on this recent study that demonstrates the role of solute carrier protein MFSD1 in preventing cancer cells from migrating. www.frontiersin.org/articles/10.3389/fonc.2022.777634/full
@ISTAustria @UZH_en @kieluni @frontiersin #metastases -
Abcam
@abcam
We are very excited to meet again in-person with #toxicology scientists at the #2022sot. Let’s discuss what disruptive research you are doing and where we can help – see you at booth 1620!
www.abcam.com/events/sot-tox-expo-virtual-event-march-2021
@SOToxicology -
Abcam
@abcam
Join us on Monday as experts from around the globe present their work at the next InflammaZoom session featuring @mogaidt’s work on ‘Novel mechanisms of pathogen sensing by the innate immune system’
www.abcam.com/webinars/inflammazoom-webinar-series
#inflammasome -
Abcam
@abcam
#icymi – Abcam was the most awarded company at 2022 #citeabawards! Read more:
corporate.abcam.com/citeab22/
#lifescience #research #reagents #awards #recombinant #kovalidation #antibodies #reproducibility -
Abcam
@abcam
Beautiful artwork from colleagues from @_hubmap on the front cover of @naturemethods. Great to see the Hickey et al., perspective on multiplexed tissue imaging: www.nature.com/nmeth/volumes/19/issues/3
@red_ven @NIH_CommonFund @StanfordPath @johnhickey22 @DrE_Neumann @NIAIDnews @StanfordMed -
Abcam
@abcam
Congratulations @GiovannaRoncad1 for your @CiteAb’s award for Significant Individual Impact! For your efforts and contributions to the field of antibody development and impact on #cancerresearch – we salute you 🙌. @CNIOStopCancer
www.citeab.com/awards/2022/award-for-significant-individu… -
Abcam
@abcam
Consistency, specificity, sensitivity and flexibility: the benefits of Abcam’s #recombinant monoclonal antibodies for ELISA assays:
www.abcam.com/kits/matched-antibody-pair-kits-for-elisa -
Abcam
@abcam
#epigenetics in the Nervous System has gone hybrid! Engage with the in-person speaking and networking opportunities, or experience the #conference talks remotely – register now
www.abcam.com/events/epigenetics-in-the-nervous-system-co…
@GoCasteloBranco @karolinskainst @apombo1 @MDC_Berlin @BIMSB_MDC @LabPombo -
Abcam
@abcam
Throughout your program, we work with you to deliver comprehensive solutions that meet your needs. Explore how we have worked with leading biotechnology companies to help them succeed.
www.abcam.com/content/we-work-with-you-to-help-you-succeed
#biopharma #antibodytherapies #drugdiscovery #drugdevelopment -
Abcam
@abcam
We can’t think of a better way to start the week than receiving 6 #citeabawards! Thank you to @CiteAb and to all the scientists who trust us to help advance their research. You’re the reason we do what we do 👊
www.citeab.com/awards
#recombinant #kovalidation #reproducibility -
Abcam
@abcam
We can’t wait to hear Charlie Evavold @Synth_Immune and Ivan Zanoni @Lo_Zanzi talking about #innateimmunity and #inflammasome biology at the next InflammaZoom live #webinar on Monday at 2 pm GMT. Register now:
us02web.zoom.us/webinar/register/4516312833931/WN_KrEQ-Hj…
@BostonChildrens @harvardmed @ragoninstitute -
Abcam
@abcam
Thank you to the inspiring life sciences researchers who trust us to advance their research and make breakthroughs that can benefit all.
Thank you @CiteAb for the report:
blog.citeab.com/who-are-the-leading-research-antibody-mar…
#reproduciblescience #reproducibility #stem #science -
Abcam
@abcam
An insightful blog piece from @CiteAb on the inspiring @asolache1 and her efforts to raise the industry standards to address the #reproducibility crisis. #reproduciblescience #recombinant #kovalidation
CiteAb
@CiteAb
What does it take to make a significant impact in your sector? We take a look at the efforts of @Abcam's @asolache1 in improving reproducibility: blog.citeab.com/making-a-significant-impact-dr-alejandra-…
-
Abcam
@abcam
Congratulations @asolache1 on your award for ‘Significant Individual Impact’ from @CiteAb. This award recognizes and celebrates Alejandra’s invaluable contribution to the life science reagents industry. Full details: www.citeab.com/awards/2021/award-for-significant-individu…
-
Abcam
@abcam
Great work, Michael Weiner 🙌 Our VP of Molecular Sciences has won the @CiteAb Lifetime Achievement award. Find out more here www.abcam.com/index.html?pageconfig=resource&rid=17009







































































































































































































































































































































































































































































































































































































































































































































































































